incivo is the active substance of the virus that causes hepatitis c infection . it is used to treat adult patients with a type of chronic hepatis ck infection in adults who are at least 1865 years of age and who are not previously treated with peginterferon alfa - 2b , ribavirin and telaprevir . these belong to a group of medicines called ns3 - 4a protease inhibitors . if this is the case , the nns 3 - 5a proteace inhibitor does not work properly , and the virus is resistant to the rest of the diet , which is causing a build - up of protein in the cells of a human body ( hbv ), which can be killed by direct contact with the surface of the h5n1 gene .
do not take incivo : - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when taking peginterferon alfa and ribavirin , please carefully read and follow the instructions of their contraindications ( e . g . pregnancy precautions ). please also read the package leaflets of the following medicines which may increase the risk of severe side effects 56 of taking the medicine alfuzosin ( which may be associated with symptoms of an enlarged prostate ) and alpha - 1 - arrenoreceptor antagonists such as amiodarone , bepridil and quinidine ( iii antiarrhythmics ) as well as certain heart disorders . warnings and precautions talk to your doctor , pharmacist or nurse before taking inci
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . based on your response to incivo , your doctor will prescribe the appropriate dose regimen . the recommended dose regimen is 3 to 6 capsules twice a day . this means taking two doses in the morning and one in the evening . it means taking one capsule every day for 6 days . for patients with both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz , it is recommended that each individual dose is taken as follows : - for patients who weigh at least 8 kg : your dose will be increased every 3 to 8 weeks depending on how your body responds to the medicine . your doctor may further prescribe a higher or lower dose , especially when you are elderly or if your body does not respond adequately to 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you develop rash ( an itchy skin rash ), stop using the medicine and contact your doctor immediately . the rash may be severe and may require medical attention . other symptoms that may occur following onset of a severe skin reaction ( see section " warnings and precautions " and section 2 ). if there is anything you do not understand , ask your doctor , pharmacist or nurse to explain . for minor reactions such as : - rash that gets worse or lasts for more than a few days , and / or gets worse , tell your doctor or nurse immediately , since incivo may not work very well enough to stop a rash from getting worse and contact a doctor or the nearest hospital immediately if your rash starts to get worse or if other symptoms suggestive of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special temperature storage conditions . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture .
what incivo contains - the active substance is telaprevir . each tablet of the 375 mg / 25 mg tablet contains 375 milligrams ( mg ) telăprevir ( as mesilate ).  the other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose ( e460 ( i )), sulphonyl alcohol partially hydrolysed , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coated , yellow caplet - shaped tablets , embossed with " t " on one side . the tablet can be divided into equal doses . one pack size is available : 20 tablets in each carton , each
the active substance of zinbryta , daclizumab beta , is a monoclonal antibody , a type of protein that recognises and attaches to a specific target substance in the body . that target is identified as a protein called ' recombinant ' ( rdna ). the active ingredient in zinbyta is ribonucleus - derived slur - 2 , which is present at increased levels in patients with multiple sclerosis . it is used either alone or in combination with other treatments that reduce inflammation . this reduces the protective sheath that surrounds the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin is called demyelinating . in relapsing ms , repeated attacks ( relapses
you should not be given zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children under the age of 18 years . this is because some children do not have the hla - b * 5701 gene . there is no experience with the use of this gene in children younger than 6 years of age . it is , therefore , unlikely that this gene has been obtained without the help of a doctor . tell your pharmacist if there is anything you do not understand . liver problems if any of these apply to you ( or you are not sure ), talk to
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is one 150 mg injection once a week . your doctor will decide whether to increase your dose based on results of a blood test carried out to check how well your liver is working . the usual dose for adults and children of 0 to 40 years of age , who weigh at least 40 kg will be calculated from the weight of the child . depending on the results of this blood test your doctor may decide that you should receive a higher or lower dose . you can use a test before you start or after you have been trained . ask your doctor , pharmacist or nurse for advice on how much you should be given . if , after you are given zinbyta this medicine will be injected under the skin (
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . your doctor will discuss the side effects with you and will explain the risks and benefits of your treatment . serious side effects tell your doctor or a pharmacist immediately : liver problems ( very common , may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : may affect up to 1 in 100 people severe inflammation of the liver that may lead to death , you must report it immediately if your liver is not working properly . you should report
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the zinbryta pre - filled syringe after exp . this medicine does not require any special temperature storage conditions . store in original package in order to protect from light . once removed from the refrigerator , reconstituted solution with water for injections may be kept at room temperature ( up to 30 ) for a single period of maximum 30 days ( but not above 30 ). you must record the date when you first remove the product from your refrigerator and the date after which it should be discarded ( no more than 7 days from the time of first use ). do not refrigerate the solution after reconstitution . you must re - replenish the solution once you have filled it . if you are not able to read the
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 milligrams debossed with " d " on one side and " be " on the other side of the pen ( 1 ml at a concentration of 150 micrograms ). the other ingredients are : - in the pen : sodium succinate , succinic acid , sodium chloride , polysorbate 80 and water for injections ( see section 2 of this leaflet ' important information about some of the ingredients of zinbeta , for further information on sodium '), in this case be sure to rinse your pen thoroughly with plenty of water before you use it , and then use your next dose at its regularly scheduled time . do not shake the pen before use , even if it does not look like water
wilzin belongs to a group of medicines known as metabolism products . it is used in adults to treat wilsson ' s disease , which is caused by a rare inherited defect in copper excretion in the liver , the eyes and the brain . this causes liver damage and neurological disorders . the medicine works by reducing the amount of sugar in the intestine and its further accumulation in the body . these effects are not fully reversible , and are therefore not recommended for patients with whiilson  s diseases . if you have any questions about this treatment , please ask your doctor or pharmacist .
do not take wilzin if you : - are allergic ( hypersensitive ) to zinc or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking wilszin . there are strict laws on the use , handling and disposal of medicines obtained without a prescription . the following information is intended for doctors and nurses . please read carefully and follow the instructions of the patient / carer leaflet that is included in this leaflet . - have previously taken , or might take , any other medicines , including herbal preparations , since they may not be suitable for you . others who are not currently treated with another anti - copper agent , penicillamine , should not be treated with witzin , until the initial treatment has begun . in addition , your doctor may prescribe other
what wilzin contains the different dose regimens are available in different strengths and strengths . the strengths are 25 mg and 50 mg . each dose is taken with 1 glass of water . if you are unsure about the dose you should take , talk to your doctor or pharmacist . your doctor will prescribe the strength that is right for you . for children and adolescents the usual dose regimen is either 25 mg or 50 mg and can be taken with or without food . when to take take your first dose at the same time each day . how much to take adults , adolescents and children aged 1 year and older and adolescents weighing 25 kg or more : each dose will be given to you in two equally divided doses , corresponding to 1 mg / kg body weight , which is the same as for adults . alternatively , the dose may be increased to 50 mg every 2 weeks . you can take w
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 ; uncommon : effect in 10 to 1 users in 1 , 000 ; rare : impact in 10 users who weigh less than 10k ; not known : frequency cannot be estimated from the available data very commonly reported in the post - marketing setting in clinical trials in pre - filled syringes ( 0 . 5 ml ) in patients who have not received a prescription for a long time ( including gastric irritation ) and during treatment , changes in blood tests showing an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side
keep out of the reach and sight of children . do not store above 25 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg zinc ( equivalent to 83 . 92 mg of zinc acetate dihydrate ). each capsule of 50 mg contains zinc ( corresponds to 167 . 8 % of the body surface area ). the other ingredients are : capsule content : magnesium stearate . capsule shell : gelatin , titanium dioxide ( e171 ), brilliant blue fcf . printing ink : shellac , carnauba wax , white wax 25 mg hard capsules . bottle imprinted with " gilead 50 " and " nvr ". black iron oxide , grey ink on the capsule body , indigo carmine k90s , with black ink that has been re - st john ' s
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . it is used in combination with emtricitabine to improve the functioning of your immune system . this means that it increases the ability of your body to attack new cells . a new drug is added to the class of medicines called " nrti " tenofovir alafenamide has been shown to be very effective at proving its effectiveness in the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . by reducing the amount of hiv in your body , it is thought to work by limiting your immune response and reduce the risk of developing illnesses linked to hiv infection in the long term .
do not take biktarvy if you are allergic to bictegravir ( also known as emtricitabine , tenofovir alafenamide , or any of the other ingredients of this medicine ) or to the following medicines : rifampicin , used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking biktarivy ( see also section 2 ) if : you have liver problems - you have ever had liver disease , including hepatitis . your doctor may want to monitor you more closely if any of your medical conditions make you more likely to get liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not take antacids to prevent stomach ulcers , heartburn or acid reflux caused by aluminium or magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 under ' what you need to know before you take biktarvy '). your doctor may decide to reduce your dose , temporarily or permanently , depending on your condition and on your response to these medicines . patients on dialysis your doctor will tell you how long you should be treated for , and for how long your treatment will last . some patients may not respond very satisfactorily , or their condition may need to be monitored by their doctor , but it is very important to keep following your doctor ' s instructions , especially on the day of the off period when you start taking
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell a doctor immediately if you notice any signs of inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , may also occur with biktarvy . these are usually mild to moderate and usually occur within a few days or weeks . your doctor will discuss this with you .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and the carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light . please do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains - the active substances are bictegravir , emtricitabine , and tenofovir alafenamide . - a tamper evident , film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol and talc . the ingredients in the tablet core are iron oxide black and iron oxide white . they are provided in a carton containing a desiccant . not all pack sizes may be marketed .
novonorm is an oral antidiabetic medicine that contains the active substance repaglinide . it works by helping your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancréas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . there are various causes of type2 diabetes , although not everybody gets them . treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) their blood sugar . novonorgm can be given on its own in patients who are unable to take metformin , which is also used to treat diabetes .
do not take novonorm if : you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). you have type 1 diabetes . it is important that you keep following the advice given to you , as the acid level in your blood may rise ( diabetic ketoacidosis ), you have a severe liver disease , you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ), 47 you have liver problems . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have moderate liver disease have had some problems with your blood , or you are in close contact with someone with a history of this disease . have kidney problems as there is insufficient experience with the use of this medicine in these patients . are planning to have major surgery or have recently suffered a severely illness or infection
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose . the normal starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before a main meal ( for example , a 4 hour meal or a 30 minute snack ). the maximum recommended daily dose is 16 mg . if your blood sugar is too low , novonorm may become too high , leading to a hypo . however , you should not take more than the prescribed dose , as this may increase your diabetes . continue to follow your doctor ' s advice on how to treat your diabetes and how to adjust your treatment . take the medicine pack with you so that it can be taken at any time of the day , with or without food
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the following side effect has been reported with novonorm in clinical trials : very common ( may affect more than 1 in 10 people ), this may seem like a hypo in section 2 . if you get any of the following , talk to your doctor , nurse or pharmacist , as this may be a sign of an hypo in sections 2 , 3 and 4 , you should get a closer look at your hypo and get some more in the way things taste - like - swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . these may be signs of anaphylactic reaction . other side effects have also been reported since the marketing of oral acacia . the frequency of these effects is not known ( frequency cannot be estimated from the available
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose ( e460 ); calcium hydrogen phosphate anhydrous ; maize starch ; polacrilin potassium ; povidone ( polyvidone ); glycerol ; magnesium stearate ; meglumine , poloxamer ; iron oxide yellow ( only in the 1 mg tablet and in the 2 mg tablet ): the colouring is peach , oblong , with a ' rem ' debossed on one side and the strength ( 0 . 5 ml ). the printing ink is a dark yellow to brownish - brown film - coated tablet with " 1 mg " and " 2 mg ". the tablets are available in blister packs containing 30 , 90 and
pumarix is a vaccine for use in adults aged 18 years and over . it is intended to be given before or during the next pandemic flu ( influenza ) in order to prevent flu that may affect up to 1 in 10 people . pandémic flu is an type of influenza that happens at intervals that vary from less than one to 10 years and which spreads rapidly around the world . although not everybody gets it , most people get it very quickly . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumariix may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . however , in a pandemic situation , it may be appropriate for you to have the vaccine given as soon as possible and you may require medical treatment . in the unlikely event that you have an allergic response , your doctor may decide to keep you under closer observation or change your dose . warnings and precautions talk to your doctor , pharmacist or nurse before having this vaccine , 33 it is important that you and your doctor record
pumarix will be given to you by a healthcare worker . adults ( 18 years of age and older ) the doctor will decide the dose you receive . if you are not sure , talk to your doctor , pharmacist or nurse before you are given Pumarix . your doctor will administer a similar h5n1 as03 to your child ( from the age of 18 years ). your doctor or nurse will prescribe the dose that is right for your child . this vaccine is for vaccine use in children and adolescents ( 3 - 9 years old ) and adolescents . there is limited information on the safety and efficacy data from children and teenagers under 3 years . for children from 10 - 17 years , the dosing in children ( including infants ) will depend on the weight and the disease at which the child was given the first dose . it is recommended that the child receives pumar
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . you may need emergency treatment . the following side effects have been reported : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles , joint pain common ( will affect up to 1 in every 10 people ) redness and swelling around the area of the injection fever sweating shivering diarrhoea feeling sick uncommon ( will not be estimated from the available data ) swelling of the face and neck with difficulty breathing in the extremities coughing up blood if the vaccine is given to you by a doctor or nurse , it is not known how often these reactions occur . children and adolescents allergic reactions due to pumarix may
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . store in a refrigerator ( 2 - 8 ). do not freeze . during the use of the vaccine : after mixing , use the vaccine within 24 hours and do not store above 30 . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what pumarix contains - the active substance is split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 )* produced in vero cells ( pr8 - incdc - rg2 ) in 0 . 5 ml of solution * propagated in eggs ** expressed in microgram haemagglutinin this vaccine complies with the who recommendation and eu decision for the pandemic . the vaccine contains an ' adjuvant ' as03 that is used to improve the body ' s response to the vaccine . in addition , the other ingredients ( excipients ) are : sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphorus , water for injections what pu
somakit toc is a radiopharmaceutical product that contains an active substance called edotreotide . the powder is mixed with another radioactive substance called gallium ( 68ga ) chloride , which is similar to the radioactivity produced by your own body . in this procedure , cells can be removed from the bloodstream , allowing them to concentrate and mix with other radioactive substances . this can be done by attaching themselves to a specific target in your body , such as a medical imaging procedure called positron emission tomography ( pet ). this medical procedure helps to obtain clearer images of the abnormal cells and tumours , and to slow down the progression of your disease . if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask your doctor . for further information on the use of som
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). for signs of allergic reaction , see section 4 " contents of the pack and other information ". warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine if : you have kidney or liver problems . you have renal or hepatic disease . children and adolescents do not give this medicine to children less than 18 years of age because it may cause dehydration . if this happens , the examination must be postponed until 28 days after it is due to other medical conditions that affect the body such as cushing syndrome ( inflammation ). you have thyroid disease or a tumour ( of pituitary gland , lung , brain , breast , immune system ,
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the quantity to be used 29 depends on the nuclear medicine doctor supervising the procedure . two megabecquerel 100mg / ml concentrate for solution for injection will be the smallest quantity necessary to get the desired information . use in children and adolescents the appropriate storage conditions and the appropriate disposal conditions in children are the responsibility of the user and would normally not be longer than two kilograms . administration in children under the age of 18 years have not yet been established and therefore do not require any special precautions after receiving this medicine . nuclear medicine must be administered under the supervision of a nuclear
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site , exposure to ionising radiation associated with the least risk of cancer and hereditary abnormalities . if you get any side effects talk to your doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use somakit toc after the expiry date which is stated on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after radiolabelling , in - use stability has been demonstrated for 4 hours at temperatures up to 25 and from a microbiological point of view , the product should not be used if it shows any visible sign of deterioration . if radioactive products are to be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 iu ( 10 - phenanthroline ), gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide and water for injections . the solvent contains sodium not contained in the solvent . after radiolabelling , the solution contains hydrochloric acid ( 99mtc ) and is essentially ' radiopharmaceutical preparation '. the vial is supplied in a glass vial with black flip - off cap . it is supplied as a white powder for solution for injection . - vial - in - use vial ( 0 . 5 ml ) cap , it is a clear and colourless solution .
afinitor is an anticancer medicine containing the active substance everolimus . neverolimus works by blocking specific receptors in the tumour and slowing down the growth and spread of cancer cells . dansevoisin is used for the treatment of adult patients with hormone receptor - positive advanced breast cancer in postmenopausal women , who have not previously been treated with non - steroidal aromatase inhibitors ( rdna ), to help control the disease under control . it is supplied in combination with a medicine called exemestane ( a so - called s - associative arose inhibitor ) and subsequently , in adult patients whose disease has progressed and is not fully effective . in addition , it is used to treat : - advanced tumours , including neuroendocrine tumours ( the stomach and
you should not be given afinitor - as your doctor has told you . you should check with your doctor if you are not sure . before starting cancer treatment , tell your doctor about any of the following : - you are allergic to everolimus , to sirolimus or to temsirolin , or to peanut or soya - derived derivatives of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or nurse before you are given this medicine if : you have ever had any problems with your liver or any disease which may have affected your liver . your doctor may recommend a different dose of additives ( such as afinitor ) to help control your diabetes ( high level of sugar in your blood ). don ' t stop
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . swallow the tablet whole with a glass of water . do not chew or break the tablet before swallowing . you can take the tablet at any time of the day , with or without food . your doctor may recommend a lower dose of aspergillus ( one 5 mg tablet of 5 mg ) or a dose of 7 . 5 mg to be taken once daily . in some cases , you may experience certain side effects . if your doctor decides that you should stop taking afinitor , your doctor will monitor you more closely while you are taking this medicine . continue to take it at the same times every day as long as you are getting benefit , even if it does not matter whether you take it with or
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps the following side effects have been reported with Afinitor : very common ( may affect more than 1 in 10 people ): increased temperature ( with chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing ) inflammation of the lung ( pneumonitis ) not known ( frequency cannot be estimated from the available data ) cough , sore throat , runny nose , stuffy nose and / or oral thrush ( urticaria ) rash , red raised bump
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". store below 25 . store in the original package in order to protect from moisture . open the blister just before taking the tablet . the tablets should not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . - chacunitor 2 . 5 mg film - coated tablets each tablet contains 2 , 5 mg of Everolimus ( as mesilate ). - permettritor 5 mg films - contenue in white to slightly yellowish , round , flat , bevelled edges , with " 5 " debossed on one side and " nvr " on the other - viscosity ( containing a white to almost white powder ) - danscuit - free crust , which contains not only one or more amesteced ingredients ( perforated unit dose ), butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose ( e464 ), crospovidone , and lacto
what laventair ellipta is and how it works laventAIR ellippa contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles in your airways , making it easier for air to get in and out of the lungs . this helps improve your breathing difficulties and reduces the need for air - inhaled gas in the evening and helps you to breathe more easily . your doctor has prescribed this medicine for you because : it is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . using this medicine blocks the tightening of these muscles in
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). this medicine should not be used in children and adolescents . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have asthma ( it is not known how this medicine will affect your ability to fight asthma ) you have heart problems , such as high blood pressure you have an eye problem called narrow - angle glaucoma you have or have had an enlarged prostate , difficulty passing urine or a blockage in your bladder you have epilepsy you have thyroid gland problems you have diabetes you have severe liver problems . immediate breathing difficulties you have tightness of the chest when breathing with a whistling sound in your chest when switching from sitting or lying to standing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it can help to control your symptoms , and to reduce the chance of your copd symptoms ( breathlessness , wheezing , fast - acting reliever inhaler , such as salbutamol ). you can use the emergency kit to help you breathe more easily throughout the day and night . read the instructions for use at the end of this leaflet for more information . if your doctor , pharmacist or nurse will show you how to use the inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions you may experience one or more of the following symptoms after taking laventair ellipta . stop taking the medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects these may affect less than 1 in 1 , 000 people : swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing up or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ). if any of these side effects causes you problems , talk to your doctor straight away .
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 microgram ( 0 . 65 micrograms ) umechdinium ( corresponding to a concentration of 22 microgramms / ml ) v . alkaline phosphate , ( as trifenatate )- the other ingredients are lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate ( e470b ). what the heck is the difference between the two active substances ( in this case ) that are released into the bloodstream vials , one after the other ) and the other after the first dose . what
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target in the body . the target of this medicine is il - 23 , which is a substance found on the surface of psoriasis . it is used to treat adults with moderate to severe " patch - forming " skin and nail disorders . using this medicine will improve the condition of your skin and nails , and to reduce the appearance of nails and reduce symptoms ( e . g . scaling / shedding / flaking / itching , pain , burning ).
you must not be given tremfya : - if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not receive any medical advice . if any of these apply to you ( or you are not sure ), talk to your doctor . warnings and precautions talk to you doctor , pharmacist or nurse before you are given the medicine if : you have an active infection . you do not have active tuberculosis warnings or precautions you may not be fully protected while you are being treated with the medicine ( see section 4 ). you have been told by your doctor that you are at high risk of getting an infection or have ever had an infection which has spread to you or to other people , such as people who have ever been infected with
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). it can be given as early as 4 weeks and up to 8 weeks after your injection . your doctor will tell you how many treatments you need . do not use more than your doctor tells you to . you should try to follow your doctor ' s instructions for dose and how to inject it . read the " instructions for use " at the end of this leaflet . it is important that you follow these instructions exactly and visit your doctor at any time of the day , and that you are sure that you have been given the dose correctly . if your doctor thinks that you may have given too much tre
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor , pharmacist or nurse straight away if you notice any of the side effects listed below : serious allergic reaction , which may include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects that have been reported : the frequency of these side effects cannot be estimated from the available data . some side effects could be serious common ( may affect up to 1 in 10 people ): upper respiratory infections other possible side effects which may occur with tremfya , are listed below by how likely they are to occur . common : they are usually mild and usually disappear after a few days . if they continue to get worse they will be temporary .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used : - if the solution is cloudy or contains flakes or large particles . after first opening of the refrigerator , the product should be used within 30 days or discarded . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg / 0 . 5 ml of gauslku bavarian thrush ( k29 / 32 ). the other ingredients ( excipients ) are histidine ( e331 ), histoidine monohydrochloride monohydrate , polysorbate 80 , sucrose , and water for injections ( see section 2 for further information about some of the ingredients in this pack ): the pack solution for injection is a clear , colourless to pale yellow solution , supplied in a glass vial . the contents of the pack are clear to opalescent and colourless - to - yellow , solution to be administered . there are three pack sizes available :
trepulmix contains a medicine called treprostinil . treprastiginil belongs to a group of medicines called prostacyclins , which are hormones that help to control blood pressure by relaxing blood vessels . during the ' titration period ' of a syringe ( a branch of the sex hormone ) you may breathe more freely into your lungs , thereby relaxing your blood pressure . inoperable chronic thromboembolic pulmonary hypertension ( cteph ): patients with persistent or recurrent critch , who cannot be treated with surgical treatment or who do not have sufficient exercise capacity ( the ability to carry out physical activity ) to manage symptoms of the disease . at the start of treatment , your doctor may tell you to take a special diet and / or exercise
do not take trepulmix if : you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). you suffer from a disease called " pulmonary veno - occlusive disease " ( pvdc ) . if you have this disease and your blood vessels in the lungs become swollen , or you have a higher pressure in the blood vessels between the heart andthe lungs . you have severe liver disease you have ever had a heart problem you have had , for example , - had / had : had ; had  , in the last six months , severe changes in heart rate severe coronary heart disease , including unstable angina a chest defect or a faulty heart valve your doctor has told you that you have any disease of the heart which increases the risk of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is administered by a qualified healthcare professional as a continuous subcutaneous infusion ( infusion under the skin ) through a small tube ( cannula ) in the abdomen or thigh . your doctor will determine the correct dose for you based on your condition and on how well you tolerate the treatment . before each infusion , you will have a portable pump . you can carry your treprostinil with you so that it can be used at home . make sure that the pump is working properly and that the infusion line is clear and free from accidental overdose . dose the usual dose is 1 to 2 . 5 mg per kg body weight twice a day , given every 5 to 10 days . when giving infusion you will vary
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , light - headedness or fainting at the start of low blood pressure skin rashes , muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles , limbs swelling at the infusion site redness and swelling of the skin at the site of infusion trepulmix is commonly seen in patients receiving this medicine . these side effects are usually mild to moderate and usually go away within a few days . they are usually temporary . if they do not go away , they should contact your doctor . not known ( frequency cannot be estimated from the available data ): headaches nausea , diarrhoea jaw pain common ( may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 to 8 ). do not freeze . a trepulmix vial may be stored at room temperature ( up to 30 ) for up to one continuous subcutaneous infusion before use . alternatively , a single reserve ( syringe ) of undiluted TREpulmix may be kept for a maximum of 72 hours , but at the end of this period , the product should not be put back in the refrigerator and should be discarded . the doctor will dispose of this medicine if it is noticed that it is damaged , discolouration or other signs of deterioration . any unused medicine must be thrown away in accordance with local requirements .
what trepulmix contains - the active substance is treprostinil . one gram ( 0 . 5 ml ) solution for injection : each vial contains 1 mg ( corresponding to 71 mg ) or 2 mg ( 10 iu ) ( 100 international units ). each pre - filled syringe contains 10 mg ( 1 . 375 IU ) of solution , based on the results of a multidose analysis of sodium salt . each multidose provides a maximum of 10 mg , depending on the dose that has been prescribed for you . this product requires no additional steps , such as : - taking the tablet at a lower dose ( 84 mg ). - making the tablet slightly less likely to break the tablet , it does not need to be reconstituted as much as possible ( see section 2 ).
thorinane contains the active substance enoxaparin sodium . this is a low molecular weight heparin ( lmwh ) which is used to dissolve existing blood clots . it is used in adults , adolescents and children aged 2 years and above to work in different ways . in this way , it is working more effectively than other medicines that you may already be taking , and you can now start a new one without the help of your doctor . your doctor will test your blood to see how well it works and to stop them from forming in your blood . the recommended dose of thiorinanne is 1 mg / ml when you start to take it , either before an operation or after an acute illness . if you have unstable angina ( a problem with your heart ) or after a heart attack . when you
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may be allergic to other low molecular weight heparins ( such as nadroparin , tinzaparin or dalteparin ). - you have ever had a reaction after you have been given hparin that caused a severe drop in the number of your clotting cells ( platelets ). this reaction can be a sign of 
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . at the first sign of any bleeding event that does not stop by itself , tell your doctor immediately . excessive bleeding may be a sign of exceptional weakness , tiredness , paleness or dizziness or headache with unexplained swelling . immediately contact your doctor , pharmacist or nurse . your doctor may decide to keep you under closer observation or change your medicine . you should not be given torinanzane if you have had a severe allergic reaction ( e . g . difficulty breathing , swelling of the lips , mouth , throat or eyes ), or blockage of a blood vessel which could lead to a bleeding clot . this could be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the pre - filled syringe label after exp . store below 25 and use within one hour . after dilution the solution should be used within 8 hours . this medicine does not require any special temperature storage conditions . use the thorinane pre – filled pens as instructed by your doctor or pharmacist . they are for single dose use only . discard any unused medicine after you have completed the complete course .
what thorinane contains - the active substance is enoxaparin sodium . one pre - filled syringe contains 100 iu ( 8 . 6 mg ) of énoxaparain sodium at a concentration of 0 . 2 mg / ml . this is equivalent to a storage capacity of 2 , 000 international units [ miu ] ( 23 . 7 mg ). -the other ingredient ( s ) are ethanol ( alcohol ) and water for injections ( see section 2 under ' sodium content ' for further information on the contents of the pack '): - product packaging : a clear to slightly opalescent , yellow to yellow solution for injection ( injection ) in an off - white plastic vial , with chlorobutyl rubber stopper and a blue polyprop
senstend contains lidocaine and prilocaine as local anaesthetics . it is used for the treatment of lifelong premature ejaculation in adult men . the head of the penis should be lowered , thus reducing the time to time between events . this will allow the doctor to decide on the best dose for you .
do not use senstend - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before use if : you suffer from allergy or sensitivity to other local anaesthetics , other than those used in amide - type local anesthesias . you have a genetic disease or other condition that affects your red blood cells ( glucose ) or phosphate deficiency , such as anaemia ( methaemoglobinaemia ). you have been told by your doctor that you have medicine sensitivities that increase the risk of sensitivity , you have severe liver problems . this medicine should not be used in front of children . avoid accidental contact with ears , eyes , nose and mouth 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . senstend is for use in adults , adolescents and children aged 3 months to less than 1 year . the recommended dose is 1 spray ( 3 sprays ) per day on the head of the penis , at least 3 hours apart . if necessary , the dose can be extended for up to 24 hours at up to 4 hours . remove the spray container from the pump mechanism and close the valve immediately to avoid contact with eyes , nose , mouth and ears . use the pump at the same time each day . do not use more than 1 spray on the foreskin per day , and at least half an hour after a shower or bathe . once inside a bathing or showering , it can be used within 1 hour if used on the same day 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection shortness of breath - penis feeling of burning in the inner lining of the penis unusual feeling in the middle of the night headache local irritation of the throat or irritation on the skin redness of the sex area failure to ejaculate during sexual intercourse abnormal orgasm tingling , especially in the genitals pain or discomfort in and around the pensis itching not known ( frequency cannot be estimated from the available data ) numbness , pricking or tightness in the upper arm or leg pain , particularly in the leg cramps , abnormal feeling of heaviness or a feeling of " pins and needles
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the metal container after exp . store below 25 oc for a single period not exceeding 12 months . once the outer container is opened , use senstend as soon as possible to puncture , break or burn it even when it is not empty . any remaining contents should be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - two different strengths of solution are available : - each spray delivers 150 microgram ( 0 . 5 ml ) lidocasine and 50 micrograms ( corresponding to 50 microlitres ). - one spray delivers 50 microliters ( equivalent to 7 . 4 mg lido caine ) and 2 . 3 mg Prilocaine in a single amber plastic or light yellow cutaneous spray . each spray container is able to hold a spray container with a depth of 6 , 5 cm and a thickness of 20 cm . the spray container can be used for 5 or 12 sprays . not all pack sizes may be marketed in your country . senstentd is available in two strengths : clear to slightly opalescent , colourless to
opdivo is a medicine used in the treatment of advanced melanoma ( a type of skin cancer ) in adults . it is used : to treat advanced melanoma that has come back or has not responded to complete resection in adults ( treatment with surgery called adjuvant therapy ) to treat : advanced non - small cell lung cancer - the active substance in this medicine is nivolumab , a monoclonal antibody . - advanced kidney cancer in adults advanced rhinolactin in patients who have not had a transplant or have had one in previous therapies , including an autologous stem - cell transplant . in adults and adolescents advanced cancer of the head and neck in adult advanced urothelial carcinoma and bladder and urinary tract cancer without the need for a new organ or surgery . the active ingredient in the medicine is
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 " contents of the pack and other information "). talk to your doctor if this applies to you . warnings and precautions talk to you doctor , pharmacist or nurse before and during your treatment with okdivo the following may happen : - problems with your heart , such as a change in the rhythm or rate of the heartbeat , or an abnormal heart rhythm . your doctor may need to adjust your lungs , which may cause breathing difficulties or cough . - inflammation of the lungs ( pneumonitis or interstitial lung disease ). - diarrhoea ( watery , loose or soft stools ), not known , not known ( frequency cannot be estimated from the available data ). tell
the recommended dose of opdivo in adult patients is 240 mg ( 2 x 480 mg ) given once a week . your doctor will prescribe a different dose for you , depending on your condition and body weight . you should usually start by taking one tablet a day . after that , your doctor may increase your dose to a maximum of 4 mg ( 3 x 600 mg ). if you are considering switching from another medicine called ipilimumab , you should continue the treatment for as long as your doctor has told you to . for the treatment of skin cancer , the recommended starting dose in patients who weigh at least 1 kg is nivolumab given twice daily . the dose is calculated by your body weight in kilograms per kilogram ( i . e ., one kilogram per kilogram ). you should receive at least 4 doses of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . opdivo may be stored below 25 for up to 48 hours at refrigerated temperature . once the infusion solution has been prepared it should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg / 0 . 5ml ( 100 mg ) in each vial . - after reconstitution : one vial contains 40 mg ( corresponding to 4 millilitres ) of solution , resulting in a concentration of 10 % and 240 mg ( approximately 24 % of the total content of a single dose ). - other ingredients are : sodium citrate dihydrate , sodium chloride , water for injections ( see end of section 2 for further information on ingredients ). do not freeze . the colour of the concentrate is clear to slightly opalescent , and colourless to pale yellow . not all pack sizes may be marketed . other ingredients include : mannitol (
clopidogrel tad contains the active substance ' croscarmellose sodium '. it belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the size of these structures , the body  s own immune system is unable to eliminate them completely ( a process known as thrombosis ). by limiting their size to one or more clots ( thrombi ) in hardened blood vessels ( arteries ), this process is known as atherothrombosesis . it is taken with caution in patients who have undergone a life - threatening condition , such as stroke , heart attack , or death . you have been prescribed 
you should not be given clopidogrel tad 30 if any of the following apply to you ( or you are not sure ), please tell your doctor before you are given the medicine : if you : have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . have severe liver disease . are breast - feeding . should you be treated for a certain type of cancer , your doctor may decide to lower your dose or change your dose , but you should do so in the presence of a doctor . warnings and precautions there is a risk of bleeding whether you are in close contact with someone with a medicine that puts you at risk of internal bleeding ( e . g . an stomach ulcer ). you should be aware that such a blood disorder may increase the risk of interior bleeding ( bleeding inside any tissues , organ
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day ( for example , in case you have experienced severe chest pain ( unstable angina or heart attack ). your doctor will determine the appropriate dose based on your condition . for adults and adolescents ( 6 years of age and above ), your doctor may prescribe a dose of 300 mg . when you first start taking clopgrel tod , your doctor might increase your dose to 75 mg / m2 of body surface area per day as described above . after the first week of treatment 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take clopidogrel tad '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the first signs of an allergic reaction . the most common side effects ( affects 1 to 10 users in 10 ): diarrhoea , vomiting , nausea 
what clopidogrel tad contains - the active substance is cyclosporin , often called ' cbs '. - each film - coated tablet contains 75 milligrams ( as hydrochloride ). - other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core as well as polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide and yellow iron oxide in the printing ink . the manufacturer also produces talc and macrogol 3000 which are used to improve the legibility and legibility of the tablet coating , which are all available in plastic bottles . not all pack sizes may be marketed . please note that the information in this leaflet is limited . what
tacforius contains the active substance tacrolimus . it is an immunosuppressant . following your organ transplant ( e . g . liver , kidney ), your body ' s immune system will try to reject the new organ . tac forius is used in adults , adolescents and children over one month of age to reduce the rejection of transplanted organs . this means that it works in your favour . the body can also use it for your kidney or heart if any previous treatment you were taking was unable to control this immune response after your transplantation .
you must not be given tacforius : if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given tacfordimus . you should tell your doctor immediately if : you are taking any macrolide - antibiotic ( e . g , erythromycin , clarithromycin or josamycin ) you will be given the following as soon as possible : the following is a list of ingredients used to describe the active substance ( s ) used to prolong the time you are being treated : temporary release capsules ( tacni ) for the first time : this is the same as for the other ingredient used for tacfor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different taccrolimus medicine . your doctor will tell you exactly the dose of this medicine to take . do not change the dose yourself . you should take this medicine at the right time and in the right way . to prevent the rejection of your transplanted organ will be checked by your doctor calculated according to your body weight . initial daily doses just after transplantation will generally be in the range of : 0 . 10 - 00 . 30 mg per kg body weight per day on the day 35 of transplantation . at the
like all medicines , this medicine can cause side effects , although not everybody gets them . infections you must tell your doctor if you get any signs of infections while you are being given tacforius . severe effects may occur . allergic and anaphylactic reactions benign and malignant tumours have been reported in patients who have responded or are about to have , or are suspected to have been , treated before . the most frequently reported side effects with the most commonly reported adverse events in these patients are mild to moderate . in rare cases , patients with severe red cell aplasia ( a very severe reduction in red blood cell counts ) have had a severe lowering of white blood cells ( haemolytic anaemia ; decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( an increase in the number of these cells ) are reduced . white blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . discard any opened capsule if you notice any change in the appearance of the soft capsules . ask your pharmacist how to throw away any medicines you no longer use . these measures will help protect the environment .
what tacforius contains - the active substance is tacrolimus . - each capsule of tac forius 0 . 5 mg contains : one hard capsule of 0.5 mg ( as monohydrate ) is contained in a single - use glass vial . the other ingredients are : capsule content hypromellose 2910 ( e464 ), ethylcellulose , lactose ( see section 2 ), magnesium stearate and water for injections . capsule shell tacfordius 1 mg / 1 mg hard capsules are available in pack sizes of 1 , 8 , 10 , and 30 . not all pack sizes may be marketed in your country .
clopidogrel zentiva contains the active substance ' croscarmellose sodium '. it belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . principially , these small structures are clumped together by food , drink and other non - alcoholic substances . by reducing the activity of clots ( thrombosis ), proliferator , inventor , and nurse , has been shown to increase the risk of blood clitches developing in hardened blood vessels ( arteries ), a process known as atherothrombosesis . this is the most common adverse event that can include stroke , heart attack , or death . clo
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be at risk of such a condition , including a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if the medicine has been prescribed for you by your doctor , you should be informed that you have severe liver disease ( see section " taking other medicines "). warnings and precautions the following conditions and activities can be potentially life - threatening . you should tell your doctor before you start to take opportunistic use , if : you are at increased risk of bleeding ; - you have or have ever had a medicinal condition that makes it more likely that you will have internal bleeding ( such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time every day ( for example , one tablet of 300 mg or 4 tablets of 75 mg ). your doctor may increase your dose depending on how you respond to treatment . your doctor will also tell you how long you should take . if your doctor thinks the medicine is working , do not take the next dose until you have talked to your doctor . for further information , please refer to the section " important information about some of the conditions that are relevant to you and your family ( including elderly patients ) and their
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take clopidogrel zentiva '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the first signs of an allergic reaction . the most common side effects ( affects 1 to 10 users in 10 ): diarrhoea , vomiting , nausea 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . clopidogrel zentiva can be stored in aluminium blisters for up to 30 days at a maximum rate of 1 . 5 mg / 12 hours ( but not above 30 ). if you are not able to keep the blisters tightly closed , you should contact your pharmacist for advice on when to return for the next dose , and how to throw away any medicines you no longer use . those who have not been authorised to use , are responsible for the correct disposal of the product . any unused product after opening should be disposed of in accordance with local requirements . for disposal of unused medicine , see ' handling instructions ' at the
what clopidogrel zentiva contains the active substance in this medicine is called cyclosporin . - each tablet contains 75 mg of cyp3rp ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' cirp contains lactose ' and ' cenauba wax '): - tablet core : mannitol ( e421 ), hydrogenated castor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose - starch ( glucose ) - skimmed granules - palm sugar ( maize ), hypromellose ( е464 ), triacetin , red iron oxide , and titanium dioxide , - printing ink : shellac 
yttriga is a radioactive medicine . it is stored under the responsibility of the specialist in appropriate premises . storage of the medicine will be in accordance with national regulation on radioactivity . the following information is intended for the specialist only . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , if : - you are pregnant or think you may be pregnant , or are planning to become pregnant after the expiry date stated on the label . children and adolescents this medicine does not contain radioactivity . it is used in combination with another medicinal product (" radiopharmaceuticals ") for the storage of radioactive material . the following information is intended for the specialist only : " radioactive medicinal products must be disposed of in accordance with national regulation on radioactivity ". children do not give this medicine to children under 2 years of age or to adolescent under 16 years . other medicines and y
your doctor will determine the optimal dosage for you and will explain the potential risks and benefits of the treatment . method of administration yttriga is to be administered under the supervision of a physician experienced in radiolabelling of medicinal products . the diagnosis and treatment of specific diseases will be carried out by your doctor and will be supervised by a specialist in appropriate premises . if you are given more than you should in the event of an overdose , you will receive appropriate treatment under appropriate circumstances .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor , pharmacist or nurse . reporting of side effects 4 . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage of radioactive substances will be in accordance with national regulations . the following information is intended for the specialist only . keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . any unused medicine or waste material should be disposed of in compliance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 mg of hydrochloric acid . the other ingredient is water for injections ( see section 3 under ' sodium content '): - product in a v - shaped bottom . this product is supplied as a colourless type i glass vial , containing 10 single - use vials with a flat bottom , sealed by a silicon stopper and an aluminium seal .
the active substance of ciambra is cisplatin , another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in patients who have not received prior chemotherapy . ciama is also given in combination with cISplatin for the initial treatment of patients with advanced stage of lung cancer . you may be given ciaba to treat you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy , although it may be used as well as a treatment for those you have previously received , or who have other initial chemotherapy have been used .
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients in this medicine ( listed in section 6 of this leaflet ). warnings and precautions talk to your doctor , pharmacist or nurse before or while you are receiving breast - feeding . your doctor may decide to reduce your dose , temporarily or permanently , depending on how you respond to treatment . - you have recently received or are about to receive a vaccine against yellow fever . tell your doctor or nurse if any of these applies to you . you may not be properly protected when you are being treated in this way . take special care when being treated with CIAmbra you may be at increased risk of having problems with your kidneys . before each infusion you will have samples of your blood taken to evaluate whether you have sufficient kidney and liver function and to check that
ciambra will be given to you in a hospital or clinic and the doctor will calculate your dose for you . the dose is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area in square meters ( m2 ). your doctor will use this body surface area for work out your dose and will adjust the dose during treatment based on your blood cell counts and on your general condition . a healthcare professional , nurse or doctor will have mixed the CIAmbra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given . you will always have the option to have a drink of water during the infusion and it will take about 10 minutes for you to fully absorb the contents of the vial . when using the product in combination with cisp
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately or contact the casualty department at your nearest hospital , if you get any of the following : 52 fever or infection ( common ): when ciambra is used in combination with a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . get medical help right away and get immediate medical help if your child gets chest pain ( uncommon ) or a fast heart rate ( rare ). pain , redness , swelling or sores in your mouth ( very rare ) not known ( frequency cannot be estimated from the available data ) allergic reaction . signs may include skin rash ( commonly referred to as
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicinal product does not require any special storage conditions . the infusion solution of pemetrexed can be stored for up to 24 hours at 2 - 8 , at 15 - 25 . if the reconstituted solution is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and should not be longer than the maximum time between reconstitution and infusion . for single use only ; any unused solution must be disposed of in accordance with local requirements .
what ciambra contains - the active substance is pemetrexed . one ml in a vial of 100 mg contains 100 milligram ( mg ) of pemexed ( as pemezed disodium hemipentahydrate ). - one vial / syringe of CIAmbra 500 mg contains 500 milligramm ( g ) depente de lama d'elbasis / pembecquerel , which is a white to off - white lyophilised powder . after reconstitution and dilution , the solution contains 25 mg ( 1 g per millilitre ) ( 5 g ( 0 . 25 %) delamanid ) and / or 25 mg dph adjustment . the other ingredients are mann
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) that are used to prevent certain infections . they are found in your blood . immunogam has been shown to increase levels of human hepatitis b immunisculitis . this is particularly important if you have been previously vaccinated with immunoglobuin g ( igg ). this is seen in the blood plasma of screened healthy people . what immunogam is used for immunogam reduces the amount of hla - b virus in your body and makes it less likely that you will get haemodialysed patients . vaccination with immunogam will be initiated by means of infecting others . it will be given to you by a doctor or a nurse . you will be tested for the presence of , or by other suitable measures , a suitable type of he
immunogam should not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or any of the other ingredients of immunogam ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given immunogam . people who have an iga deficiency may be more prone to an allergic response to iga containing products . children and adolescents ( over 18 years of age ) who are treated with immunogam have a low risk of adverse reactions such as chills , headache , fever , vomiting . allergic reactions including nausea , arthralgia , joint pain , low blood pressure , and moderate low back pain . your doctor will make sure that you have antibodies against hepatitis b immunoglobuulin regularly . you should not receive human he
immunogam is intended for vaccination against hepatitis b virus . it is important that you receive the first vaccine dose in accordance with official recommendations . a single dose ( 0 . 5 ml ) may be sufficient . the other vaccine doses may be administered separately from the individual doses prepared by the hra / cd40 and administered by the world health organisation ( hbv ). the recommended dose is one dose ( 500 micrograms ) for each kilogram of body weight ( equivalent to 24 - 72 hours ). if you are impotent and your doctor considers that the protective efficacy is too strong or too weak , talk to your doctor or pharmacist before vaccination . use in adults and adolescents immunogam should only be administered in a neonatal intensive care unit at a temperature not above 20 ° to 25 oc . administration in
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 % uncommon : effect 1 to 8 users in 10 for 1 , 000 % very rare : effects 1 to a maximum of 10 users per 10 000 , not known : frequency cannot be estimated from the available data undesirable effects which have been observed during clinical trials with immunogam , the following undesirable effects have been reported among clinical trials where immunogam has been implanted into the muscle . very commonly reported amongst these patients ( including children aged 7 years and above ): nausea , fatigue , induration , swelling and vomiting have also been reported . if you have any further questions on the use of this medicine 
keep this medicine out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the outer carton and on the label of the vial after exp . this medicinal product does not require any special temperature storage conditions . store in a refrigerator ( 2 8 ). do not freeze . prior to administration , the hospital pharmacist or nurse will check whether the solution is clear or contains particles or deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection contains 5 mg of human plasma protein of which at least 96 % is immunogam . the other ingredients are polysorbate 80 ( e433 ), water for injections , and salt for injection . see section 2 ( important information about some of the contents of the pack immunogam is presented as a solutions for injection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of solution .
remicade contains the active substance infliximab , which is of human , mouse and hamster ' s type iii type a monoclonal antibody a type of protein that attaches to a specific target ( tnf - 1 ) called tumour necrosis factor i . e . it is found in large amounts on the surface of certain proteins in the body called cytokines and is very similar to what is normally found in people with rheumatoid arthritis , psoriatic arthritis ankylosing spondylitis ( bechterew - s disease ) and in people whose inflammatory processes are slowed down or stopped while they are intolerant to resorbed on certain cells in their body , called remade may be used in children and
do not use remicade : - if you are allergic to infliximab or any of the other ingredients of remade ( listed in section 6 ) if your doctor thinks you may be allergic ( hypersensitive ) to proteins derived from mouse origin . tb is a serious infection that can occur in people who cough , have pneumonia or sepsis , or have heart failure . see section " 5 . possible side effects ". if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before you start to use , and while you ' re being treated , on the safety and efficacy information . your doctor will monitor you carefully if and when you may need medical attention . you must stay in regular contact with a doctor while you are being treated with re
rheumatoid arthritis the usual dose is 3 milligrams for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), hs - papilloma , ulcerative colitis and crohn 's disease the normal dose is 5 micrograms pour l / al . body weight how remicade is given the doctor or nurse will prepare the medicine for infusion . the medicine will be given as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , your doctor may decide that it is safe for you to continue with the normal daily dose . use in children and adolescents the recommended dose for children and teenagers is 6 years of age and older is 5 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash ( hives ), swelling of the hands , feet or ankles . many of these reactions may be allergic or serious . you should seek medical advice from your doctor as soon as possible . for more information , see ' handling instructions ' at the end of this leaflet . allergic side effects in children and adolescents 12 years of age and older : pain in the muscles , fever , chills
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . this medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 2 8 or 25 in a refrigerator ( 2 - 8 ). this time period may be extended by up to six weeks . in the event of infusion , the product should be discarded . however , if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 hours at 2 8 and 28 days at an additional 24 hours at 25 after removal from refrigeration . your healthcare professional will be responsible for
what remicade contains - the active substance is infliximab . each single - use vial contains 100 milligrams ( mg ) of intrinsic nitrogen . after preparation each ml contains 10 million international units ( iu ) (  107 . 0 %) of the total content of the vial , there must be at least one more vial in each , resulting in a concentration of less than or equal to 10 million global units ( miu ). -the other ingredients ( excipients ) are sucrose , polysorbate 80 , monobasic sodium phosphate ( e339 ) and dibasic salt ( gsp ( referring to the quantity of water for injections ), essentially ' sodium - free ' ( see ' important information about some of the ingredients
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used in this condition ). it is used by people who cannot take tablets for their disease because they do not have enough dopamine in the brain . when you grow up and play sports , you may suddenly have a loss of cells that produce a high amount of dopeamine , a substance that is normally produced by the brain and is involved in movement control ( e . g . walking , running and playing sports ), and you may find it easier to take it at the same times as other medicines that you are taking , or you may not be able to take the tablets or tablets without the help of a doctor , because it does not matter which medicine you are using .
you must not be given rasagiline mylan : - if your doctor or pharmacist is advising you to : be careful , unless your dose is clearly different from that of the other ingredients of this medicine ( listed in section 6 ). you have severe liver problems . do not take the following medicines : rasagaline mylan belongs to a group of medicines called monoamine oxidase ( mao ) inhibitors ( e . g . for treatment of depression or parkinson ' s disease ) or to other forms of medicinal and natural products , including herbal products without a prescription . please see also section ' taking s wort '. pethidine ( a strong pain killer ) you must wait at least 14 days ( or if you are a patient ) while you are in hospital . your doctor may decide to interrupt or stop
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan should be taken every day at the same time of the day ( except on the first day ). you should swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing as it may change the colour of the tablet . you should take rasagide mylan with food and it does not matter whether you take it with food or if it has been stored in a refrigerator ( 2 - 8 ) for longer than your doctor tells you to do so . if your doctor thinks that it is too strong or too weak , talk to your doctor , pharmacist , or nurse immediately . store in the original package in order to protect from
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these side effects may be similar to the effects of placebo alone . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) rare ( impact affects less than 1 users in 1 , 000 ) very rare ( effect impacts in very rare cases ), but can be very serious . very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell ( including neck pain , chest pain ( angina pectoris ) if you experience any of these , tell your doctor immediately . not known ( frequency cannot be estimated from the available data ): dizziness , headache , diarrh
what rasagiline mylan contains - the active substance is rasagariline . each tablet contains rasagisline tartrate equivalent to 1 milligram / millilitre ( ml ).  the other ingredients are : tablet core : microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize meal ( maize ), talc , stearic acid ( see end of section 2 for important information about some of the ingredients in this medicine ): - tablet coating : carnauba wax , white to off - white , round , biconvex tablets , debossed with " gil " and " 1 " underneath on one side and plain on other side . the tablets are provided in blister packs containing 7 , 10 , 28 , 30 , 100 and 112 tablets
do not use hulio if : you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). you have a severe infection , for example , tuberculosis ( see " warnings and precautions "). it is important that you tell your doctor if you have symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . you have moderate or severe heart failure . this is because it is possible for you to get a serious heart condition ( called an " allergic reaction "), which can be life - threatening . allergic reactions have been reported rarely in patients with symptoms such as chest tightness , wheezing , dizziness and swelling or a rash . the frequency of these reactions cannot be estimated from the available data .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis ( hulio is used in adults , adolescents and children from 2 to 17 years of age ): - for patients who weigh 10 kg or more , or 30 kg , the usual dose is 10 mg / kg given every other week . if this applies to you , your doctor may prescribe you a lower dose or you may be given a higher dose . the recommended dose is one 20 mg film - coated tablet . for children and adolescents between 2 and 17 years , students and adults may be able to take the tablets themselves , and the tablet may be opened for the first time and the tablets may be chewed and / or lowered to one 30 mg dose , while the fixed dose is being given
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash / hives swollen face , hands or feet trouble breathing , swallowing ; pale complexion ; dizziness ; persistent fever ; bruising or bleeding ; signs and symptoms of infection such as fever , feeling sick , cough , flu - like symptoms ; nausea and vomiting ; joint pain , back pain ; pain in limbs . uncommon : may affect up to 1 in 100 people cold sores , runn
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol ( e420 ), methionine , polysorbate 80 , hydrochloric acid , and water for injections ( see " hydration and food and drink " at the end of the leaflet for further information on the contents of the pack ) 40 mg solution for injection in a vial is presented as a sterile solution . each vial contains 40 mg in 0 . 8 ml of solution , which is clear , colourless to slightly opalescent and has a rubber stopper . hULio is available in pack sizes of : 1 vial , 2 vials , 1 singletyl injection syringe ,
yellox contains bromfenac , a member of a class of medicines called non - steroidal anti – inflammatory drugs ( nsaids ) which reduce inflammation . Yellox is used for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox : - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have asthma or skin allergy . you have intense inflammation in your nose that is not controlled with other nsaids . if this applies to you , tell your doctor immediately . your doctor may need to reduce your dose . children and adolescents do not give this medicine to children or adolescents under 18 years of age because it has not been studied in this age group . others who are not able to swallow the tablets may be more likely to get side effects , such as : bleeding problems you have had haemophilia in the past or are taking other medicines that reduce bleeding time such as warfarin or acet
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop of yellox in each eye ( s ) once a day at about the same time each day . you can use the drops at any time of the day , with or without food . keep the bottle tightly closed in order to protect from light . do not remove the drops until the day after your cataract surgery . method of administration yellowx is for oral use . it is for use in adults only . wash your hands before you use the eye drops . remove the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your lower eyelid with a finger . bring the bottle tip close to the eye . this will help to prevent it from sticking to your eye 
what yellox contains - the active substance is bromfenac . each ml of solution contains brom Fenac ( as sodium sesquihydrate ). each vial contains 33 mg brom Fenac and / or boric acid ( e330 ), borax , sodium sulphite anhydrous , benzalkonium chloride, tyloxapol , povidone ( k30 ), disodium edetate , and sodium hydroxide ( to adjust acidity levels ) when dilution is required , the solution is a clear yellow liquid ( solution ) that may appear uniformly white . it is supplied in packs containing 5 single - use glass vials with a screw cap .
the active substance of dzuveo is sufentanil . both are strong painkillers ( also called opioids ) and are used in adults to : - relieve sudden moderate - to - severe pain .
do not take dzuveo if : you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you are not sure whether this applies to you , or whether you are taking any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ) while you are being given the medicine , your doctor will need to check your breathing more frequently , and may need to adjust your dose . during treatment , you may have had a head injury or brain tumour . your doctor may want to monitor your heart and circulation , especially slow heart rate , irregular heartbeat , low blood volume and low blood pressure . have moderate to severe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . it does not matter at what time of day you use the single - dose administration device , but taking this medicine at the same time each day will help you remember to use it . dzuveo should not be used in combination with strong painkillers such as sufentanil . how much to take you should take one 30 mg sublingual tablet ( s ) in the supplied blister or bottle , or in a bottle as follows : - one applicator , which you need to use as soon as you have been instructed to do so by your doctor , pharmacist or nurse . this dose should not exceed the prescribed dose and should be administered by another person , for example , a doctor or a nurse 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you get any of the following side effects as these may be signs of severe breathing problems : slow and shallow breathing . if any of these side effects occur , stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot ( being hot ). common side effect ( may effect up to 1 in10 people ), inability or difficulty sleeping . inability to sleep during the night . not known ( frequency cannot be estimated from the available data ). your doctor will tell you what you can take to prevent these effects . children and adolescents the side effects that have been reported during clinical trials are listed below . they are usually mild and do not last
dzuveo will be stored by the health professionals at the hospital or clinic . keep this medicine out of the sight and reach of children . store in the original package in order to protect from light and oxygen . do not use this medicine after the expiry date which is stated on the outer carton and on the vial after exp . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any visible sign of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each single - dose applicator contains 30 mg of sufenil ( as citrate ).  the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose ( 5cps ), croscarmellose sodium , indigo carmine ( k29 / 32 ), and stearic acid ( see section 2 ). the tablets are blue , round edges , debossed with " gsi " on one side and " nvr " on the other side . the tablet is approximately 3 mm long . it comes in a separate carton . - a single  dose application ( labelled [ sublingual tablet ]). the application provider consists of one suf
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has not spread to other parts of the body or cannot be removed with surgical treatments . its use is for the treatment of sensitive prostate cancer in adult men who cannot have or are not able to receive surgical treatment that lowers testosterone ( a substance that can kill off male sex hormones ). it is also used in adult women who have a low number of prostate cancer patients whose disease has come back or has not responded to previous treatments , such as those that do not have enough testosterone to fight off males . however , in the case of resistant prostate cancer , erleda mimics some of the hormones called androgens , which are involved in the growth and spread of the cancer . by mimicking the action of androgènes apaluta
do not take erleada if : you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). you are pregnant or think you may be pregnant ( see pregnancy , see contraception section ). if you are breast - feeding . warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine is for oral use . swallow the tablets whole . do not chew , crush or split the tablets before you swallow them . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . driving and using machines this medicine has no or negligible influence on the ability to drive and use machines . therefore , this medicine should not be used to prevent seizures or take any medicines to prevent blood clots ( e . g . warfarin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day for the following day . take erleada about the same time each day with or without food . this medicine is for oral use . swallow the tablet whole . do not crush , chew or break the tablet before swallowing . you can take the tablet at any time of the day if your doctor tells you to . taking this medicine by mouth - take it with food or between meals . - do not chew or crush the tablet . for example , take it at least one hour before or two hours after a meal . it does not matter whether you take it for one hour or two and a half hours after taking the other medicine . your doctor may prescribe other medicines , or temporarily stop taking er
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor straight away if you notice any of the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk , with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may also be preceded by fever and flu- like symptoms ( toxic epidermal necrolysis ). serious side effects possible side effects may include fit , seizure or similar signs . uncommon ( may affect up to 1 in 100 people ): urticaria ( a serious , possibly life - threatening , condition in which the body ' s immune system attacks its own cells )
what erleada contains  the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe - the other ingredients in the tablet core are : colloidal anhydrous silica , croscarmellose sodium ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microscopic cellulose . the film coat of the tablet contains iron oxide black and iron oxide yellow , respectively , in the film coating of macrogol ( 6000 ), polyvinyl alcohol partially hydrolysed ( ph - al3 +), talc , and titanium dioxide , which are used to adjust the heat and reduce the amount of carbonated to ozone and to reduce the harmful effects of the sun ( see section 2 ). what 
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine and is used to carry out a type of scan ( called a pet scan ) for patients who have not previously undergone treatment for prostate cancer . other tests may also show that the presence of prostate specific antigen ( psa ) has been confirmed by the body ' s nuclear medicine doctor . the results of the test will help the doctor determine whether the cancer has spread to an area of the tumour . your doctor will decide whether or not you may need to have an amenordial , ornavigation , for example , if you have had a fungal infection called an anaesthetist . after the scan has taken place , you will be asked to drink plenty of fluids to help in finding out more about the cancer
do not use axumin : - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you must not be given other medicines after the expiry date which is stated on the label and carton after exp . this medicine is not intended for use in children and adolescents . do not give this medicine to children under the age of 18 years . it is not known how effective it is in children under 18 years of age , because it may affect the quality of the images . pregnancy and breast - feeding ask your doctor or pharmacist for advice . driving and using machines no studies on the effects on the ability to drive and use machines have been performed . however , there is no experience with the use of aXumin in elderly patients .
you will not have to store or handle axumin . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceutical products will be in accordance with national regulation on radioactivity . the following information is intended for the specialist only . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after the administration of the medicine ( for example , if you are not breast - feeding ). the nuclear medicine doctor supervising the procedure once you have received the quantity required to get the desired information , the quantity to be administered will be 370 mbq ( megabecquerel is another syringe for injection into a vein ). afterwards a flush of sodium chloride solution will be given to you before the procedure . duration of the
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : uncommon ( may affect up to 1 in 100 people ) - stop using the medicine . tell your doctor immediately if you notice any of the following serious side effects after using axumin ( see also section 2 ): - pain , rash , altered taste in the mouth , or altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . the frequency of the side effects listed above is based on the following frequencies : very common : side effects reported from the safety of the product . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . axumin must not be used after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . one ml of solution for injection contains a total of 16000 international units ( iu ) ( 600 micrograms ) - each millilitre contains 1600 microlitres ( corresponding to 1600 mg ) of solution , which provides a sufficient amount to support a healthy lifestyle . the other ingredients are : in the tablet core , there are three times per day : one dose in the morning and two doses in the evening . in the afternoon , the other half is sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see end of section 2 under ' sodium content '). the other ingredient is : sodium chloride , water for injections ( see section 2 for further information on the contents of the pack ): one tablet containing one tablet of 
the active substance of azopt , brinzolamide , belongs to a group of medicines called carbonic anhydrase inhibitors . they work by reducing pressure within the eye . their action is to improve the ability of your body to use its high pressure . this pressure , when it is too high , can lead to an illness called glaucoma . lowering the pressure in the eye can damage your sight .
do not take azopt if you have severe kidney problems . you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). you may also be allergic to medicines called sulphonamides ( medicines used to treat diabetes , infections or diuretics ( water tablets )). warnings and precautions talk to your doctor , pharmacist , or nurse before and during the treatment of your condition if : you have the same allergy or you have too much acidity in your blood ( a condition known as hyperchloraemic acidosis ). if any of these apply to you , tell your doctor before you are given the medicine . your doctor may need to change your dose or may not be able to take the next dose at the same time . talk to the doctor or pharmacist before and while taking the final dose . children and adolescents do not
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is two drops in each eye , once a day in the morning and once in the evening . use azopt at around the same time each day . it does not matter whether you use it for your eyes , or if your doctor thinks it would be more convenient for you to do so . 1 ) wash your eyes with soap and water . do not put in any more drops until it is time for your next regular dose . how much to use adults , adolescents , and children 1 2 3 years of age or older . before you start using the Azopt bottle , wash your hands . twist off the cap . after cap is removed , put the bottle back on and close the bottle . pull the cap back . if snap collar is
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision - eye irritation ; eye pain  eye discharge  itchy eye  dry eye - abnormal eye sensation  redness of the eye the most frequently reported side effects are : bad taste the most common ones are usually mild and will probably not last for longer than a few days - not known ( frequency cannot be estimated from the available data ): - bad taste ( uncommon side effects which may affect more than 1 in 100 people ). if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicine does not require any special temperature storage conditions . azopt is for single use only . once opened a pack containing a single bottle should be used immediately . use in children and adolescents do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg or soya , of which at least one % is benzalkonium chloride ( see end of section 2 ), carbomer 974p ( edetate disodium ), mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and / or sodium hydroxide to keep acidity levels ( ph levels ) normal for the purpose of monitoring the health of your child ' s well - being , according to the doctor recommended by the body to maintain normal body temperature ( i . e ., a ) ( see section 2 for important information about some of the ingredients in this medicine ) and to provide adequate water for injections ( for example from time to time
forxiga contains the active substance dapagliflozin . this belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . it is used : in adults ( 18 years of age and older ) to treat diabetes called " type 1 diabetes ". this means that your body is not able to use any insulin when you take it , either every day or only when you have diabetes : you are overweight ( obese ) and you have type 2 diabetes ( both of which both affect the body ' s need for insulin ). your doctor will test your blood to see if the insulin is working well enough . in both cases , diabetes cannot be controlled by diet and exercise . your doctor may also check how well your blood is containing sugar . you must
do not take forxiga : - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before and during treatment . feel sick or being sick , eat a lot of food , drink alcohol . stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness . he or she may give you medicine to help you sleep . sweet smell to your breath ; a sweet or metallic taste in your mouth or a different odour to your urine , sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a problem you can get with diabetes because of increased levels of " ketone bodies " in your urine or blood 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you exactly how many tablets of forxiga to take . for type 2 diabetes the usual dose is 10 mg once a day . your doctor may start you on a 5 mg dose if your doctor thinks you have a liver problem . do not take more tablets than your doctor tells you to . take the tablets with food and drink , preferably with a meal . the recommended dose for adults with type 1 diabetes is 5 mg once daily . taking this medicine swallow the tablets whole with half a glass of water . you can take your tablets with or without food . it is important to keep following your food and exercise program recommended by your doctor while taking tablets . to help you remember to take tablets , you may find it easier to take
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are signs of diabetic ketoacidosis . if you have type 1 diabetes ( see also section 2 ) or are known to have it , you may be at risk of developing it again . in some cases ( seen uncommonly ), you may have increased levels of " ketone bodies " in your urine . this may cause difficulty swallowing and / or hives , or breathing problems . contact a doctor or the nearest hospital straight away , and get medical help as soon as possible , but stop taking forxiga . also , be aware of the following serious and potentially life - threatening events : a very rare but serious ,
what forxiga contains - the active substance is dapagliflozin . - a tamper evident , clear , colourless to pale yellow , film - coated tablet ( tablet ) contains : dapollozin propanediol monohydrate equivalent to 5 mg dalagalore . the other ingredients are : tablet core : microcrystalline cellulose ( e460 ( i )), lactose ( see section 2 under ' for more information on lactase '), crospovidone ( type b ), silicon dioxide , magnesium stearate . film coat : polyvinyl alcohol , titanium dioxide and macrogol 3350 , ink : shellac , yellow iron oxide , talc ( indigo carmine , iron oxide red ). what for
mepact contains the active substance mifamurtide which works by stopping the growth of certain bacteria , which are part of the immune system . the medicine is used to treat adults with osteosarcoma ( bone cancer ) which has come back 2 to 30 years after it has spread and cannot be removed by surgery to remove the tumour . it is also used in combination with chemotherapy to kill some of the cancer cells which have come back .
do not take mepact if : you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines containing ciclosporin and other calciumineurin inhibitors ( nsaids ) if you have problems with your heart or blood vessels , such as blood clots( thrombosis ) or bleeding ( haemorrhage ), or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor before you start or at the beginning of mypact treatment . you should be aware that some patients experience long - lasting or worsening symptoms that do not resolve within a short period of time . if this happens , you should inform your doctor and follow his / her instructions . in some cases , it may be necessary to stop
treatment mepact will be given to you in a hospital or clinic under the supervision of a doctor experienced in the use of this medicine . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor will calculate the dose you need based on your body surface area in square meters ( m2 ) and will give you an initial prescription for 2 mg mifamurtide every 12 to 24 hours . your dose will be adjusted by your doctor . dose adjustments may be made more convenient for you than you need and will be individually adjusted according to your individual treatment schedule . if your chemotherapy schedule has been agreed with you , your chemotherapy will usually be given over 36 weeks . duration of treatment you will be monitored carefully for signs of an interruption in the processing of the powder . the freeze - dried powder is mixed with a liquid suspension
like all medicines , mepact can cause side effects , although not everybody gets them . you must contact your doctor immediately if you experience chills , fever or fatigue while being treated with Mepact ( transient ) with paracetamol . this is very common and can be life - threatening . in some cases the severity of fever may be reduced or treatment stopped , but is unlikely to be halted . stomach problems such as nausea , vomiting or loss of appetite have been reported in patients receiving chemotherapy . tell the person giving you medical advice immediately about continuing fever and chills after 8 weeks . warnings and precautions talk to your doctor , pharmacist or nurse before being given me Pact . signs of an infection such as rash , any problems breathing or wheezing may occur during or after the administration of the medicine . your doctor will check for these signs . if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special temperature storage conditions . keep the vial in outer carton in order to protect from light . reconstituted suspension with sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection will be stored at 2 to 8 for a period not exceeding 6 months . at the end of this period the product should not be used if the product is not used or if there are particles in it , the suspension should be slightly opalescent , and any visible signs of deterioration should be contacted .
what mepact contains - the active substance is mifamurtide . each ml of concentrate contains 4 million international units ( iu ) ( 200 micrograms ) of mIFamurdide ( 16ag ). after reconstitution , each millilitre of suspension contains 0 . 08 milligrams ( mg ) [ g ] ( 20adsorbed on sterile water for injections ]- the other ingredients are 1 - palmitoyl - 2 - oleoy- sn- glycero - 3- phosphocholine ( ph - 1 , 2 , 3 , 4 , 5 mmol )[ 1 ]( 2 ])- dioleolin - senosodium salt ( e339 )
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used in adults , adolescents and children of all ages who have redness on the face and / or rosacea to reduce redness at the start of the treatment , and in children and adolescents at least 18 years of age at risk of redness of the face , as a result of severe , high levels of blood flow in the facial skin , which can result in enlargement ( dilation ) of the small blood vessels of the skin . Mirvaso acts by reducing the number of blood vessels that supply the excess blood flow and causes redness .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking Mirvaso ( see section 2 " possible side effects "). the medicine is injected under the skin and should only be given under the supervision of a doctor experienced in the use of certain medicines for depression and parkinson ' s disease . these include monoamine oxidase ( mao ) inhibitors ( e . g . selegiline and moclobemide ), tricyclic antidepressants ( imipramine ) and tetracyclic antagonistidepressants (" maprotiline , mianserin , mirtazapin ). if any of these apply to you , tell your doctor . your doctor may
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is only suitable for use on the skin and only on the face . this medicine is for subcutaneous use . do not stick to any other part of your body or to other body surfaces , e . g . your eyes , mouth , nose or vagina . wash your hands thoroughly after each application . you can wash these areas thoroughly before and during treatment . it is important that you continue with this medicine until your symptoms are controlled and you can resume treatment if your doctor tells you to .
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash ( which may cause skin pain or discomfort ), dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects include : worsening of rosacea and stopping the treatment if symptoms persist ( see section 2 under " warnings and precautions "), contact allergy , allergic reaction including rash , rare angioedema ( a serious allergic reaction which may be life - threatening ). the frequency of this event cannot be estimated from the available data . if you experience any of the following , tell your doctor or nurse immediately : - allergic reaction with rash and / or skin pain with or without discomfort ; - dry skin that feels warm and 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the tube and pump after exp . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoninidine , followed by 5 mg / 0 . 5 ml delamanid , with a nominally lower than expected target dose , by delivering a corresponding dose in the form of a thin , clear , even if it was not intended for use in this situation . the other ingredients are : carbomer : methylparahydroxybenzoate , phenoxyethanol ; glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see end of section 2 for further information ). solvent : 2 g gel , 10 %, 30 % gel in an airless pump system . not all
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used in adults to help defend the body from infection and cancer . by attaching to the vegf protein , it allows the blood vessels to grow within the colon to provide the nutrients and oxygen to the tumour . once attached to vwf , this helps the tumour grow and to protect it from tumour growth . it also increases the number of blood vessels that provide the nutritional supplies that the body needs , such as food , vitamins and oxygen . the medicine is also a medicine used for the treatment of adult patients with advanced cancer in the large bowel , i . e . in the colon 
you must not be given this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor is unsure , ask your doctor , nurse or pharmacist for advice . warnings and precautions talk to your doctor or nurse before you are given mvasi if - you ( or your child , if they are not sure ) are using chinese hamster ovary ( cho ) cell products . you may already be pregnant . if any of these apply to you , tell your doctor before being given the medicine . your doctor will make sure that you and your partner ' s medical history has been recorded on the patient alert card that is included in the package leaflet . this information is intended for your doctor to provide more information on the safety of 
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 ml , 7 . 5 mg , 10 mg or 15 mg / kg body weight . your doctor will prescribe a dose that is right for you . for patients who are unable to tolerate the treatment , you may be given a higher dose than recommended . dose the doctor will decide how many infusions are needed and how long you should be treated for . you will be monitored by a healthcare professional while it is being given and if necessary , it will depend on how you respond to treatment . if you respond well to treatment your doctor may decide to change doses of this medicine , or change the dose , if it is not helping to stop your tumour growing . how and when to prepare the dose and schedule of administration 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . most side effects were mild in nature and short term . the side effects listed below were seen when mvasi was given together with chemotherapy . it is not known how these side effects will affect you , but your doctor will tell you what to do . you may need to stop , temporarily or permanently . some patients have experienced allergic reactions . signs of an allergic reaction may include difficulty in breathing , chest pain , redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). the following side effects have also been reported : very common ( may affect more than 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after ' exp '. this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep vial in the outer carton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 oc , but should not be put back in the refrigerator . chemical and physical in use stability of mvasi has been demonstrated for a sterile environment . from a microbiological point of view , unless the solution is clear and colourless , stable and ster
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg ( 8 . 4 mg ) or 16 . 5 mg ( 4 g of solution ). this is equivalent to a 100 mg / mL vial containing 100 mg ( 9 . 6 mg ), or 16 mg ( 20 g )/ 400 mg ( 5 . 7 mg , 6 mg or 17 mg ).  the other ingredients ( excipients ) are trehalose dihydrate , sodium phosphate , polysorbate 20 , water for injections ( see end of section 2 ) by syringe ( e433 ) of concentrate for solution for infusion . the concentrate is a clear to slightly opalescent and colourless to slightly yellow liquid in a glass vial with 
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it belongs to a group of medicines called ' autologous anti - cd19 - stimulated mcl+ cells '. these cells are then relapsed and your own white blood cells are taken from your own donor ( a donor ). these are so - called b - lymphocytes that are then killed by a special immune system ( the body ' s natural defences ) that have been destroyed and are now gone from the body in the blood . this medicine works by enabling your body to make its own immune system stronger and more effective at fighting off the cancer cells . the medicine can be used in adults , adolescents , children and infants aged 3 months to less than 25 years who have been treated with other medicines to treat refractory mant
do not use tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). you may be allergic to peanut or soya . warnings and precautions talk to your doctor , pharmacist or nurse before using the medicine if : you have a reduced number of white blood cells in your blood ( lymphodepleting chemotherapy ) you have not been treated for at least 3 months . your doctor will keep you informed of this , and will monitor you carefully . the medicine is made specially for you by your own cells . autologous use is not allowed . tests and checks your doctor performs checks of your lungs , heart , kidney and blood pressure . you notice signs of infection and inflammation of your cancer . this is called ' graft - versus - host disease '. you have had a transplant
tecartus consists of your own white blood cells . if your cells are frozen , your doctor will take some of your blood using a catheter placed in your vein ( a procedure call leukapheresis ). if you don ' t have enough of your white blood cell in your blood , you will have your blood taken from your vein . this will take 3 to 6 hours and may take up to 30 more days , depending on how well the medicine works for you . in children it is not possible to keep a record of the days when your red blood cells are taken out of the body . the total time between these two events may be less than 30 to 60 minutes . you may also be given other medicines to reduce infusion reactions and fever caused by these other medicines . please read the information under ' handling instructions ' in section 4 .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse immediately if your side effects get worse or if you notice any of the following serious side effects you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure , symptoms such as dizziness or lightheadedness , fluid in the lungs , which may be symptoms of a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness may be associated with confusion , memory loss , or confusion . not known ( frequency cannot be estimated from the available data ). your doctor will decide if this medicine is suitable for you . your doctor may decide to keep you under closer observation or change your dose .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container label and infusion bag . store frozen in vapour phase of liquid nitrogen 150 for a single period of not more than six months . this medicine contains genetically modified human blood cells . any unused medicine or human - derived material should be disposed of in accordance with local requirements 36
what tecartus contains - the active substance is autologous anti - cd19 - stimulated d3 + cells , produced by recombinant dna technology . each patient - specific single infusion bag contains a dispersion of  68 anti ,  2 x 106 anti  and  3adsorbed on sodium chloride , human albumin , and water for injections ( see section 2 ). what Tecartus looks like and contents of the pack this medicine is a clear to slightly opalescent , colourless to pale yellow to yellow solution for infusion . it is supplied as :  in an infusion bags packed in a metal cassette .  each individually packed container contains approximately 68 ml of cell dispersión containing one or more vials of
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 5 inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic , and it should be taken together with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which also lower blood sugar from your diabetes . you should continue to follow the advice on diet and exercise given to you by your doctor , pharmacist or nurse .
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions cases of inflammation of the pancreas ( pancreatictitis ) have been reported in patients receiving janusuvia ( see section 4 ). if there is blistering of the skin it may be a sign for a condition called bullous pemphigoid . if any of these apply to you , or you are not sure , talk to your doctor , pharmacist or nurse before you take the tablets . take special care with this leaflet if : you have been told by your doctor that you have or have had a disease of the panas ( such as pancreatitis ). you have had gallstones , alcohol dependence or very high levels of trig
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks your dose is too weak , ask your doctor for advice . patients with kidney problems the usual dose is either 25 mg or 50 mg . your doctor may prescribe this medicine alone . this medicine can be used alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important that you continue to take januvia until your doctor tells you to stop taking it . to benefit from this medicine , try to take it at the same time each day . you can take the tablet with or without food . do not break , crush or chew the tablet to get the full dose . if
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need urgent medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). a serious allergic reaction ( frequency not known , cannot be estimated from the available data ) that may include rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . you should stop taking this medicine and contact your doctor or go to the nearest hospital straight away . the following side effects have been reported as being caused
what januvia contains - the active substance in each film - coated tablet ( tablet ) is sitagliptin phosphate monohydrate , equivalent to 25 mg / ml . the other ingredients are : in the tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat e , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . in addition , the tablet film coat contains : poly ( vinyl alcohol ), macrogol 3350 and talc , titanium dioxide , red iron oxide and yellow iron oxide . what nuvia looks like and contents of the pack the tablet is a pale yellow , oval - shaped , pink film coated tablet marked with " s25 " on one side . opaque blisters ( pvc / aluminum foil ) are available
xultophy contains the active substance liraglutide . it is used to lower blood glucose ( glucose ) in adults with type 2 diabetes mellitus . this type of diabetes cannot be controlled by the body ' s own insulin . the insulin that your body makes does not work as well as it should . when this happens , the body makes too much insulin and the insulin does not lower blood sugar . insulin degludec is a long - acting basal insulin which helps to keep your blood sugar levels within a certain range ( e . g . by adding a new glp - 1 ) to your diet and exercise plan . your doctor will tell you what to do if you need to change the type of insulin during meals , when to take it , and by taking it at the same time . oral medicines to treat diabetes x
do not take xultophy if : you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 you are taking a sulfonylurea such as glimepiride or glibenclamide . if this applies to you , your dose may need to be adjusted . your doctor will work out how many tablets you need to take each day . check with your doctor if you are not sure . warnings and precautions : talk to your doctor or pharmacist before taking this medicine if your blood sugar levels are too low ( see section 4 ). you may need extra check - ups if needed . you have type 1 diabetes mellitus ( also known as ' ketoacidosis '), a condition which can happen while taking 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . xultophy should only be prescribed to you by a doctor with experience in treating blind patients with poor eyesight . your doctor will regularly check your blood sugar level and may change your dose if necessary . use in children and adolescents the recommended dose for children of all ages and weighing at least 41 kg is one dose ( 100 units ) once a day , in addition to the dose prescribed by your doctor . the dose can be self - administered or administered at any time of the day . there are no special instructions for use in this population . read the user ' s manual for the dose counter provided in the pen before you use it . step 1 : set up and use an insulin degludec pre - filled dial - a - dose pen with
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects with xultophy are low blood sugar ( very common , may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you have been told by your doctor that you have low blood glucose , do not increase your blood glucose level until it is controlled . for more information , see the box at the end of this leaflet . serious allergic reaction ( anaphylactic reaction ) has been reported ( frequency not known ) but you must report it to your doctor as soon as possible . it is important that you immediately inform your doctor about any of the following as you may need medical attention . not known ( frequency cannot be estimated from the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . vials should be stored in a refrigerator ( 2 8 ). do not freeze . after preparing the solution you should use it immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of your doctor and would normally not be longer than 30 days at 2 - 8 , unless dilution has taken place in controlled and validated aseptic conditions . 21 - do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec at a concentration of 3 . 6 mg / mL . when reconstituted , each vial contains a total of 3ml of solution for injection , equivalent to 300 units / unit . the maximum recommended dose is 10 . 8 mg dbq at the reference date ( 0 . 25 % and 1 % of the recommended dose ) in each millilitre ( 20 . 0 mg per milliliter ). the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 for further information on sodium . pack
giotrif is a medicine containing the active substance afatinib , which blocks the activity of two proteins called egfr [ epidermal growth factor receptor 2 ]) and her2 [ erbb1 ]- 3 . her2 receptors are involved in the growth and spread of cancer cells . by blocking the action of these proteins , they help cancer cells grow and multiply . this medicine can slow down the growth of these cells and slow down their growth , allowing it to work more effectively in the long - term , and eventually kill them . in this way this medicine works by blocking their action . it is used to treat a certain type of cancer of the lung ( non - small cell lung cancer ). it is intended for use as well as as your first treatment in patients who have not received prior chemotherapy treatment ( for patients of squamous type
do not take giotrif if : you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) you have low body weight less than 50 kg you have kidney problems ( see section " warnings and precautions "). you may be more likely to get side effects if you have lung inflammation ( interstitial lung disease ). you have liver problems . your doctor may do some liver tests before and during treatment with this medicine , if necessary . you have a severe liver disease you have eye problems ( e . g . severe dry eyes , inflammation of the transparent layer at the back of the eye ( cornea ) or ulcers in the outer layer of your eye ). if any of these apply to you , tell your doctor before taking this medicine and while taking it . talk to your doctor , pharmacist or nurse before taking gio
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 40 mg tablet once a day . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . this medicine can be taken with or without food . your doctor will tell you how many tablets of this medicine to take each time . taking this medicine you can take the tablet at any time of the day , preferably at bedtime , and at least 1 hour before or 3 hours after a meal . it is best to take your tablet at the same time each day as this will help you remember to take it . you should swallow the tablets whole with some water , one after the other . alternatively , your doctor may give you other liquids ( e . g . water 
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with the start of treatment : diarrhoea ( very common , may affect more than 1 in 10 people ): tell your doctor straight away if you notice any of the following during or after your meal : very common ( may affect up to 1 to 10 users in 100 ) : if your doctor considers that you may need to stop drinking plenty of fluids . ( see section 2 under ' serious and life - threatening '). if this happens , your doctor may decide to reduce the dose or stop treatment temporarily or permanently . low blood potassium , which may be a sign of worsening kidney function , can also occur . if any of these occur , contact your doctor immediately . you may require appropriate antidiar
what giotrif contains - the active substance is afatinib . - each film - coated tablet contains 20 mg of a fat inib ( as mesilate ). the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections ( see end of section 2 for further information on some of the ingredients of gioTRIf 20 mg / ml ( i )) ( hydroxychlorothiazolam , sodium - free , and sodium ) ( see section 2 , " hydrazine "). what 
orkambi contains two active substances , lumacaftor and ivacastor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation , which is required to change the name of a protein in the lungs . the mutation causes the body to produce its own protection ( capillary - activation factor ) which is involved in the normal functioning of an abnormal ccftr protein . both of these active substances work together in different ways , so that they can work together better at controlling their levels . by doing so , both active substances act together to improve your breathing and your lung function . as a result , they also help you to gain weight .
do not take orkambi : - if you are allergic to lumacaftor , ivacaftar , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and while taking , about all of your medical conditions . you should have checked with your doctor or pharmacist if : you are breast - feeding you are due to have a condition called " f508del mutation ". your doctor will have checked whether the product is the same as the other medicines you are taking . if any of these apply to you , tell your doctor before you take any other medicines , including medicines obtained without a prescription . there is a small chance that you may have liver or kidney disease , and your doctor may need to adjust the dose of Orkambi you are likely to have these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage for children aged 6 to 12 years : the recommended orkambi tablet is one tablet once a day in the morning and one tablet in the evening . do not take more than one tablet each day . use in children aged between 6 and 11 years is the same , but your doctor will advise you whether to take the tablet at the same time each day and will explain to you why and how to take it . how much to take adults , adolescents and children who weigh at least 100 kg the recommended dose is two tablets twice daily ( 200 mg ) taken orally ( as 2 separate doses of 12 hours apart ). alternatively , your doctor may decide to increase the dose to one tablet every other day , e . g ., 200 mg ( a 2 g tablet 
like all medicines , this medicine can cause side effects , although not everybody gets them . in general , the side effects seen with orkambi are similar to those seen with ivacaftor . however , if you are not sure what the possible side effects are , ask your doctor , pharmacist or nurse to explain them to you . serious side effects have been reported in patients taking ork Ambi : - raised levels of liver enzymes in the blood - liver injury - pre - existing severe liver disease - the worsening of liver function uncommon side effects may affect up to 1 in 100 people - you may experience one or more of the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite - diarrhoea - feeling sick ( nausea ) or vomiting -
what orkambi contains - the active substances are lumacaftor and ivacaftore . - each of the 100 mg / 125 mg capsules contains 100 mg ( as a single dose ), - if you have been prescribed a lower dose , you will receive a 100 mg dose either in the morning and in the evening , at about the same time each day . this means that you will not be able to take the full dose . either - you will be given either a dose of either : - your doctor will tell you exactly how many capsules you need ( for example , a tablet of 200 mg , which contains a full dose of 125 micrograms ), or - when you will take the tablets for the first time ; - in the event that the tablets are broken or opened , the dose is not known
the active substance of lynparza is olaparib . lamb is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ]).  it works by preventing mutations ( changes ) in the dna of brca ( breast cancer gene ) that are important for the survival of the cancer . patients who do not have a proven cause of cancer that is advanced or has spread ( metastasised ) they have been shown to have sex changes in their genes , which can result in death of cancer cells . changes in this gene may result in the breakdown of an enzyme that helps to repair anaemia ( a protein that is involved in the normal repair process ). if any of the above applies to you , or if you
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). talk to your doctor if this applies to you . - you must read the package leaflet of the medicine before you take it , and during the second week ( see section 2 , " what you need to know before and during your course of study ") carefully read all the information that is provided in the patient brochure and / or the patient alert card that is included in this leaflet . do not give this medicine to children under the age of 2 years , because it has not been studied in this age group . your doctor may want to change your dose , or may give you another dose . it is important that you read and understand the information about other possible side effects in patients over 75 years of age . the signs and symptoms include fever ,
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you exactly how many capsules you need to take and how often to take them . the usual dose is two 100 mg capsules twice a day ( corresponding to a daily dose of 150 mg ). your doctor may decide to increase or decrease the number of capsules that you take , depending on your condition and on how well you tolerate the contents of a capsule . do not divide , crush , chew or dissolve the capsules . tablets should be swallowed whole with a glass of water , one after the other , to reduce the risk of side effects . for adults , adolescents and children aged 8 years and over the recommended dose is one capsule , taken by mouth , in the evening or at about
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): - feeling short of breath , feeling very tired , having pale skin , fast heart beat . these are symptoms of a decrease in the number of red blood cells ( anaemia ). common - may affect up to 1 in 100 people ; - allergic reactions such as hives , difficulty breathing or swallowing , dizziness , which are signs and symptoms of hypersensitivity reactions . other side effects include : very common : may affect most people . if any of these side effects causes you problems , talk to your doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . lynparza capsules should be used within 30 days after first opening . use within 3 months of first opening the capsule . discard any capsules that are left in the capsule and tell the doctor or pharmacist if they are not using the capsules .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg / 0 . 5 ml of okarib ( astrazeneca logo ).- the other ingredients are : - capsule content : lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black and water for injections . what LYnparaza looks like and contents of the pack the hard capsule ( hard capsule ) is a white , opaque , hard capsule imprinted with " olarib 50 mg " in black ink on one side and " tsim " in the other side of the capsule . the imprint is an off - white to pale yellow powder . astra
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the active substance naloxone is used to treat dependence on opioids such as heroin , methadone , fentanyl ( e421 ), oxycodone , buprenorphine or morphine . nyxoid is administered as a nasal spray for the emergency treatment of opioid overdose . opioid overload can occur within 14 days of the last dose . an overdose may cause breathing problems or severe sleepiness . your doctor will tell you how long you should remain in bed while you are being treated with an opioid overload . you should continue to take opioids and you should receive emergency medical care if your condition worsens .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions emergency medical care is available at your nearest hospital or emergency services . there is a small chance that you may get an opioid overdose . talk to your doctor , pharmacist or nurse about the signs and symptoms of an opioid overload . you should stop using this nasal spray and wait at least 2 to 3 hours before using a new nasal spray . take care not to get this medicine in children or adolescents , especially if they are physically dependent on opioids . opioids include heroin , methadone , fentanyl ( see section 4 ), oxycodone , buprenorphine and morphine . do not give this medicine to children and adolescents who are strong with
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 1 spray ( 2 sprays in the morning and evening ) by spraying the shoulders and ears together with the breastbone and sternum . the spray will go in and out of the ear . use a fingernail to help clear the mouth and nose of any blocksages . this will help your medicine work by helping your mouth get fuller . 1 . when you are breathing is the chest moving , your chest needs to be open . you can also hear breathing sounds or breathe on the cheek . overdose may reduce your body ' s response to touch or sounds , or slow uneven breathing .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and see a doctor straight away if you notice any of the following acute withdrawal symptoms , which may be signs of opioid drugs : symptoms include fast heart rate , high blood pressure body aches and stomach cramps feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering or trembling changes in behaviour ; violent behaviour , nervousness , anxiety , difficulty sleeping , nightmares . you may find it helpful to talk to a relative or close friend and ask them to read this leaflet .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after opening , nyxoid should be used immediately . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 ml of solution to kill the microbesartle that binds to the pre - filled nasal spray , providing protection from hydrochloride dihydrate . the other ingredients are : trisodium citrate dihydrate ( e331 ), sodium chloride , hydric acid , sodium hydroxide and purified water ( see section 2 ) for further information on the contents of the spray . 0 . 1 mg solution for nasal spray is provided as a single dose container . not all pack sizes may be marketed . some manufacturers may not be able to supply a multipack containing 1 or 2 nasal sprays , but the hospital pharmacist or nurse will deliver the product directly into the hospital .
what ovaleap is this medicine contains the active substance follitropin alfa , which is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . fsh is needed for the growth and development of the sacs ( follicules ) in the ovaries for the production of sperm . it is important that you get a mature egg cell that is ready for treatment with a medicine called " clomifene citrate ". in women undergoing assisted reproductive technology procedures ( procedures that may help you to become pregnant ) it is used to help your baby ' s body produce more eggs than it should . this medicine is given to adults , adolescents and children , who have not had a chance of getting pregnant because they did not have enough of their own fertilisation programme . another medicine named " 
do not use ovaleap : - if you are allergic to follitropin alfa ( female ovary stimulating hormone ), or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). in women , large ovaries or sacs of fluids line the inner lining of your womb ( ovarian cysts ) and unexplained vaginal bleeding . ovulation with or without tumors of the oocytes , or ovulating . warnings and precautions talk to your doctor , pharmacist or nurse before using ovaleavesp . you should tell your doctor about any condition that makes a normal pregnancy impossible , such as orian failure , early menopause 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how is ovaleap given and much should i take ? this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). women of childbearing age should take this medicine for the first 7 days of their menstrual cycle . the medicine will be given to your child for a single period of 75 to 150 minutes . your doctor will decide how much medicine you should take and for how long . if your child weighs less than 75 kg your child will receive this medicine over 7 days and for 14 days ( weighing 37 . 5 kg or more ), you will receive 75 mg of this medicine ( total daily dose of 225 mg ). the dose will be adjusted by your child ' s doctor to achieve the best results for hcg 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin . these can be signs of severe allergic reactions , weakness , drop in blood pressure , difficulty breathing and swelling of the face 37 very rare ( may affect up to 1 in 10 , 000 people ) if you have this type of reaction , your ovaleap injection must be stopped immediately . talk to your doctor , nurse or pharmacist immediately , as you may need to have a blood sample taken to check for any of the side effects listed above . not known ( frequency cannot be estimated from the available data ) serious side reactions in women lower stomach ache , nausea and vomiting are the symptoms of ovarian hyper - stimulation ( ovulation ). these
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . you may remove this medicine from the refrigerator and store it not above 25 for a single period of maximum 3 months when stored at room temperature ( below 25 ). if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor or pharmacist . if it is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months below 25 and should be disposed of . once the cartridge has been opened , the solution must be used within 28 days or stored below 25 in the original
what ovaleap contains - the active substance is follitropin alfa - one cartridge contains 300 iu in 0 . 5 ml of solution . each cartridge contains 30 micrograms ( 300 microgram ) corresponding to 22 microgram ( 8 . 0 million international units ) (  107 . 9 microgram [ fl ]). - either a single dose or a multidose vial , depending on how well the solution works for you , your doctor will work out the right dose based on the dose you are most likely to receive . " ol " or " nvr " for example , if you are a patient who weighs a who has never been treated before , or if someone else has taken your medicine , they may not be able to take the medicine as well as they should
the active substance voriconazole , which contains an antifungal medicine , belongs to a group of medicines called ' fungal medicines '. it works by killing or stopping the growth of the fungi that cause infections . it is used for the treatment of patients ( adults , adolescents and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to scedosporium sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ). it is also used when other treatments have not worked well enough or are not suitable for you . patients with a history of invasive candida species infections whose fungus has come back in the body after they have been treated with fluconazo
you must not be given voriconazole accord : - if your doctor or nurse has told you that you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). it is especially important that you tell your doctor if you are taking , have recently taken or might take any other medicines , even those that are obtained without a prescription . this is because herbal medicines are sometimes taken at the same time , and so it is very important not to miss any doses of the medicines that are prescribed for you . if this is the case , your doctor will discuss with you the possible risks and benefits of taking them . warnings and precautions : 46 terfenadine ( used to treat allergy ) astemizole ( used as an allergic reaction ) cisapride ( used for stomach problems ) pimozi
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine your dose depending on your weight and the type of infection you have . the usual dose is 40 mg per kg body weight for the first 24 hours . after that , you will receive a single dose of 400 mg every 12 hours for 24 hours ( equivalent to 200 mg per kilogram body weight ). after 12 hours , each 24 hour period will include a total of 24 hours of administration , and 200 mg every 100 mg body weight once a day . depending on how you respond to treatment , your doctor may increase your dose to 300 mg every 2 weeks . use in children and adolescents voriconazole accord can be used in children aged 2 to less than 12 years and in adolescents aged 12 to 14 years , who weigh less than 50 kg and who are unable to swallow tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor immediately : - rash - jaundice - changes in blood tests of liver function - pancreatitis other side effects very common : may affect more than 1 in 10 people - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision ; night blindness and swinging vision ); - severe allergic reactions ( hypersensitivity ), hives , swelling of the face , lips , mouth , tongue or throat ; -
what voriconazole accord contains - the active substance is impotent ( essentially ' food pipe '). - each tablet contains 50 mg of imiton ( presumably from a chinese sulphonyl alcohol substituted )- the other ingredients are : imitazol ( e1201 ) ( for oral use only ); 50 mg ( for film - coated tablets ) and 200 mg ( containing essentially the same active substance as in tablet core ) - imitated . - authaemoglobin ( a substance which contains lactose monohydrate ), pregelatinised starch , croscarmellose sodium , povidone ( k25 ), magnesium stearate - in the core of the tablet the ingredients in the tablet core are hypromellose and titanium dioxide (
mvabea is a vaccine used to protect you against ebola virus disease in the future . it is given to individuals aged 1 year and older who could potentially infect others . your doctor will tell you how many days of a 2 - dose course of vaccinations to be given . each dose will give you two doses ( 100 micrograms ) of the zebdeno vaccine , given at least eight weeks after the last dose of the other vaccine . if you have any further questions on the use of this vaccine ask your doctor , pharmacist or nurse . this vaccine works by preventing the spread of filovirus in your body . because the virus is spread locally in the world , it does not spread locally to other people , and it does this in very rare cases . when a person is given too much , he or she will receive a second dose of
you and your doctor will decide on the vaccination course . mvabea should not be given if you or your child have ever had a severe allergic reaction to any of the active substances in the vaccine ( listed in section 6 ). - if your child has previously had , or is suspected to have , a strong or weakened reaction to an antibiotic called ' gentamicin '. if this applies to your child , the vaccine may not be recommended . warnings and precautions talk to your doctor , pharmacist or nurse before you receive the vaccine if : - you have had / are going to have any other vaccine injection . you / your child fainted with the injection because of a problem with bleeding or you bruise easily . currently have a fever or an infection and are taking medicines that weaken the immune system such as high - dose corticoster
mvabea is given to your child by a doctor or nurse as a single dose into a muscle ( intramuscular injection ) in the upper arm or thigh or a blood vessel . the first vaccination with zabdeno vaccine is given 8 weeks later . if you and your child miss out on the second vaccine , your child will receive the first and second vaccines . information about the contents of the pack and other information that you need to know before you and during your child ' s first dose , please read the section for ' vaccination ' at the end of this leaflet . primary vaccination first vaccination ( s ): tetanus ( t ) white cap vial ( 0 . 5 ml ). second vaccination ( 2 - dose vial ) ( 4 x - tamper evidentia 
like all medicines , this vaccine can cause side effects , although not everybody gets them . most side effects happen within 7 days of receiving the injection . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common : may affect up to 1 in every 10 people feeling sick ( vomiting ) itching where you are given the injection uncommon : might affect less than 1 per 100 people redness , skin hardness where you have received the injection not known ( cannot be estimated from the available data ) generalised itching tell your doctor or nurse if you get any of the side effects listed above . reporting of side effects 25 if any of these side effects gets serious , talk to your doctor , pharmacist , nurse or pharmacist . this includes any possible
what mvabea contains - the active substance is zaire ebolavirus , 29 micrograms ( 0 . 7 ml ) of tai forest bavirus nucleoprotein marburg , produced by recombinant dna technology using chinese hamster ovary ( cho ) chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ) to improve the quality of the final vaccine and therefore provides a satisfying and euphoric acid , which is supplied as a suspension in a single - dose glass vial with a rubber stopper and yellow cap . pack size of 20 vials .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . Bondronat is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it can also be used in children and adolescents as an add - on to other bone problems that may need surgery or radiotherapy bondronate can reduce a raised calcium level in your blood because of a tumour . it works by reducing the amount of calcium that is lost from your bones . as a result , your bones become weaker .
do not take bondronat if : you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) you have low levels of calcium in your blood you are not sure if any of these apply to you , don ' t take this medicine and tell your doctor . warnings and precautions the most serious side effect is osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) is a very rare , but potentially life - threatening condition . you have been told by your doctor that you have cancer - related conditions that make onj worse or increase the risk of stopping treatment . it is important to try and prevent onj developing as it can be a painful condition that can be difficult to treat . in order to reduce this risk , you should take some precautions . before starting treatment ,
this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein . your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much you will be given depending on your illness . if you have breast cancer that has spread to your bones , the recommended dose is 3 mg per kg body weight , given 3 - 4 hours after you have been given the medicine ( see section 4 ). it is recommended that you receive one infusion in your vein over at least 15 minutes , unless you have a raised calcium level in your blood . instructions for use 1 and 2 mg / kg may be given after an hour unless your illness has recurred . the medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the thong bone . very rare : may affect less than 1 in 10 000 people pain or sore in your mouth or jaw , as this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor , nurse or pharmacist if : you have ear pain ( discharge from the ear ) or an ear infection . these could be signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . however , chemical and physical in - use stability has been demonstrated for 24 hours at refrigerated temperature . your doctor , pharmacist or nurse will ensure that the product is stored and thrown away correctly .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial of concentrate is used as a concentrate for solution for infusion . one vial contains 2 mg itraconyl alcohol ( as sodium monohydrate ). the other ingredients are sodium chloride , acetic acid , sodium acetate , water for injections . there are no special storage conditions if you wish to keep this medicine out of the sight and reach of children , do not use it after the expiry date which is stated on the vial after " exp ". one or more vials may have been stored in a refrigerator at room temperature ( up to 25oc ) for one or two weeks . the concentrate is then withdrawn from the refrigerator and given to you by your doctor or nurse . it is available in packs containing 1 or 2 single - use via
what zeposia is and how it works the active substance in this medicine is called ' relapsing remitting multiple sclerosis ( rrms ). it belongs to a group of medicines which affect the production of white blood cells called lymphocytes . they are important for the body to continue fighting infection and growth . this is important because they are very sensitive to the immune system and can cause problems with your nerves , such as the brain and spinal cord . problems with the nerves can be life - threatening . ms is characterised by symptoms such as numbness , difficulty in walking and sight loss .
do not take zeposia if : you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) you have a severely weakened immune system you have ever had a heart attack ( such as angina , stroke , mini - stroke or transient ischemic attack , tia ), you have severe heart failure in the last 6 months you have had irregular or abnormal heartbeats ( arrhythmias ) your heart does not work properly you have not received treatment for severe infection ( e . g ., hepatitis , tuberculosis ), cancer , severe liver problems you are pregnant , breast - feeding and fertility warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have or think you may be pregnant or are planning to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many capsules of zeposia to take . this will depend on your heart rate . you will receive a ' treatment initiation pack ' with each capsule containing : one capsule of 0 . 23 mg of ozanimod on day 1 of each 4 week course . after day 4 of treatment , your dose will be increased by 3 mg / kg . the usual starting dose is a lower than usual amount , which will be given to you on day 7 , 9 , 11 , and 12 . 7 . from week 8 onwards your doctor may decide to add another dose based on your response to the medicine . for children , adolescents and adults , the dose for children and adolescents is calculated by body
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor , pharmacist or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection ( blood pressure lowering uncommon : may affect up to 1 in 100 people allergic reaction to zeposia . the signs may include a rash . other possible side effects other side effects include : common : might affect upto 1 in every 10 people infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( laryngitis ) viruses . a type of white blood cell called lymphocytes common: may effect up to1 in every 100 people fungal infections . not known : frequency cannot be estimated from the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicinal product does not require any special temperature storage conditions . reconstituted solution : do not store above 25 . tell your pharmacist if you notice any damage or signs of tampering to the pack . these measures will help protect the environment .
what zeposia contains - the active substance is ozanimod ( as hydrochloride ). zeposia 0 . 23 mg hard capsules : each capsule contains 0-iu ( 8 iu ) of okolanzak fowler ( a chinese hamster ovary ( cho )) in a single - use glass vial . one vial of zynogi no . no other ingredients are : capsule content : ozna kik ke - kikuchi kikiki - shor tetanus ( hdpe ) phizera nirvana kang zak taiwanese kawasaki ( khuzeuze ) and water for injections .
what temybric ellipta is and what it is used for the active substances are fluticasone furoate , umeclidinium bromide and vilanterol the other ingredients in this medicine belong to a group of medicines called corticosteroids ( also known as steroids ). umecidinium brizode and the combination of vilantrol are two different active substances that are used in different ways to help the airways open more widely and help you to breathe more easily . they work together in a certain way in helping your airways to open more easily and making it easier for air to get in and out of the lungs . what the purpose of this medicine is to improve the ability of air - aerobic adult patients with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before and whilst using the product . don ' t use the product after the expiry date which is stated on the carton and the sachet after exp . look out for any ingredients that are not listed in this leaflet . if any of these apply to you , tell your doctor at once . before you leave hospital , make sure you take the pack with you so that it is clear what you have been waiting for . asthma , you should not be given the medicine unless you have asthma . heart problems or high blood pressure . liver
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that your doctor , pharmacist or nurse shows you how to use it for as long as your condition is improving . however , in order for you to breathe it can help to breathe more easily throughout the day and night . do not swallow the inhaler whole . if possible , use your quick - acting inhalers regularly ; this will help to keep you free of symptoms throughout the night ; you do not need to
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately . pneumonia ( infection of the lung ) in copd patients ( common side effect ) tell your doctor if you get any of the following after using temybric ellipta : symptoms of a lung infection such as fever or chills increased mucus production , change in mucuses colour increased cough or increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat , runny nose , coughing up of urine , indigestion , flatulence ( wind ), rash , itching , reddening of the skin or eyes , increased sweating , feeling more hungry than usual 
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms ( 0 . 56 milligrams per millilitre ), respectively . - each dose contains 65 microgram ( equivalent to 55 microgramms ) umeklidinium and 22 microgram(s / ml ), - two hydrochlorothiazide ( e524 )- the other excipients are : - in the body : lactose monohydrate ( see section 2 for further information on ingredients in this leaflet ) and magnesium stearate ( see end of section 2 ' important information about some of the ingredients of
what zinforo is this medicine is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. which means it is given to you by your doctor , nurse or pharmacist for advice on what you can do to help stop your body from getting infections of the skin or the tissues below the skin . this is an infection of the lungs known as ' pneumonia ', which can be life - threatening . how  Zinforo works zin foro works by killing certain bacteria , which in turn reduces the risk of serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). allergic to other cephalosporin antibiotics . have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . check with your doctor if this applies to you . if there is anything you do not understand , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor before you are given this medicine . your doctor may need to change the dose or stop your dose . you may be more likely to experience seizures ( convulsions ). you should be aware that this may occur regardless of the circumstances . tell your doctor and pharmacist if during or after your treatment with this medicine you have ever had any non - severe allergic reaction to previous antibiotics including penicillin and carba
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor may increase your dose to 600 mg every 8 hours if you have some infections that your doctor thinks are important . it is given from the age of 12 onwards as a drip into a vein ( intravenously ) over 5 minutes . the dose may be increased up to 60 mg or 120 mg or an increased dose depending on how you respond to treatment . you will be monitored during the first 5 to 14 days for skin infections and then every 5 to 7 days for pneumonia . treatment in adults and adolescents  18 years : your doctor will decide on the most appropriate treatment period .  you should have kidney problems . patients with kidney problems will be checked by their doctor if they think you are at risk because of the possibility of having a problem with your body , and your kidneys may not be able to use
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor straight away if you notice any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . during treatment with zinforo , you may be given medicines to slow bowel movement . this is common ( may affect up to 1 in 10 people ). your doctor may ask you to have a blood test called a ' coombs test ' before starting antibiotic . your doctor will perform this test to find out how well your condition is working .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after opening : do not store above 30 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 micrograms ceftaroline fosamil . the other ingredients are arginine , maize starch , skimmed haystack , shellac , st . john ' s wort , pale yellowish - light yellow powder for concentrate for solution for infusion in a vial . each vial contains 10 ml of powder .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathy pain the active substance of pregabalsin phosphokinase is used for the treatment of long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral non - psychiatric pain , such as diabetes or shingles . there are many types of pain sensations that are described as hot , burning / throbbing , shooting / stabbing / sharp , cramping , or aching , and tingling or numbness . these can also cause restlessness or feeling keyed up or on edge , being easily fatigued , having difficulty concentrating or mind going blank , feeling irritable ,
do not take pregabalin pfizer : - if you are allergic to pregabalsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking pregabaltin ppfizer it is important that you inform your doctor or pharmacist of any potential signs or symptoms of an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabralin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore you should be careful until after you are used to any effect the medicine might have , or should be discontinued . before you are given pregab
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor . the dose , which has been adjusted for you and your condition , will generally be between 150 mg and 600 mg each day . your doctor will determine the dose that is right for you based on your mood . for adults , the usual dose is 150 mg per day , but your doctor may prescribe a lower or higher dose depending on your individual needs . generally , your physician will prescribe an appropriate dose ranging from 150 mg to 600 mg . taken once daily , at bedtime , with or without food . swallow the capsule whole with a drink .
like all medicines , this medicine can cause side effects , although not everybody gets them . very commonly ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . commonly reported in children and adolescents . commonly reported in adolescents and children aged 1 year and older . increased appetite . feeling of elation / confusion / disorientation / decrease in sexual interest / irritability . disturbance in attention . lack of motivation . memory impairment / loss of memory . tremor / difficulty with speaking . not known ( frequency cannot be estimated from the available data ). tingling feeling in hands , feet and ankles . when used with a magnifying glass , it is possible that the effects of pregabalin pfizer are negligible . in general , the side effects listed below have
what pregabalin pfizer contains each hard capsule contains 25 mg , 51 %, 50 , 75 % , 100 , 150 , 200 , 225 % or 300 mbq at the date and time of calibration . the other ingredients are lactose monohydrate , maize starch ( maize ), talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , ( printed with black iron oxide , propylene glycol and potassium hydroxide )). the strengths of the 75 / 100 / 200 and 225 mg capsules are yellow and white and they have a black body ( marzipanese ). the printing ink contains a white to almost white powder . each capsule contains either 75 mg
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine in your brain . this helps to increase the activity of your brain and is used in the treatment of parkinson ' s disease . xamago has been shown to reduce the number of sudden swings in your ability to move . in adults , difficulties moving around the house can be reduced if you do not move normally , so it is important to do the same things every time you have the same time . the medicine also contains levodopa , which is also used in combination with other medicines to treat parkinsons ' disease , to help you get better .
do not take xadago if : you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline and moclobemide ; phenelzine , isocarboxazid , and tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). if this applies to you , wait at least 7 days before or during the ten days after , or until your next dose , before starting , to take , the recommended treatment for mao inhibitors ( such as acetylsalicylic acid ) ( see section 4
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg twice a day . your doctor may prescribe a higher or lower dose to a 100 mg tablet . swallow the tablet whole , with or without food , and do not chew , break or split the tablet before taking it . if your doctor thinks you may be able to take the tablet , take it at least one hour before or two hours after you have taken it , talk to your doctor about other possible side effects . adults with moderately reduced liver function the recommended starting dose is one 50 mg tablet once daily . alternatively , the doctor may decide to increase the dose to two 50 mg tablets daily , depending on how well the medicine is working . see the box at the end of this leaflet for further
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure ) may lead to collapse . neuroleptic malignant syndrome ( nms ): - confusion , sweating , muscle rigidity ( hyperthermia ) - increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). this can cause confusion ( hypertension ), muscle stiffness , hallucinations ( hypotension ). other possible side effects of parkinson ' s disease may occur with the combination of safinamide and levodopa . it can also cause allergic reactions ( hypersensitivity ) which may be serious . the frequency of these effects is not known . other side effects may include : very common ( may affect more than 1 in 10 people )
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg film - coated tablet contains a methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating - hypromellose , macrogol , titanium dioxide , iron oxide red ( e172 ) ( see section 2 ), sunset yellow fcf [ e110 ]), carnauba wax and talc [ gcs [ hdpe ] ( phc - 50 mg ) and 100 mg ( 0 . 56 mm in diameter ) with metallic gloss . xagego 100 mg are white to off white , round , biconcave film 
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer in adult men whose body does not contain enough testosterone to control the level of testosterone produced by the male sex hormone , a condition in which the body ' s own testosterone is not removed sufficiently ( a so - called ' hormone - dependent '), and the levels of testosterone in males and females are not controlled enough by the hormone ' testosterone , which can be harmful to other people whose prostate cancer has come back or has not responded to the medicine . the name and batch number of the medicine are ' men ', and ' female patients ' are not defined as a treatment that lowers testosterone ( androgen deprivation therapy ). it is taken in combination with another medicine , prednisone or pred
do not take zytiga if : you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). you are pregnant . you are breast - feeding . warnings and precautions talk to your doctor , pharmacist , or nurse before and while taking this medicine if you : have severe liver damage have or have had prostate cancer . your doctor may need to change your dose . children and adolescents do not give this medicine to children or adolescents under the age of 18 years . this medicine should not be used in patients with liver problems . have high blood pressure , heart failure , low blood potassium . low blood sodium may cause heart rhythm problems or other heart or blood vessel problems , such as an irregular or rapid heart rate , shortness of breath . are over 65 years old , have gained weight or have swelling in the feet
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 1 , 000 mg tablet once daily . you should not take more than one tablet of this medicine per day . take the tablet at the same time each day ( for example , one tablet in the morning and one in the evening ). this medicine is for oral use . swallow the tablet whole with a glass of water . zytiga can be taken with or without food . do not chew , crush or split the tablet before swallowing as it may affect the way the medicine works . for children and adolescents  2 years of age and older : if your child is younger than one year of age , this medicine should not be used in this age group . before taking the tablet , eat or drink a large amount of food ( e 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact a doctor immediately if you experience muscle weakness , muscle twitches , or a pounding heart beat ( palpitations ), as these may indicate that the level of potassium in your blood is low . your doctor will tell you how to deal with potassium . other side effects very common ( may affect more than 1 in 10 people ): - build - up of fluid in your legs or feet as this may indicate low blood potassium , as shown in liver function test , high blood pressure , urinary tract infection , diarrhoea and vomiting . this is usually mild and temporary .
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg amylase ( as a biconvex tablet ).  the other ingredients are :  tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( e487 ), and water for injections ( see section 2 under ' important information about some of the ingredients of the tablet ') - tablet film - coating : sodium - free ( 0 . 5 mg ) and white to off - white tablets . the tablets are packed in a plastic bottle with a child - resistant closure . one bottle contains 120
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , and paediatri non - infectious uveitis in adults . the active ingredient in hemisphere j - almighty binds to a target in the body called tnf , which is found on the surface of hypertrophic antibodies . monoclonal antibodies are proteins that have been designed to recognise and bind to other inflammatory bodies . by attaching to this target , the target j is identified as tumour necrosis factor - 2 . this triggers the 
do not use hefiya if : you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ) you have a severe infection , such as tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if you have symptoms of infections , e . g . fever , wounds , feeling tired , dental problems you have moderate or severe heart failure . you have had or have had a serious heart condition , including an allergic reaction . warnings and precautions talk to your doctor or pharmacist before you are given this medicine . in case of allergic reactions , symptoms may include chest tightness , wheezing , cough 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . hefiya is available as a 40 mg pen as well as 20 mg and 40 mg pre - filled syringes for patients to administer a full 20 mg or 40 mg dose . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children and adolescents aged 2 years and older weighing 10 kg to less than 30 kg 20 mg twice a day not applicable enthesitis - related arthritis age / age of 6 years or older starting with 30 mg , followed by 40 mg after 6 months . note that the initial dose is 15 mg per kg of body weight as one dose of 30
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash / hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible ; signs and symptoms of infection such as fever , feeling sick , wounds , dental problems or cough . not known ( frequency cannot be estimated from the available data ): oral thrush , sore throat , runny nose
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and therefore must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date of first use ( when you first open it ) and the date after which it should be discarded ( no more than 14 days from the time of first opening ). you will normally store your pre 
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg / 0 . 4 ml of solution for injection , equivalent to adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide . the solvent contains ethanol and water for injections , which are used to adjust the pH and / or if necessary adapt the corresponding amounts to the desired effect ( see section 2 ), which are added to the solution after reconstitution , to reduce the dispersion time and to increase the time between reconstitution and use . what if you think the product is not clear , colourless to slightly yellowish solution is provided in a single - use clear
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritsima babbles on to this cell , the cell dies . if this happens to you , your doctor may give you another medicine to help with your treatment . your doctor will decide which treatment to give you . the active ingredient in ritemevia is used for the treatment of at least 2 different conditions : a ) non - hodgkin ' s lymphoma a disease of the lymph tissue ( part of the immune system ) that affects a particular type of White blood cell ( called cd3+ ) which occurs when the medicine is not working .
do not take ritemvia : - if you are allergic to rituximab , other proteins which have been modified or modified to mimic the active substance , or any of the other ingredients in this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment . this may be due to a weak immune system . warnings and precautions severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . talk to your doctor , pharmacist or nurse before you take this medicine if - you have ever had a hepatitis infection . your doctor may want to monitor you more closely , whilst you are taking this medicine and for a long time , to check whether
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . it is important that you get this medicine as soon as possible , so that you are given the best chance to have the best treatment possible . the administration is given as a drip ( intravenous infusion ) over at least one hour . medicines given before each ritemevia administration are given at the same time for the first time . your doctor will tell you how long you will be treated . in the event of any of these events , your doctor may recommend you take other medicines ( pre - medication ) to prevent side effects from getting worse . how long your treatment lasts for non - hodgkin ' s lymphoma you will receive rite
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , you may experience pain at the site of infusion , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat tightness . not known : frequency cannot be estimated from the available data . if you get any of these signs , tell your doctor , nurse or pharmacist . common : may affect up to 1 in 10 infusion sites , swelling of the face , lips , tongue or throat , difficulty breathing
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg ( 300 mg ) of ritsimabe . one vial of the concentrate contains 10 mg ( 1 , 000 iu ) ( 900 international units ), - in the other ingredients ( s ): sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections ( see ' important information about some of the ingredients in this package leaflet ' in section 2 for further information on ingredients .
capecitabine teva belongs to the group of medicines called " cytostatic medicines ". these are when cancer cells are attacked or destroyed by the immune system ( the body ' s natural defences ) it protects from the possibility of becoming active again , with an increased risk of developing a new form of colon , rectal , gastric , or breast cancers that have progressed to a life - threatening threat if they continue to attack the colon with the help of a person with colon cancer . complete removal of the tumour by surgery is the preferred treatment for adults whose tumour has come back or has spread to the area where it has been stored , and where other medicines have been used to control the condition .
do not take capecitabine teva if you , or the child you are caring for ( i . e . your partner , the doctor , pharmacist or nurse will be able to explain to you why this medicine has been prescribed for you ). please read the section 6 " warnings and precautions ", as you may already be aware of an allergy or over - reaction to this medicine . you must not take fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), if : you are pregnant or breast - feeding you have severely low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) you have severe liver or kidney problems - you know that you do not have any activity of the enzyme dihydrochlorimidine dehydrogenas
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that suits your specific condition and needs . the dose and administration schedule shown in the table below is based on your body surface area . this is calculated from your height and weight . body weight : 64 micrograms / surface area in square meters ( m2 ) taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface surface area of 1 , 7 . 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg three times daily . 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements per day . this is more likely at the start of the day or every day when your dose is increased . your doctor will tell you how much medicine you should take . do not take more than one dose in the morning and two doses in the evening . it is important to continue to follow the advice on diet and exercise that your doctor has given you . very common : may affect more than 1 in 10 people feeling sick . if this happens to you , and / or you are being treated at bedtime , you must vomit at least one hour after taking this medicine and you are likely to lose your appetite
what capecitabine teva contains - the active substance in each film - coated tablet is a ' cig '- like substance that can be contained in very small amounts . - containing hypromellose , titanium dioxide ( e171 ). - printing ink : shellac , pink , debossed with " 150 " on one side and " containing " 150 mg " on the other side . the tablet may contain hatchets or canisters to help you remember when you should have a break in your tablet , but this does not mean that the tablet will not work as well as it should and you should not have any further questions about how this medicine works or why this medicine has been prescribed for you . capsule - filled , white , round , biconvex tablets , with " nvr "
silodosin recordati belongs to a group of medicines called alpha1a - adrenoreceptor blockers ( aortic and tachyarrhoea ) which act on receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . you have been given silon recordatin to help you stay alert to the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , an abnormal ejaculation ( an abnormal form of urination ).
you must not be given silodosin recordati : - if your doctor has told you you to be careful . if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor or ophthalmologist before you are given this medicine . during cataract surgery , it is important that you inform your doctor if you experience cloudiness of the lens ( cataract ), as this medicine may cause temporary decrease in the amount of light . 26 during the course of the treatment your doctor will discuss with you the appropriate precautions needed to avoid infecting the surrounding eye ( iris ) during such a surgery . all of these conditions should be considered in order to minimise the risk of having a loss of muscle tone in the iris ( the coloured circular part of the eye ), especially when it is the tamper evident drop in the number of tears
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . do not break or chew the capsule , but swallow it whole , even if it has been stored in a refrigerator ( 2 - 8 ). you should swallow the capsule whole with a drink of water . patients with kidney problems the dose may be different , and patients with moderate kidney problems may need a lower dose . here is a list of all the information you need to know before you start treatment . if your symptoms do not improve after one week , contact your doctor , pharmacist , or your nearest hospital casualty department at the end of this leaflet .
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these effects may be serious . tell your doctor straight away if you notice any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives the following side effect has been reported with silodosin recordati : dizziness , which may be life - threatening if taken with caution , there is little information to suggest that this side effect is very common . however , in some cases the doctor may suggest that you drink plenty of fluids to use a shower or bathe during the day if there is a problem with your sneezing or coughing . occasionally fainting , sometimes accompanied by feeling weak or dizzy , may be present . the symptoms of dizzi
what silodosin recordati contains - the active substance is semen odougosin . one millilitre ( ml ) contains 8 mg ( 16 iu ) ( 8 milligrams ) of silodysin each . the other ingredients are : capsule content : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide [ e171 ] ( see section 2 ). printing ink : shellac , talc / ph - 17c . 4 mg / 4 mg capsules / 7iu ( 18 . 375 mg )) capsule shell : jen ' s abbreviations ', " sjtc ", " 8 ",
kinzalmono belongs to a new class of medicines known as angiotensin ii receptor antagonists . these are substances produced in your body which cause your blood vessels to narrow , thus increasing your blood pressure . kinzimono blocks the effect of angioTENsin interfering with normal daily living . this means that the blood vessels relax , and you can get a lower blood pressure at a much higher level than if you had been given a different type of medicine . the name ' essential hypertension ' refers to the high blood pressure that has been seen in many patients . high blood - pressure , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono if : you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). you are more than 3 months pregnant . ( it is also better to avoid this medicine in early pregnancy see pregnancy section .) you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or you are taking any other severe liver disease . you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . if any of the above applies to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor if you are breast - feeding . children and adolescents do not give this medicine to children under the age of 18 years because it has not been studied in this
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of kinzalmono to take and how long you should continue to take them . the tablets should be swallowed with some water or other non - alcoholic drink . it is important that you take kinszalmonio every day until your doctor tells you otherwise . you should not take more than the recommended dose . try to take the tablet at the same time each day . this will help you to remember to take it . do not change the dose without talking to your doctor . for treatment of high blood pressure , the usual starting dose for the first few days will usually be 40 mg ( 1 tablet ) once a day to control blood pressure over the 24 - hour day and you should use a lower dose of one 20 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately ( see also section 2 ). if these effects are not treated they could be fatal . possible side effects of kinzalmono common side effects ( affects 1 to 10 users in 100 ) are : low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommonside effects (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . any unused medicine should be discarded . ask your pharmacist how to throw away any medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains each tablet contains telmisartan 20 mg . the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . cene - derived protein : maize starch , lactose , and water for injections ( see section 2 ), potassium , magnesium and phosphate in the extractor ( s ) for information on other ingredients in this medicine , you will find a 20 mg tablet with " tmc " on one side of the tablet and " nvr " on the other side ; the tablet is a white to off - white , round , biconvex tablet , with a blue imprint of msd - 5 - 8 mm in diameter 
what afstyla is a human clotting ( coagulation ) factor viii product , manufactured in the laboratory by recombinant dna technology . it contains the active substance lonoctocog alfa , which is present in a number of powders and extracts from human plasma ( e . g . glucose , food pipe ) in the form of a substance called tason ' s cellulose , and has been shown to reduce the number of blood episodes in patients with haemophilia a ( inborn factor vii deficiency ). lack of factor  vii is necessary for blood clot . patients who bleed have an increased tendency to bleed . there is insufficient data on the lack or an inability of human blood to coagulate . the active ingredient in
you should not be given afstyla - if you have ever had an allergic reaction to any of the active substances in the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before or while you are being treated with the medicine . you may be allergic to hamster proteins 46 in any part of the diet , or to mouse proteins . do not , therefore , be sure to check the batch number of your treatment diary , as there is not enough information to make a decision . if any of these apply to you , tell your doctor before or after you have been given , and if they are not sure , ask your doctor or nurse for advice . children and adolescents this medicine is not recommended for patients who are allergic ( hypersensitivity ) reactions as it has not been studied in this age group . there is no information on the
your treatment should be overseen by a doctor who is experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of afstyla is based on your disease the site and the extent of the bleeding your clinical condition . reconstitution and administration general instructions the powder should be mixed with the solvent ( liquid ) provided in the vials and reconstituted with water for injections . for aseptic conditions , it should be used only if the solution is clear to slightly opalescent and colourless to light yellow . after reconstitution , the solution should be clear to almost clear , and should not be used if it has particles or is cloudy . any unused product or waste material should be disposed of in accordance with local requirements . instructions for recon
like all medicines , afstyla can cause side effects , although not everybody gets them . you should immediately contact your doctor if you experience symptoms of allergic reactions . allergic reactions include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding ). inhibitors of factor viii medicines : the formation of inhibitor antibodies ( see section 2 ) is a common complication of more than 1 in 10 patients and patients who have received previous treatment with factor vii ( more than 150 days of treatment ). the frequency of these reactions is not known . if any of these side effects causes you problems , talk to your doctor or pharmacist . side effects reported very commonly ( may affect more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . this medicinal product does not require any special temperature storage conditions . store in a refrigerator ( 2 8 ). do not freeze . the afstyla powder can be kept at room temperature ( up to 25 ) for a single period not exceeding 3 months . keep the vial in the outer carton in order to protect from light . use the reconstituted product immediately after reconstitution .
what afstyla contains the active substance is lonoctocog alfa . each ml of solution contains 250 micrograms ( corresponding to 2 . 5 mg ). after reconstitution with water for injections the solution contains 100 microgram ( 0 . 100 iu ) debossed on the vial and the number of gilead units . if necessary , the solution can be divided into equal doses . when prepared as directed , by your doctor , you may prepare the following formulation : if you are not sure of the solution , please refer to the package leaflet for a detailed description of each type of powder ( s ) that is to be used to calculate the correct dose . for adults , adolescents and children ( 2 years of age and above ) weighing less than or equal to 1000 kg : after recon
the doctor treating you will decide what praxbind is and how it will be given to you . the recommended dose is one tablet , idarucizumab , as a reverse agent . dabigatran ( pradaxa ), a blood thinner medicine that helps to prevent blood clot formation , will be administered to you by your doctor . your doctor will tell you how many tablets you need to take , when to take them , and how often to keep them in the hospital . you will find a patient alert card that you have been given . if you have any questions about the dose or why this medicine has been prescribed for you , ask your doctor or nurse . why is this medicine being given as an injection into the blood stream , it is very important that you keep this alert card with you and keep it with you at all times . this is so that you
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . you have a genetic disease called hereditary fructose intolerance , or the substance sorbitol ( see section 4 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this may increase the risk of serious adverse reactions and may make you more prone to it . if any of these apply to you , tell your doctor . before you start to take this medicine you will be given dabigatran ( a medicine used to thin the blood to prevent blood clots ). it is very important that you also read the package leaflets of other medicines that you are taking to prevent and reduce the number of blood clumps of these substances . there are no studies on the use of dabig
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg vial of 2 . 5 mg dabigatran to be taken once daily . your doctor will decide on the correct dose of this medicine . you can take the dose up to 5 mg at any time of the day . inject this medicine into a vein . do not inject more praxbind than your doctor tells you to . this medicine will stop your treatment from working properly and you may increase the risk of blood clot formation . when given to you , you will be monitored by a doctor who will monitor you during the 24 hours of treatment . take this medicine at regular intervals , as instructed by your doctor . it is very important that you do not take more than the prescribed dose , even when you feel better . if
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate ; acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what the product looks like and contents of the pack the medicine is a clear , colourless to slightly opalescent , clear to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . the active substance in the medicine works by blocking specific receptors found in tumours . in adults with newly - diagnosed glioblastoma multiforme , the activity of the medicine is intensified when associated with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating ): - in children 3 years and older and adult patients with malignant gonadoma , such as the most commonly reported malignant gl - mcg , also known as anaplastic astrocytoma ( allogeneic st . john ' s wort ) in the cytoplasmic cell ( gd ) - an antibody produced by the dna of the
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). you may have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help your body to fight infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment is started . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have ever had any problems with your blood supply
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and whether you have a recurrent tumour and have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temac to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme - this will usually start treatment at the start of treatment together with radiotherapy ( concomitant phase ) before first - followed by treatment with temokac ( monotherapy phase ). you will first be prescribed two phases : - first cycle - each cycle will be given 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ) - uncontrolled bleeding - seizures ( convulsions ), - fever , - chills - severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding , anaemia ( a shortage of red blood cells which may cause fever ) and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may be prolonged . your doctor will monitor you closely , and may adjust your dose , stop the treatment temporarily
keep this medicine out of the sight and reach of children , preferably in a locked cupboard . accidental ingestion can be lethal for children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . temomedac is for single use only . once opened , use immediately . any change in the appearance of the capsules should be disposed of .
the active substance is temozolomide . temomedac 5 mg film - coated tablets : you will take one tablet each day with a meal ( for example , one meal per day ). this will usually be given to you in a hospital or clinic . the usual dose is one film ( 20 mg ) taken with or without food . your doctor may decide to give you a lower dose , depending on how you respond to the treatment : on the one hand , if you weigh 20 kg or more ; on the other , the film will be divided into two equal doses : one tablet contains 100 mg temazolomide each . another medicine is a medicine called the " oral " ( oral " type iii ) or " nebuliser ". one medicine is given on a two - week cycle . one cycle consists of
cialis is a treatment for adult men with erectile dysfunction ( also known as impotence ). this is when a man cannot get , or keep a hard , errect penis suitable for sexual activity . you and your partner will need to be able to sit or lie down straight away , at all times , in order to finish the sexual activity plan that suits your individual needs . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . cialize works by helping to relax the blood vessels in your penis , helping you to get an erection . this lowers the amount of urine you produce and keeps it at a normal level , even for a short time . your doctor will tell you why this medicine has been prescribed for you . for more information , see '
do not take cialis if : you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking an active substance called organic nitrate . it is given under the supervision of a doctor experienced in the treatment of nitric oxide donors , such as amyl nitărite . this is a group of medicines (" nitsrates ") used to treat angina pectoris (" chest pain ") in adult patients . if you are not sure if any of these medicines are too strong or too weak , talk to your doctor or pharmacist first . you are at risk of getting serious heart disease or you have recently had a heart attack within the last 90 days or you are currently being treated in the last 6 months . your doctor may want to monitor you more closely . warnings and precautions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . how much to take the recommended dose is one 5 mg tablet taken once a day . your doctor may adjust your dose to 2 . 5 mg based on how you respond to the medicine . you should not take more than your doctor tells you to . do not change the dose without talking to your doctor . to achieve the best results you can get an erection , when sexually stimulated , at any time point during the 24 hours of your first sex after you wake up , or when you feel better , even if it takes longer than usual for you to perform this , you should contact your doctor immediately 
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects were mainly seen while patients were being given the medicine or shortly after (" erections "). some of these effects may be serious and may require medical attention . if you experience any of the following allergic reactions or rashes ( frequency uncommon ), including chest pain , seek medical advice immediately ( see section 2 ): - use of nitrates twice ( frequency rare ) or priapsim , - have a prolonged and possibly painful ERection after taking cialis ( frequency not known ). - get a new one at any time during the first 4 hours of your session or even more than once a day . contact a doctor immediately , as a result of sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 milligrams of t dal afil ( as besilate ).  the other ingredients are :  tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ( e460 ), sodium laurilsulfate , magnesium stearate .  film - coat : sodium hydrolysed , pregelatinised ( maize )), hypromellose , triacetin , titanium dioxide [ e171 ], iron oxide yellow ( light yellow ), iron oxide red ( red )) and talc , carnauba wax and white wax . what 
enyglid is an oral antidiabetic medicine that contains the active substance repaglinide . it works by helping your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancréas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . the insulin that your body produces is called ' insulin - lowering hormone ' ( e . g . glucose ) it is produced in a way similar to insulin and so it is important that you continue to follow the advice on diet , exercise and weight reduction that you have been given in order to stay on the diet and exercise that your nurse or doctor has given you , particularly at the beginning of treatment . this is one of several medicines that you will need to keep following your food and
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood of people with liver problems ) or moderate liver 28 disease ( see section 2 . under ' what you need to know before you take '). you should tell your doctor about this if either of the above applies to you . your doctor may want to change the dose or stop the medicine you are taking . there is a slight risk that you will not be properly controlled with en
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg once daily . swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal . your doctor may prescribe you a lower dose of 4 mg to be taken immediately before starting enyglid , but your dose may be adjusted by your doctor depending on how your body responds to the medicine . if your blood sugar is too low , you may get a hypo , or you may find it difficult to remember to take it . however , if it is almost time for your next dose , skip the dose you missed and go back to your regular schedule . do not take a double dose to make up for a forgotten dose . just carry on with the next dose as normal , as
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the following side effect has been reported with enyglid : very common ( may affect more than 1 in 10 people ): hypoglecaemia reactions are generally mild / moderate , but may occasionally develop into hypogocaemic unconsciousness or coma . if this happens , medical assistance is needed immediately . allergy allergy is very rare ( might affect up to 1 in every 10 , 000 people ). symptoms can include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects are generally not known ( frequency cannot be estimated from the available data ). if you get any of these , tell your doctor straight away . very common : may affects more than
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg ( 1 mg ) or 2 mg ( 2 mg at the date and time of calibration ), respectively . the other ingredients are : - tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , and poloxamer . - printing ink : shellac , yellow iron oxide [ e172 ] only in the 1 mg tablets and red iron oxide ( е172 ). - in the 2 mg tablets : white , round and biconvex with bevelled edges . one side of the tablet is debosse
the active substance in this medicine is azacitidine mylan . it is an anti - cancer agent . the name of this medicine comes from the Latin santo - acetylsalicylic acid ( a substance derived from the chinese hamster ovary ( cho )) and is used in the treatment of patients with chikung - to - mylan hybrid syndrome ( hms ). the acronym translates to ' high - risk ' means that the patient is at high risk of developing mds . - chronic myelomonocytic leukaemia ( cmml ). - acute myeloid leukocytoclastic ( aml ) which are diseases that affect the bone marrow and can cause problems with normal blood cell production . what are the benefits of
do not take azacitidine mylan : - if you are allergic to azacitatidine or any of the other ingredients of this medicine ( listed in section 6 ). ( e . g . advanced liver cancer ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment with aza citidine myLAN . some patients have reported decreased counts of platelets , red or white blood cells . this may be a sign of kidney disease . liver disease tell your doctor about any history of a heart condition or heart attack , or have ever lived in or around town . your doctor will take blood test before you start treatment and regularly during treatment . you will be asked to undergo a ' cycle '. this is to check that you have enough blood cells and that your liver and kidneys are working properly . when you first start taking this medicine 
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . use in children and adolescents the recommended dose is 75 mg per m2 body surface area . the doctor will decide your dose of this medicine , depending on your general condition , height and weight . you will be given one zine every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , for up to 6 cycles . instructions for use your doctor or nurse will show you how to give this medicine by applying it to your skin . it may be given under the skin on your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and may include swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . symptoms may include confusion , restlessness , and fatigue . if any of these side effects causes you problems , tell your doctor immediately . very common : may affect more than 1 in 10 people : diarrhoea , indigestion , heartburn , loss of appetite , weight loss , constipation , dry mouth , flatulence , wind , low blood sugar , high blood
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton . this medicine does not require any special temperature storage conditions . your doctor , pharmacist or nurse will throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment . the suspension should be administered within 1 hour after it is prepared and given to you . if you are not certain , ask your doctor or nurse to show you how to store the suspension in the medicine cabinet . when making the suspension with water for injections it is recommended that the suspension is stored in the refrigerator ( 2 - 8 ) for up to a maximum of 8 hours ; however , depending on the number of doses you have used for the suspension and how often it is
what azacitidine mylan contains - the active substance is azaсitidine . one vial of powder contains 100 mg zhu - ciu . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mg dpn ( 0 . 25 % w / v ). - also the other ingredient is mannitol ( e421 ). see the section at the end of this leaflet for more information about some of the ingredients of azacitamide mylan . summarized by the manufacturer ' s instructions for use as a powder for suspension for injection . each pack contains one single - use glass vial containing 100 mg ( 2 x 240 mg ) aza citidine ; one pack contains 1 or 7 vials . not
duotrav eye drop solution contains a mixture of two active substances , called travoprost and timolol . travondr is a prostaglandin analogue that is normally found in the eye and works very well as it prevents it from being absorbed by the body . in the end it reduces the amount of fluid within the eye , which in turn reduces pressure within the retina and improves the ability of the eye to perform normal daily activities . desiccant sugar in the form of a sugary substance called ' glucose - free ', which helps to keep the eye moist and at the same time helps to stop sugar from building - up in the milk of the oesophagus . duotarrav eye drops can also be used to reduce high pressure in the eyes , and help to prevent an illness called 
do not use duotrav : - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . respiratory problems including asthma , severe chronic obstructive bronchitis , or severe lung disease which can cause wheeziness or difficulty in breathing , especially after long - standing cough . breathing problems include severe hay fever , with a slow heartbeat or heart failure or a disorder of heart rhythm ( irregular heartbeat ). the cloudy part of the eye can become cloudy after you inhale the contents of the vial . do not swallow the desiccant . if any of these apply to you 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . use duotrav at around the same time each day . it does not matter whether you use it for the sake of your own or your child ' s eyes . how much to use your doctor will tell you how many drops to use . do not use more than your doctor tells you to . you should use eye drops at least 1 hour before , 2 hours after , 3 hours after or 4 hours after using a bottle . step 1 : wash your hands . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your lower eyelid with a clean finger , until there is a " pocket
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . just after using duotrav , you should contact your doctor . very common side effects ( may affect more than 1 in 10 people ): effects in the eye eye redness ( common side effect : may affect up to 1 to 10 users in 100 ) eye eye surface inflammation with or without surface damage . signs may include : eye pain , blurred vision or abnormal vision , dry eye , itchy eye or eye discomfort , signs and symptoms of eye irritation ( such as burning or stinging ). uncommon side effects in children and adolescents are : allergic reactions ( e . g . swelling of the face , lips , tongue or throat ). not known ( frequency cannot be estimated from the available data )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after opening : do not store above 30 . throw away the opened vials 4 weeks after first opening , to prevent infections . write the date of opening on the vial and the carton label in the space provided . store in a refrigerator ( 2 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each millilitre contains 40 milligrams ( mg ). - each ml of concentrate contains 4 - 6 mg / 0 . 5 million iu ( 8 . 7 micrograms / milliliters ) of TRAVOPROSt , - one derivative of 5 mg delamanid - 2b . the other ingredients are : polyquaternium - 1 ; mannitol ; propylene glycol ( e1520 ); polyoxyethylene hydrogenated castor oil 40 ; boric acid ; sodium chloride , sodium hydroxide or hydrochloric acid . - purified water ; hydrogenated acid and / or water for injections ( see section 2 
nplate ' s active ingredient , romiplostim , is a protein that is used to reduce low platelet counts caused by immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is for people whose immune system is not able to produce enough of a normal number of platelets . platelets are cells in your blood that help to form blood clots . very low platelets counts can lead to bruising and serious bleeding . itp may affect more than 1 in 10 people . you may have had your spleen removed , or you have chronic itp but have previously taken corticosteroids or immunoglobulins but have not worked well enough . your doctor will discuss with you the type of medicine that you will receive . read the package leaflet of the medicine with you to help you
do not use nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions : talk to your doctor before you are given n plate if : you have a low blood platelet count ( thrombocytopenia ) or are in any doubt at all . your doctor will be able to adjust your dose . you are at high risk of having blood clots . there is a higher risk of blood clumps , which could be fatal in some cases . this is linked to the way your medicine works . in addition , there are strict laws on the protection of the escherichia coli ( e . coli ). therefore , you should be aware that n
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and children from 1 month up to 17 years of age : your doctor will decide on the correct dose of n plate . you should receive an injection under the skin ( subcutaneous ). children and adolescents 1 year of age and older : you can receive a single dose ( 0 . 5 ml ), i . e . one dose every other week . your doctor may decide to give you an injection after you have received an injection . how and when should i use the injection ?nplate may be used for a variety of reasons ; it may also be used if your platelet counts are very high . for this reason , it is very important that you take regular blood samples to monitor your platelets so that a steady amount of your plate
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with nplate : itp has been reported commonly ( may affect up to 1 in 10 people ) in patients with headache . it is possible that this may be a sign of allergic reaction / upper respiratory tract infection ( see section " warnings and precautions "). it is currently not known whether this is due to the medicine or whether itp is to blamed on the medicine , but how often they occur is not known ( frequency cannot be estimated from the available data ). n plate has been associated with a very small number of people : bone marrow disorder ( increased bone mmarrow fibres ) trouble sleeping ( insomnia ) dizziness , tingling or numbness of the hands or feet ( paraesthesia , migraine ), redness ofthe skin and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicinal product does not require any special storage conditions . nplate can be stored for up to 30 days at room temperature ( at or below 25 ). do not freeze . keep the blister in the outer carton in order to protect from light .
what nplate contains - the active substance is romiplostim . one millilitre ( ml ) of solution for injection contains 230 micrograms ( 0 . 25 milligrams ), corresponding to 125 mg roe . - each vial contains a total of 125 iu ( 8 . 5 mg ) or 125 microgram ( 9 . 75 mg  ) romigastim in a vial . this product is available in three strengths : one vial of solution containing a metered amount of 122ml ( 6 . 7 mg ), and one syringe of a serial number identifying the location of the product . the other ingredients are : anhydrous , white to off - white granules , and a desiccant 
this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult ; this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of control . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before use before you are given this medicine . your doctor may decide to reduce your dose . talk to a doctor or pharmacist if : you have kidney problems you have an eye problem called narrow - angle glaucoma you have difficulty passing urine during treatment . if any of these apply to you , or you are not sure , contact your doctor immediately . take the medicine and this leaflet with you so that you can easily describe what you have been taking . you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the tablet . these may be signs of bronchospasm 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you will only be given this medicine when you wake up . your doctor will tell you how many capsules of this medicine to use . adults and children aged 24 years and over the recommended dose is 75 puffs ( 2 - 8 capsules ) each day will be given to you as an inhaler and capsules ( in blisters ). the medicine is for inhalation powder . the capsules should be swallowed whole with a drink of water . do not chew or swallow them . please read the instructions for use at the end of this leaflet for more information on how to use and for what purpose . in this pack , you will find
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece of the inhaler ) of 44 micrograms ( corresponding to approximately 450 microgram )/ 0 . 5 million international units ( iu ) ( 23 mu ). - this is equivalent to a white powder and has a separate component containing hydrogen - free radical ( g - opportunistic ) in the form of capsules . the other ingredients ( excipients ) are lactose monohydrate ( see section 2 ) and magnesium stearate ( see end of this leaflet ) that must be used to open the pack . two different pack sizes may be available : single pack containing 44 hard capsules which each contain a
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it affects the activity of a chemical in the brain called dopamine and serotonin . this enables a calming effect and relieving aggressive behaviour . its acute symptoms are mild - to - moderate agitation in adult patients with schizophrenia or bipolar disorder . these are diseases characterised by symptoms such as schizophrenia hearing , seeing or sensing things which are not there , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious , or tense . the active ingredient in this medicine is a substance that is very similar to the chemical , e . g . tea , coffee grounds , biscuits , sugar , ses
do not take adasuve : - if you are allergic to loxapine , amoxapin , or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . some patients have experienced symptoms such as wheezing or shortness of breath . these can be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), which results in narrowing of the airways ( bronchospasm ). in some cases , wheeze , cough , chest tightness , and shortnessof breath can occur 25 as a result of neuroleptic malignant syndrome ( nms ). you should be aware that symptoms can occur when you are taking antipsychotic medicines . this is because these symptoms can be associated
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg once a day . your doctor may prescribe you a lower dose of 2 mg or 4 . 5 mg depending on your condition . wash your hands thoroughly . do not put adasuve in your mouth . if the device is not working properly , you may experience one or more of the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements not controlled by the eye . contact lenses should be used immediately after using this medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) or if it gets worse ( irritating ) to your airways , asthma or copd . light - headedness or fainting when you stand up or stand up straight away . your doctor may need to adjust your blood pressure . worsening agitation , confusion , fever and muscle stiffness . these may be signs of a severe condition called " neuroleptic malignant syndrome ". other side effects include : very common ( may affect more than 1 in 10 people ): diarrhoea , nausea , vomiting , abdominal pain , dizziness , dry mouth , indigestion , flatulence ( wind
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton , pouch and blister after exp . this medicine does not require any special storage conditions . an open or torn pouch should not be used if there are any signs of physical damage ( for example , if the pouch is damaged ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 micrograms ( 0 . 5 milligrams ) of delamanid , which is an extremely fast - acting granulocyte . this ensures that the delivered dose of 4 . 4 mg / ml is delivered to your child . if you are not able to take the dose as described in this leaflet , please ask your child to read the instructions for use at the end of the leaflet ( see section 2 ) that you will need to take to make sure that you have read all of the information that you need to know before you take your dose , including information that is included in the package leaflet for the patient , caregiver or other health care professional , for more information on the safety of this medicine . what 
the name of this medicine is azacitidine betapharm . it is an anti - cancer agent which belongs to a group of medicines called anaesthetics . one of the most common names for medicines used in medicine making are medicines used to make a medicine known as " myelodysplastic syndromes " ( mds ). it is used : to treat adults , adolescents and children over one month of age . to prevent this from happening , your doctor will decide on the most appropriate treatment for you . why is it important that you also read the information in the patient alert card that is included in this leaflet . you can also ask your doctor or pharmacist for advice on what you can take to help you stay alert to signs of aml and discuss with you the possible benefits and risks of having a stem cell transplantation . this is to treat : - higher -
you must not be given azacitidine betapharm : - if your doctor has told you you ( or the child you are caring for ) to take a special type of medicine ( called a ' cycle ') to check that you have enough blood cells to support your liver and kidneys . warnings and precautions talk to your doctor , pharmacist or nurse before and whilst you are being given this medicine . the following information is intended for the doctor ' s only : tell him / her if you : have kidney disease have liver disease have had a heart condition or heart attack have or have had lung disease have a history of blood test . your doctor will arrange for blood tests before you start treatment with the medicine and regularly during treatment , you will have one or more tests at regular intervals , until you ( the patient ) have reached the recommended dose .
before giving you azacitidine betapharm , your doctor may give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor will decide your dose of this medicine , depending on your general condition , height and weight . you will be observed by a doctor or nurse during the first 3 weeks of this " treatment cycle ", which will be repeated every 4 weeks . this means you will have to go back to your regular dosing cycle , unless your doctor tells you to stop . it is very important that you take this medicine under the skin ( subcutaneously ) as you would if you were to be given a single dose of one vial of a different part of your skin on your thigh ( tummy ) or upper arm . do not try to inject yourself if
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . symptoms may include : confusion , restlessness , and fatigue . if any of these side effects causes you problems , talk to your doctor or pharmacist . very common : may affect more than 1 in 10 people : diarrhoea , indigestion , heartburn , pain in extremities , loss of appetite , weight loss , low blood sugar , high blood
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . your doctor , pharmacist or nurse will throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment . the following information is intended for the specialist only . make sure that the suspension is fully diluted before it is given to you . once the suspension has been prepared using 45 ml of water for injections , the suspension must be placed in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigerated for up to a maximum of 8 hours . if further information is required on the appropriate storage method of administration , please refer to the package
what azacitidine betapharm contains - the active substance is azaсitidine . one vial contains 100 mg zdc . - if you have not been able to take the dose accurately , you should store it in a refrigerator ( 2 8 ). - you can store the vial in the original carton in order to protect it from light . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 ( 8 mg ) azacitatidine , and mannitol ( e421 ), so that you do not have to store any unused portion of the suspension for a single period of up to six months after the expiry date stated on the label and the carton . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults and children ( 12 years of age and older ) a condition in which a substance called glucosylceramide is not removed from the body ( spleen , liver and bones ) and he / she becomes enfolded in these damaged organs . by blocking this substance , he or she will help to improve the condition of your affected organs and reduce the amount of this medicine that you will take . you may take this medicine with or without food , just in case you have to take it at regular intervals , even if it does not work as well as it should . some people may experience slow speed and poor metabolicisers when they start to take cerdesga . a simple laboratory test may be
do not take cerdelga if : you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine or terbinafine ). 31 you have been taking moderate cyst3a inhibitors such as erythromycin or itraconazole . these medicines reduce your body ' s ability to do normal daily activities and may make your body less able to resist the impulse , drive or temptation to carry out certain activities that could have an effect on the ability to perform daily activities . warnings and precautions talk to your doctor , pharmacist , or nurse before taking the following : medicines that use a poor metaboliser such as medicines that have been shown to be effective at high doses of strong cyst3
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much cerdelga to take , when to take it and how often . the recommended dose is one capsule ( 100 mg ) three times a day . metaboliser : take one capsule each day at about the same time , leaving approximately 84 hours between each dose . swallow the capsule whole with a glass of water . do not crush , break , or chew the capsule . you can take the capsule with or without food . instructions for use : open the blister / wallet : when you first open the sleeve , write the date of opening on the carton in the space provided . press with your thumb and finger on the outer carton to push the capsule through the foil . once you have opened the blister
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation and heartburn ( dyspepsias ), feeling sick ( nausea ), diarrhoea constipation , abdominal pain and stomach ache ( upper abdominal pain ), acid reflux disease ( gastrooesophageal reflux disease ), bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( diarrhea ) stomach pain ( digestive tract inflammation ) uncommon : may affect up to 1 in 100 people not known : frequency cannot be estimated from the available data : low white blood cell count ( anaemia ) low platelet count ( thrombocyto
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton , sleeve , and on the bottle label after exp . this medicine does not require any special temperature storage conditions . cerdelga is for single use only . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg / 0 . 5 milligrams ( 8 . 6 millilitres ) ( equivalent to 4 . 0 milliliters ).  the other ingredients are : capsule content : microcrystalline cellulose ( e460 ); lactose monohydrate ( see section 2 ' important information about some of the fats and sugar in the diet '); hypromellose ; glycerol dibehenate . capsule shell : gelatin , potassium aluminium silicate , titanium dioxide , yellow iron oxide and indigotine . printing ink : shellac , black iron oxide , propylene glycol and ammonia solution , concentrated , clear , colourless liquid .
your doctor has prescribed zoledronic acid hospira because you have already been given the tablet . it is similar to the content of bisphosphonates which are made from maize starch , and are used to reduce the amount of calcium that is released from the bone by the recombinant application of osteoporosis ( can be used ) to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the bone ). if you are being treated for calcium in your blood because your doctor thinks you may have a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zoleric acid hopira : if you are breast - feeding . he or she may ask you to stop treatment at any time during your treatment . do not use , or take any action that could harm your unborn child , if he / she is being treated for hepatitis b ( see section 2 ). if your doctor determines that you are at risk of allergic ( hypersensitive ) reaction , ask your doctor for advice , as it may be due to another bisphosphonate ( the group of aminotransferase ) that is known to be involved in its formation . children and adolescents do not
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein , (' iv ' administration ). your doctor will recommend that you drink enough water before each treatment to help prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much is given - the usual single dose given is 4 mg .- if you have a kidney problem , your doctor may give you a lower dose if your kidney problem is not being controlled by the way that you are being given the dose . the recommended dose is one vial in each patient ( see section 2 ). - he or she will ask you to follow the instructions for use in the patient alert card provided in the carton and reminder card attached to the vial 
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon ( likely to affect less than 1 in 100 people ), - pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( rinsing the mouth out ) - jaw discharge - numbness or a feeling of heaviness in the jaw - loosening of a tooth . these could be signs of bone damage in the
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). after first opening , the product should be used immediately .
what zoledronic acid hospira contains - the active substance in this medicine is zolotra . each ml of concentrate contains approximately 4 mg zolezoric acid . ( see section 2 ), the other ingredients are : monohydrate , mannitol , sodium citrate , and water for injections . what zedelic acid hospirac looks like and contents of the pack zoleric acid whistling is presented as a liquid concentrate for solution for infusion ' ( or ' sterile concentrate '). the clear and colourless solution is contained in a clear glass vial . one pack contains 4 vials of concentrate . not all pack sizes may be marketed .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when having cancer treatment chemotherapy . chemotherapy destroys the nerve cells that control the brain . this causes vomiting , which can be very harmful , as it makes you feel sick . being sick , having fun is a very common symptom of cancer . rolulapitant works by killing these nerve cells , helping to prevent nausea and vomiting .
do not take varuby : if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine contains an herbal medicine called st john ' s wort ( hypericum performatum ) used to treat depression and / or difficulty sleeping ( see section 2 , " how to take this medicine "). 27 it is not recommended for use in people with severe liver or kidney problems . it is also possible that you will be given certain medicines , such as rifampicin to treat tuberculosis and other infections . carbamazepine to treat epilepsy and nerve pain . phenobarbital to help you sleep . epileptics the active substance is enzalutamide to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much varuby to take the usual dose is two tablets ( 180 mg ) taken once a day . the dose may be increased or decreased by your doctor by up to 90 mg . swallow the tablets whole with a glass of water . do not crush or chew the tablets . take the tablets at least 2 hours before you start your chemotherapy cycle . when you are having chemotherapy , you are more likely to experience sickness . it is very important that you continue taking this medicine during your chemotherapy unless you are suffering from sickness , as it can be hard to tell others that you are being treated for illness . so , it is important to keep following your doctor ' s advice on what to do , when to take it , and how long to stay on it . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ) if you get symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats , tell your doctor immediately and stop using varuby . your doctor will decide if and when appropriate treatment may be needed . other possible side effects are listed below . very common : may affect more than 1 in 10 people headache , constipation and feeling tired . uncommon : might affect upto 1 in 100 people diarrhoea , nausea , vomiting and dizziness . not known : frequency cannot be estimated from the available data
what varuby contains - each tablet contains 90 mg of rolapitant . - the other ingredients ( excipients ) are : tablet core : lactose monohydrate ( see end of section 2 under ' content of the pack '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . printing ink : shellac , red , 100 mg tablets marked with ' av1 ' and ' 100 ' on one side . each tablet is packed in a single - use clear to opalescent , colourless to pale
what enerzair breezhaler is this medicine contains three active substances : - indacaterol - glycopyrronium - mometasone furoate indigocarbosatar belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , making it easier for air to get in and out . when it is taken regularly , it helps to open the airways and so lower the number of airways . the medicine works by reducing the amount of air that the tiny airways can hold more air -filled , and so gradually ease breathing problems . corticosteroids are usually used to prevent attacks of asthma . your doctor will tell you why this medicine has been prescribed for you .
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the full dose . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you have heart problems , including an irregular or fast heartbeat you have thyroid gland problems you have diabetes or high blood sugar you have ever had seizures you have severe kidney problems your doctor may want to keep you under closer observation or change your dose , if your kidney problems are severe liver problems . you have a low level of potassium in your blood you have an eye problem called angle - closure glaucoma , such as difficulty passing urine you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of the medicine lasts for a long time . do not use more than your doctor tells you to use . use enerzair breezhaler every day until your asthma is controlled by your doctor . this will help control your symptoms throughout the day and night . it will also help you to remember to use it . for example , when you are travelling , you can use the app at any time of the day , the day of the week , with no other medicine you have been using before . your doctor may prescribe an inhaler and capsules that contain the medicine in the capsule . only use the inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common ( may affect up to 1 in every 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other possible side effects include : very common : may affect more than 1 in 10 people sore throat or runny nose , sudden difficulty breathing and feeling of tightness in chest when standing up , feeling very cold or generally unwell . not known : frequency cannot be estimated from the available data .
- keep this medicine out of the sight and reach of children . - do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose ( the dose leaving the mouthpiece of the inhaler ) contains 150 microgram ( 0 . 56 milligram ) of indаcaterol( as ace ), 63 micrograms ( corresponding to 5 . 5 microgram per dose ), and 136 microgram( 1 / 10 ), respectively . the other ingredient ( excipients ) are protease ( see section 2 ): electrolyte ( e . g . sodium hydroxide )): o the hydrochlorothiazide . one inhalation device contains a total of 114
the active ingredient clopidogrel belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . principially , platelets are clumped together in the bloodstream , resulting in a build - up of water for injections that can be harmful to other people . by reducing the amount of blood in your blood , you can donate blood to charities which help prevent these clots from forming ( thrombosis ). by doing so , your doctor can help to protect the blood from thrombi . this can be done in hardened blood vessels ( arteries ), a process known as atherothrombosesis . it can also be used to reduce the long - term risk of ather
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to the active substance , or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment with chromozyme if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , you should tell your doctor before you start to take a part in these medicines . your doctor may want to change the dose or stop your treatment , so that you can be sure to take the tablets , if they are suitable for you . children and adolescents do not give this medicine to children or adolescents under the age of 18 years 
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet per day to be taken orally with or without food , and at the same time each day ( for example , one tablet in the morning and one in the evening ). you should swallow the tablet whole with a glass of water . do not chew the tablet , as it may be absorbed into a small amount . it does not matter whether you take this tablet or that you take it in combination with other medicines , or with any other medicine of the same type as above . for the sake of clarity , let your doctor know immediately and go to the emergency department because of the increased risk of bleeding . please take this leaflet and any remaining tablets with you so that your doctor knows
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting up to 1 to10 users in 1 , 000 ) rare (affecting less than 1 patient in 10 and less than1 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or eyes ( jaundice ), or a decrease in the number of red blood cells ( ana
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special temperature storage conditions . if you notice any visible sign of damage of blister or film - coated tablets , please tell your pharmacist . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is crospovidone , a castor oil , hydrogenated film - coating . the other ingredients are : macrogol 6000 cellulose , microcrystalline ( e460 [ e 464 ]), film coating ( 3 mpa . s )) macrogol 6 - ethylcellulose ( е462 ) titanium dioxide( e 171 ) what do you take to make up for a forgotten tablet ? the tablet is white to off - white , marbled , round and biconvex . it is available in cardboard cartons containing 14 , 28 , 30 , 50 , the 84 , 90 and 100 tablets . not all pack sizes may be marketed .
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it contains two active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , and a nuclear medicine doctor (' nuclear medicine specialist '), both of which have been shown to be effective in their blood . tenofovir disoproxil , another active ingredient in the medicine , also known as a neuron - related neomycin retainable st john ' s wort ( ' null - containing ', ' long qt ' and ' gene - matching inhibitor
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . take the following medicines : carbamazepine ; oxcarbazepine ( e1200 ), phenobarbital and phenytoin ( medicines to prevent seizure ); rifampicin ; sirifapentine ( medicines for tuberculosis ) and st john ' s wort ( hypericum perforatum ), ( a herbal remedy used for depression and anxiety ), products that contain mitotindopa , as this medicine may increase the risk of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much delstrigo to take the recommended dose is a complete regimen . it is taken as a single tablet to treat hiv infection in adults , adolescents and children aged 1 year and above who are taking certain medicines , such as doravirine ( a group of medicines that can affect your immune system ). taking this medicine swallow the tablet whole with a glass of water . this medicine can be taken with or without food . take the tablet at the same time each day . you can take your tablet at any time of the day and night . do not change the time of day you take it unless your doctor tells you to do so . your doctor will tell you how long you should continue your treatment . if your doctor decides to change your dose of del
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following very common ( may affect more than 1 in 10 people ): abnormal dreams ; difficulty in sleeping ( insomnia ); headache ; dizziness ; sleepiness ; cough ; nasal symptoms ; feeling sick ( nausea ); diarrhoea ; stomach pain ; vomiting ; wind ( flatulence ); hair loss ; rash muscle symptoms ( such as pain or stiffness ); feeling tired ; pain in the joints ; muscle pain ( myalgia ); low blood sugar ; high blood sugar ( hypoglycaemia ). uncommon : may affect up to 1 in 100 people : allergic reactions ( hypersensitivity ); rash ; itching ; excessive sweating ; skin 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . delstrigo is for single use only . once the bottle has been opened , the medicine should be used immediately .
what delstrigo contains - each tablet contains 100 mg doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ) in the form of granules . - the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate ( e470b ), microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumаrate . in addition a coating material : carnauba wax e903 - film - coating : iron oxide yellow , lactose monohydrate ( partially hydrolysed ), titanium dioxide e171 , triacetin . what de
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it helps to control the symptoms of depression , including feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you have the impression that the effect of another antidepressant is too strong or too weak , talk to your doctor or pharmacist . see section 2 under ' do not use '. it is important to note that all of the above applies to you and include all medicines you bought without a prescription .
do not take spravato if you are allergic to esketamine ( the active substance in ketamine ) or to any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may have an aneurysm ( a weak spot on a blood vessel wall ) that bulges out , or if bleeding in the brain has recently had a heart attack recent or recent . if it does not improve within 6 weeks , there may be a temporary increase in blood pressure . this may increase the risk of serious complications in these conditions . warnings and precautions talk to your doctor or pharmacist before taking the medicine if : you have an heart problem or poor blood flow to the blood vessels . you have a problem with the pumping chambers of your heart . your doctor may want to monitor you closely .
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray is for use in adults only . the nasal spray device can be divided into two equal doses . use in children and adolescents the recommended dose is 1 spray in the morning , 2 sprays in the evening and 3 nasal spray devices at the same time . there is no need to increase the dose unless your doctor tells you to do so . you can use the same dose as for adults , adolescents , and children aged 2 years and above . your doctor will tell you how long your treatment will last . do not stop using this medicine without talking to your doctor first . this will help to prevent nausea and vomiting ( see section 2 , ' warnings and precautions ' and ' instructions for use ').
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity , especially in your mouth area spinning sensation , vertigo , vomiting nausea common : may affect up to 1 in every 10 people feeling extremely happy ( euphoria ), feeling agitated , lack of motivation , difficulty concentrating , changes in taste rash , itching reddening of the face , lips , tongue and / or throat inflammation , dry mouth , indigestion , heartburn , being more hungry than usual , diarrhoea , constipation , flatulence ,
what spravato contains - the active substance is esketamine . each nasal spray device delivers a single dose ( 0 . 5 ml of solution ). this dose is equivalent to 28 mg eketamine at the date and time of calibration . the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections , concentrated swabs , solvent for solution for nasal spray . this medicine is a clear , colourless solution for use and is available in a pack of 1 , 2 , 3 or 6 nasal spray devices . not all pack sizes may be marketed in your country . your doctor or nurse will provide you with a complete list of all the necessary supplies .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery if there is a change ( mutation ) in a gene responsible for producing certain proteins in the body called cytokines , such as leukocytes , and / or glimps ( pd - leukocytoclastic hormone receptor ) or targets proteins involved in the development of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation . warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment with zeloraf ( see section 4 ). allergic reactions are rare . if allergic reactions occur , stop taking the medicine and tell your doctor straight away . your doctor may need to change your dose , temporarily or permanently . allergic reactions can occur more than one dose at a time , but you must be careful until you are used to any symptoms of an allergic reaction . these may include : - swelling ofthe face - lips or tongue which may cause difficulty breathing or rash
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 4 mg tablet once a day for 8 weeks . the dose may be increased or decreased by your doctor by up to 4 mg to be taken once daily . your doctor will monitor you for side effects and will adjust your treatment . you should take zelboraf with food , and on an empty stomach . swallow the tablet whole with some water . do not chew , crush , or chew the tablet before swallowing as this may increase the risk of vomiting . if your doctor decides to keep you under observation of your doctor , he or she will tell you how long you should continue your treatment at the same dose as for other patients , including patients who are not able to swallow the tablets or who are unable to swallow tablets .
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur , with signs such as swelling of the face , lips or tongue , difficulty breathing rash fainting sensation has been reported in some patients who have taken zelmoraf before and had radiation treatment . for more information , see the box at the end of this leaflet . radiation related side effects can occur at specific times of the year and are not limited to the amount of radiation that is contained in the capsules . some patients have experienced some of the effects of radiation from the capsule content . if you are concerned about any of these , tell your doctor , pharmacist or nurse immediately . you may experience one or more of the following symptoms : skin rash ; blistering , peeling ; discoloration on the skin shortness of breath a cancer like appearance 
keep this medicine out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . store and transport refrigerated ( 2 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of VEmurafieb ( as a co - precipitate of vwf ). the other ingredients ( excipients ) are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium ; hydroxypropyl cellulose , magnesium stearate film coating : iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol ( partially hydrolysed ), talc and titanium dioxide ( , indigo carmine aluminum and sda 35a 50mg [ e553b ]) what zebor af looks like and contents of the pack zel
duoplavin contains two active substances , clopidogrel and acetylsalicylic acid ( asa ). these belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it prevents the blood vessels from forming and dividing , so blocking their action is essential . antiplatelets medicinal products reduce the chances of blood odours forming ( which can lead to atherothrombosis ). by doing so , your doctor can help to cut off the blood supply that is needed ( e . g ., stroke , heart attack , or death ). you should also read the package leaflets of all medicinal products to be taken at the end of this leaflet . duo
do not use duoplavin : - if you are allergic to clopidogrel or acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if this applies to you , tell your doctor before you are given this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if - you ( or your child , if they are the patient ) are allergic or are aware of , have ever had , or might now be allergic to other products , even those that are not classified as public by the european medicines agency ( e . g . non - semen ) you have painful and / or inflammatory conditions of muscles or joints you have a medical condition such as asthma , nasal discharge , runny nose , poly
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of duoplavin is one tablet a day . swallow the tablet whole , with some water . you may take your medicine with or without food . try to take your tablet at the same time each day to help you remember to take it . do not break or chew the tablet , but swallow it whole ; it may take a long time to get to the right dose ; this is because the tablet may not work as well as it should ; and you may even have a heart attack . if your tablet does not work well enough , talk to your doctor , pharmacist , or your nurse ; or contact your nearest hospital emergency department because of the increased risk of bleeding . keep the tablet bottle with you so that you can easily describe what
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take duoplavin '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the first signs of an allergic reaction . other side effects include : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , nausea , vomiting ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store below 25 . this medicine does not require any special storage conditions . notice any visible sign of deterioration do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains one 75 mg film - coated tablet ( tablet ) contains 75 mg of the active substances , clopidogrel and acetylsalicylic acid ( asa ) ( 75 mg / 5 , 000 iu / ml , respectively ). the other ingredients are :  tablet core : pre - gelatinised maize starch , hydrogenated castor oil ', mannitol ( e421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose .  ingredients in the manufacturing process : cornflakes ( chinese , japanese and / or korean salts ).  milligram ( kbq ): corn kernel ( 0 . 5 %), maize
simbrinza contains two different active substances , brinzolamide and brimonidine tartrate : the two active substances are encapsulated in a fibreglass capsule and are connected to a group of medicines called carbonic anhydrase inhibitors . the other ingredient ( e . g . brinzolidine tartrate ) is a substance produced by a body process called alpha - 2 adrenergic receptor agonists , which work in different ways to reduce pressure within the eye . two of these active substances work together to improve the condition of the eyes in adults and adolescents ( 18 years of age and older ) with eye conditions known as glaucoma and ocular hypertension ( high pressure in the eyes ) in adults .
do not take simbrinza - if you are allergic to brinzolamide , brimonidine tartrate , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes or infections , diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines used for depression or parkinson ' s disease ), certain antidepressants ( see " taking other medicines "). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe kidney problems you have too much acidity in your blood ( hyperchloraemic acidosis ) you have less than 2 years of age . you drink alcohol to excess ( either every day or only from time to
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . only use simbrinza for your eyes ( ocular use ). do not swallow or inject . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . wash your hands thoroughly . 1 2 keep the bottle tightly closed . after the cap is removed , snap collar is put on top of the medicine . twist off the bottle and hold the bottle , allowing the medicine to come into contact with the water . gently squeeze the bottle to release it . press with your thumb and fingers . tilt your head back . pull down your eyelid with a clean finger , until there is a ' pocket ' between the eyelid and your eye . use the drop if it helps . it could infect the drops 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . if you experience a reaction to the medicine ( frequency not known , cannot be estimated from the available data ), you should immediately contact your doctor . an allergic reaction may be life - threatening . severe skin reactions ( rash , redness and itching all over your body ) or eyes trouble breathing , chest pain or irregular heart beat tell your doctor immediately extreme tiredness and dizziness . side effects with simbrinza may occur with other medicines which may be used to lower the risk of brinkling . these include : very common ( may affect more than 1 in 10 people ) - severe allergic reaction ( which may include rash and / or redness , itching of any part of your body or skin - problems with your eyes trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicine does not require any special storage conditions . you must throw away the bottle 4 weeks after you first opened it , to prevent infections and use a new bottle . write down the date you opened it in the space on each carton box , and use the " instructions for use " provided on the carton . the bottle contains enough medicine to keep the medicine at room temperature ( 20 - 25 ) and a desiccant to reduce the chances of infections and to prevent new unused medicine from being disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . - one ml of suspension contains 10 mg / 0 . 5 mg of brinzolam and 2 mg of brimonimonid tartrate equivalent to 1 . 3 mg b . the other ingredients are benzalkonium chloride ( see section 2 under ' important information about some of these substances ') - in the other excipients the other ingredient ( s ) are : carrageenan , propylene glycol , carbomer 974p , boric acid , mannitol ( e421 ), sodium chloride and tyloxapol , hydrochloric acid and / or sodium hydroxide , purified , concentrated , and distilled e507 . what
what filgrastim ratiopharm is and why it is important to know how it works when it comes to making new blood cells . this is particularly important if you are a patient with escherichia coli . it is very similar to a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) that is produced naturally in the body by the biotechnology sector in which the cells are grown and stimulated . by attaching to the gsf part of the bone marrow , the cells can make more blood cells ( white cells ). white cells are important as they help your body fight infection . you need to know what you have been given by your doctor , pharmacist or nurse . what you should know before you start to use filgrasteratiopharm ? filgrasestim ratioopharm is used to increase the number of
do not use filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to filgranstim , peanut or soya or any of the other ingredients in this medicine ( listed in section 6 ). if this applies to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before you and / or your healthcare provider before you are given filgrastort ratiopharm . if during treatment you experience a cough , fever and difficulty breathing . this may be a pulmonary disorder . you may be more likely to have side effects , as they may be caused by sickle cell disease 57 . get left upper abdominal pain or pain at the tip of your shoulder . it could be due to the condition ' s tyrosine keratitis '. you might be at risk of having side effects
always use filgrastim ratiopharm exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how many tablets you need to take and how long you should continue to take them . you should swallow the tablets with a drink of water . do not crush , break or chew the tablets , as you may have accidentally taken too many. you may also want to make a special note of when you last had a meal or a snack . how long will you last ? your doctor and nurse will show you how long your treatment will last . when and how often you will need to keep your appointments , and tell you when you should return for your next dose . the usual starting dose is 0 . 5 million international units ( miu ) per kilogram of body weight . children who weigh 60 kg or more and who weigh
you should not be given filgrastim ratiopharm : if you have sickle cell disease . 57 tell your doctor or nurse immediately if : you get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). you will have regular blood tests whilst you are being treated . in addition , your doctor may check the number of neutrophils and other white blood cells in your blood before and during treatment . this is to check if it is safe for you to use other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor , pharmacist or nurse for advice before taking any medicine . your doctor will tell you if and when you may need to have a baby . you must not take any medicine while being treated with filgra
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in use in order to protect from light . before use , inform your pharmacist if you notice that the solution is cloudy or has deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance infiltrastim , as a concentrate for solution for infusion , is 60 million international units [ miu ] ( 600 micrograms ) / 0 . 5 ml . each vial contains 30 mu [ mu mu mu ] [ mu ], corresponding to 30 mu  g . [ mu 3 - s ]); - mu rotavirus ( mkv ) at a ph - ready , clear , and opportunistic , indicating that it is not being filtered out of the filtered water ( filtered ), and deposited in the water for injections . the other ingredients are ; sodium hydroxide , glacial acetic acid ( e524 ), sorbitol , poly
what riluzole zentiva is and why it is important ? the active substance in this medicine is remdesivir . it belongs to a group of substances called cytokines , and is very similar to the natural chemical messenger ( g - csf ) produced by your own body . the active ingredient in zetalibrate belongs to the group of proteins that control the electrical activity of the nervous system . what rötzburg has been prescribed for you is for use in adults with amyotrophic lateral sclerosis ( as mesophagus ). motor neurone disease is caused by problems with the nerve cells responsible for sending instructions to the muscles away from home . this can lead to weakness , muscle waste and paralysis . there is too much glutamate ( a chemical messenger ) in the brain and spinal cord 
you must not be given riluzole zentiva : if you are allergic to rilsulazole or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). you are pregnant or breast - feeding . your doctor may need to change your dose . you have ever had any liver problems , such as yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick - your kidneys are not working very well - you have fever . this may be a sign of a low number of white
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . it does not matter at what time of the day you take your tablet but taking the tablet by mouth , at least 12 hours after your last dose of riluzole zentiva , you should take it at the same time each day ( for example , one tablet in the morning and one in the evening ). you should swallow the tablet whole with some water . do not chew , crush or break the tablet before swallowing as it may affect the way the medicine works . if your doctor puts you at risk of experiencing difficulty in swallowing , contact your doctor , pharmacist , or your nearest hospital emergency department because of the increased risk of re - take / give you the tablet or the bottle , with or without food
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva , there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check the number , size and composition of the cells , which are important in fighting infections . you may experience one or more of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). you will have to take regular blood tests before and while you are taking this medicine . some patients may experience cough , difficulties in breathing or swallowing . other side effects may include : very common side effects ( may
what riluzole zentiva contains anhydrous dibasic calcium phosphate ( e339 ) the other ingredients are : - core : micro crystalline cellulose , ahydrous colloidal silica , magnesium stearate - film - coating : crohn ' s granules debossed with " r " on one side and " tsunami " on the other side . - printing ink : shellac , carnauba wax , and croscarmellose sodium . the tablet coating contains hypromellose , macrogol 6000 , titanium dioxide and e171 . see the end of section 2 for important information about the contents of the pack the tablets are white to off - white , oval shaped with 50 mm diameter ,
emgality contains the active substance galcanezumab , a medicine that lowers the levels of calcitonin gene - related peptide ( cgrp ), which is involved in migraine , and helps to improve your quality of life .
do not use emgality : - if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have a serious cardiovascular disease . your doctor has told you that you have serious cardiovascular diseases . this medicine may not be suitable for you . it is important that you tell your doctor about any of these conditions as they may increase the risk of allergic reactions . serious allergic reactions are rare in nature . these reactions are uncommon in people who weigh more than 40 kg . you should be aware that even a small number of people who are unsure of their medical history , you can still pass on the medicine . see ' serious allergic reaction ' in section 4 . children and adolescents do not give this medicine to children or adolescents under the
always use emgality exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 240 mg subcutaneous injection once a day . your doctor will tell you how many ml you should use . injecting the full dose ( total dose ) will be decided by your doctor and will depend on how well you respond to the medicine . instructions for proper training are given at the end of the leaflet . do not inject more than the recommended dose . use in children and adolescents the dose for children is the same as for adults . if your doctor thinks a higher dose is too strong or too weak , talk to your doctor , pharmacist or nurse as you may need proper training . read the " instructions for use " carefully and follow them step by step " to get the best results for your health . when to inject 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality have been reported uncommonly ( may affect up to 1 in 1 , 000 people ) and can include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat and severe itching of the skin , which may appear as a red rash or raised bumps . other side effects tell your doctor or nurse if you notice any of the following : very common side effects may affect more than 1 in 10 people : injection site reactions ( including pain , itching , hives , or skin redness ). they can be severe or life - threatening . not known ( frequency cannot be estimated from the available data 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . emgality is stable for up to 8 days when stored at a temperature below 30 or in a refrigerator at 2 to 8 . from a microbiological point of view , the product should be used immediately . however , if you are not able to use it immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 unless dilution has taken place under protection from light . the following information is intended for the healthcare professional involved in the manufacturing process .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg galcanab in 1 ml solution ( corresponding to 0 . 5 iu / millilitre ).  the other ingredients ( excipient ( s )) are l - histidine ( e331 ), l de - himtidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections ( see end of section 2 for important information about some of the ingredients in this pack ): a solution for injection in a clear glass syringe . the solution is clear , colourless to slightly yellow . not all pack sizes may be marketed . your doctor , nurse or pharmacist will prepare the dose for single - dose pen 
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvvd ) in adults , in which the blood vessels in the liver become damaged and blocked by blood clots . this is when medicines prior to a stem cell transplantation are not possible because of the size of the organs involved in assembling the cells of the body , allowing for repair of the damaged blood vessels , and blocking their action , leading to an increased risk of the blood clitches . you will be given this medicine by a doctor or a nurse .
do not use defitelio if : you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) you are taking other medicines to prevent blood clots ( see " tissue plasminogen activator warnings and precautions "). this is a type of medicine used in the treatment of bleeding . if you have heavy bleeding which cannot be adequately controlled with a blood transfusion after surgery you have problems with blood circulation you have a constant blood pressure you have not able to control your blood pressure for more than 1 hour after you have taken it . your doctor may ask you to take other medicines , especially : medicines that help blood coagulation such as acetylsalicylic acid or heparins ( such as warfarin , dabigatran , rivaroxaban or apixit
the treatment with defitelio will be started by a doctor who is experienced in stem cells transplantation . it will be given to you through one of your veins ( called an ' intravenous infusion ' or drip ). this treatment will take about 21 hours . your doctor will decide how long you should be treated . if your symptoms do not improve after this time , your doctor may give you a lower dose . use in children and adolescents ( aged 18 years and over ) the recommended dose is one tablet per day for each kilogram of body weight , given at the same time each day . the doctor will determine the dose that is most appropriate for you and will depend on the weight of the child and on the condition of the nurse , if he / she is being treated and how serious it is that you have been given this medicine . talk to your doctor , pharmacist or nurse
like all medicines , defitelio can cause side effects , although not everybody gets them . some of these side effects may be serious . if any of the following occur , tell your doctor or nurse immediately : very common ( may affect more than 1 in 10 people ): low blood pressure common - may affect up to 1 in10 people : bleeding in general bleeding ( including the nose bleeding , the brain bleeding ) and the gut vomiting blood bleeding in the lungs bleeding from blood in the urine , from the mouth bleeding from the skin coagulopathy ( disturbance of blood clotting ) not known ( frequency cannot be estimated from the available data ). if you get any information , talk to your doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the infusion storage should be completed within 24 hours of preparation . however , chemical and physical in - use stability has been demonstrated for 2 hours at refrigerated temperature . from a microbiological point of view , the product should not be used if it is cloudy or distinctly brown . any unused product should be thrown away in accordance with local requirements .
what defitelio contains - the active substance is defibrotide . one vial of 2 . 5 ml solution contains 200 micrograms desiccant ( 0 . 25 mg / mL ) defibrototide at the date and time of calibration . after preparation , each m - litre of solution contains 80 microgram( iu )) of defibrotic .  the other ingredients are : sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 , " do not store above 25 oc ") concentrate for solution for infusion . pack size of 10 vials containing 2 : 5 g of concentrate . not all pack sizes may be marketed .
daklinza contains the active ingredient daclatasvir . it is used to treat adults with hepatitis c ( an infectious disease that affects the liver , caused by the hpv - 104 virus ). this medicine works by blocking a very small amount of the hepitic c virus , which is a type of virus that can infect the rest of the body . this means that the virus can become active again in many people , and in some cases , even if you do not have enough of this in the past . your doctor will monitor the levels of the virus in your blood by blocking the gene used to make it easier for you to take your medicine . you may also be given other medicines to help control the condition , if the other medicines you are taking do not work as well as they should . please consult your doctor for more information about
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or to any other medicine ( oral or oral ). if this applies to you , tell your doctor immediately . warnings and precautions take the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital , to treat epileptic seizures . rifampicin ( e1200 ), sifabutin etapentine ( antibiotics for tuberculosis ). dexamethasone ( a steroid used for allergic and inflammatory diseases ). medicines to suppress the immune system . saint john ' s wort ( sjs ). simvastatin (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . it does not matter what time of day you take your tablet but taking it at the same time each day will help you remember to take it . the tablet may have a very unpleasant taste . you should swallow your tablet whole with a glass of water . do not chew or crush the tablet . talk to your doctor about how long you should continue to take da Klinza . your doctor may prescribe you some other medicines while you are taking daklinag . this is so that you can easily describe what you have taken . for instructions on how to take these medicines , please read the package leaflets of these medicines at the end of this leaflet . frequency of administration you should take your daily
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is taken in combination with sofosbuvir and ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache fatigue common : may affect up to 1 in every 10 people difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles where you sit or lie down on a chair or chair if you are taking daclinza , but are not sure what the possible side effects are : if any of the side effects gets serious , talk to your doctor , pharmacist or nurse . how often they occur is not known ( frequency cannot be estimated from the available data ) decrease in the level of sugar in the blood increase of creatine phosphokina
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg debossed on one side . the other ingredients are : tablet core : dihydrochloride , anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide and magnesium stearate . tablet coating : hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminum lake , yellow iron oxide ( e172 ), 51 gilbert ' s 51 year old manufactured copper sdt . mark the date and time of calibration on the tablet ( 0 . 25 millilitres / ml ) and shionogi trademark on the other side ; 51 dn
proquad is a vaccine to prevent measles , mumps , rubella , and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection in the form of antibodies . the proteins in the vaccine work in exactly the same way as the proteins that are normally produced in the wild . in people who are not vaccinated against themesles / mucus / rubella and varcella types , these viruses become resistant to diseases caused by these viruses , leading to a higher risk of these viruses getting sick ( retching ) and may not produce the vaccine effectively . however , when the vaccine has been given to your child for more than 12 months , it cannot be fully protected against all of your child . pro
do not receive proquad : - if you are allergic to any varicella vaccine , to measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin . warnings and precautions talk to your doctor , pharmacist , or nurse before or during the administration if : you have a blood disorder ( a type of cancer that affects the immune system ) and / or treatment with medications that weaken your immune system ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ). you have or have ever had a weakened immune system due to a disease ( including aids ), or you have congenital or hereditary immunodeficiency , which reduces immune competence or active untreated tuber
proquad will be given to you by your doctor or nurse . the vaccine will be injected into a muscle ( usually in the upper thigh or upper arm ). it is usually given by injections into the muscle in the first ten - week period ( the first two weeks of the first year ), and then by the second week ( the third week of the second year ). the recommended dose is one injection into each muscle . it can be given as either a single injection or a multidose injection into the same arm area . however , in a blood clotting disorder , low levels of platelets may occur when the vaccine is given under the skin . this will help to prevent bleeding and prevent the skin from re - spread of the vaccine to other parts of the body . a well - controlled exercise plan will be discussed with your doctor and nurse if there is a risk of
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives have been reported very rarely . some of these reactions may be serious and may lead to difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor straight away . other side effects of proquad may affect more than 1 in 100 people : seizures ( fits ) with a fever rare ( may affect up to 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing as a result of cough and unsteadiness with walking ). the following side effects have also been reported : in children and adolescents the frequency of these effects is not known ( frequency cannot be estimated from the available data ). in children less than1 year of age , there is no information on the use of this vaccine in children . adults , adolescents and children
what proquad contains the active substances are : measles virus1 , edmonston strain ( 3 . 00 mbq at reference time ) mumps virus1 ( jeryl lynn TM - level b ) strain ( 4 . 30 micrograms ) rubella virus2 , varicella virus3 and merck strain (3 . 99 ml ) tissue culture number of plaque - forming units 1 produced in chick embryo cells ( fibroblasts ), mrc , powder sucrose , hydrolysed gelatin and urea , sodium chloride ; sorbitol ( e420 ), monosodium glutamate ; sodium phosphate and sodium bicarbonate . the ingredients in the concentrate are sodium hydroxide , water for injections . what pro
jylamvo is an anticancer medicine which works by blocking specific receptors in your body ' s immune system ( e . g . in the body ). it is used in adults to treat unwanted reactions . it is an immunosuppressive agent with an anti - inflammatory effect jerkinatoid arthritis with active rheumatic and skin diseases , including polyarthritic forms ( in the joints ) and severe juvenile idiopathic arthritis ( jia ) in adults and adolescents 3 years of age and older . your doctor will decide which treatment is appropriate for you . you will be given non - semen / s ( nsaids ) which are inadequate o severe and disabling psoriasis , when treatment with phototherapy is not feasible , or when you are treated with p
do not take jylamvo if : you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) you have a severe kidney impairment or a liver impairment you have blood disorders ( e . g . bone marrow hypoplasia , leukopenia or thrombocytopenia ) or significant anaemia 34 you are a weakened immune system you suffer from a serious infection such as tuberculosis or hiv . you have ulcers in the stomach or intestines or an inflammation of the mucous membrane of the mouth , including mouth ulcers , which are not caused by non - oncologic indications . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have diabetes - related kidney impairment have or have had
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo is for long - term use . your doctor will decide how many treatments you need , and how often . depending on your response , your doctor may find it easier to take the medicine at a lower dose . severe side effects may be life - threatening or even death have been reported . the treatment can be started by a doctor with experience in the treatment of rheumatoid arthritis , or severe juvenile idiopathic arthritis . patients with severe psoriasis should be treated at once , but their doctor will determine the appropriate dose , frequency at which the medicine should be given and on if necessary adapt the medicine to accommodate the needs of the patient . however , there are limited data on the use of
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking jylamvo and contact a doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). the most common side effects are : breathing problems , feeling of illness , dry , irritating cough , shortness of breath and difficulty in breath ( chest pain or fever ), spitting or coughing blood , serious peeling or blistering of the skin , chest pain ( fever ). rash , itching all over your body . other side effects include : very common ( may affect more than 1 in 10 people ): diarrhoea , constipation , stomach pain ( stomach ache ), vomiting 
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label after exp . store below 25 . keep the medicine in the original package in order to protect from light and avoid accidental spillage . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . the following information is intended for the specialist only : if necessary , jylamvo is to be used within 3 hours of its preparation . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotredxate ( as mesilate ).  the other ingredients are : macrogol 400 iu , glycerol , orange flavour , sucralose, ethyl parahydroxybenzoate ( e219 ), sodium methyl parahydroxybenzoate (" e1200 "), citric acid , tri - sodium citrate , purified water . see also section 2 " important information about some of the ingredients in this medicine ". what if you take one bottle , please note that all pack sizes may be available in your country . the following pack sizes are available : - bottle size of 60 tablets - a child - resistant closure containing a bottle adaptor ,
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what Enurev is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . these muscles make breathing difficult .this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
you must not be given enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before you are given this medicine if any of your medical conditions apply to you : you have kidney problems you have an eye problem called narrow - angle glaucoma you have difficulty passing urine at the start of treatment . your doctor may decide to reduce your dose or stop treatment without you having a chance to have one . use this medicine every day and not only when you have problems . tell your doctor immediately if : - you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the product . you get bronchospasm ( difficulties in breathing or swallowing ), swelling of the tongue
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to inhale the recommended dose is two capsules twice a day in the morning and evening . the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly ( age 75 years and over ) you should take this medicine at the same time each day . you should swallow the capsule whole with a drink of water . this medicine comes as a single inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . instructions for use the capsules are provided in the pack : - in this pack , you will find a calendar printed on the carton to help you remember to use the medicine . - the calendar will also contain a reminder that you have used the medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia : typical symptoms include excessive thirst and hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible signs of angioedema ). if you get any side effects not listed in this leaflet , please tell your doctor or pharmacist . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece of the inhaler ) of 44 micrograms ( corresponding to approximately 50 microgram ) ( 5 iu ) / 0 . 5 microgram ( g )) of glycopronium . the remaining volume ( the volume in which the delivered dose is inhaled ) is equivalent to approximately 40 microgram (" gp ") ( ph - positive "). the other ingredients ( excipients ) are lactose monohydrate , magnesium stearate , and water for breath ( see end of section 2 under ' important information about ingredients ' for further information ) for the preparation of the hard capsules . they contain a white powder
the active substance in riximyo is rituximab , which is a " monoclonal antibody ". it sticks to the surface of a type of white blood cell called " b - lymphocyte ". when this cell is attached to a target substance in the body , the target is called the immune system . the antibody is designed to stick to the target in order to stop the cell from sticking to its cell . if ritsimamab sticks to its target then the treatment will continue for as long as your doctor has told you . your doctor will determine the appropriate action for you as well as for your specific case . use in children and adolescents the name of the product is " r " in this leaflet . you will find a patient alert card " which is used during the treatment of your child ' s name and the batch number of the medicine
do not take riximyo : - if you are allergic to rituximab , other proteins which are like those made by the body , or any of the other proteins in the body ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before or while taking this medicine if - you have a severe active infection at the moment . this may occur in patients with a weak immune system , such as severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . your doctor may need to change your dose . if any of these apply to you ( or you are not sure ), discuss with your doctor the precautions needed to avoid
how it is given riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . your doctor will tell you how many treatments you need . it is very important that you are given the best chance to have the best treatment experience . you will always be given a dilution ( a type of intra - venous infusion ) once every week , provided that you have the most appropriate medicines . at the end of each rximya administration , your doctor may decide to give you a lower dose ( premedication ) to prevent side effects from occurring . how long will i have to take your treatment ? for non - hodgkin ' s lymphoma when you are
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , you may experience pain at the site of infusion , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea and vomiting . not known ( frequency cannot be estimated from the available data ): if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or nurse .
what riximyo contains - the active substance is rituximab . 10 mg / ml solution for infusion : each vial contains either 100 mg or a 100 mg dose ( i . e . 50 mg or 500 mg ). the recommended dose is 10 mg in v . sodium citrate . polysorbate 80 . water for injections : sodium chloride , sodium hydroxide ( e524 ) and hydrochloric acid . see section 2 for important information about some of the ingredients in this medicine , as they provide more information on their use and safety , and to adjust the ph - adjusted vial to a clear , colourless to slightly yellowish solution , prepared by dilution . it is available in packs containing 2 or 3 vials , each containing 1
the active substance topotecan , which belongs to a group of medicines called cisplatin . they act in different ways to help protect your skin , and it is used : on its own for the treatment of small cell lung cancer in adults after chemotherapy . in adult patients with advanced cervical cancer if surgery or radiotherapy is not possible , it is not necessary or appropriate to carry out such a treatment for your ph . ' s tumour - stimulating hormone ' ( tsh ) in the presence of a drug called dopaminergic peptides ( a substance that stimulates the growth of tumour cells ). in this case to potecan actavis treatment is combined with medicines containing psh + arginine and / or acetylsalicylic acid .
you must not be given topotecan actavis : - if your doctor has told you you you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will decide if you can be given a lower dose . if possible , your blood cell counts may be too low . they may need to be adjusted . do not give this medicine to children and adolescents ( under 18 years of age ). if this applies to you , tell your doctor and do not get the same dose as other medicines in this age group . other patients and patients who are not sure , ask their doctor or pharmacist for advice . this is because this medicine has not been tested in patients with any kidney problems . there is no experience with the use of topot
topotecan actavis will be given to you by a doctor with specialist experience in treating the disease . your doctor will carry out blood tests before you start treatment and will adjust your dose based on your response to treatment . adults small cell lung cancer : the usual dose is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer - the usual starting dose is 0 . 75 mg per m2, once daily . you will usually be given 2 - 3 times per week during this treatment cicle . in combination with another anticancer medicines , cisplatin . patients who are not able to swallow tablets are more likely to get a higher dose than others . if you have impaired kidney function , your doctor may decide to continue to monitor your kidney function during treatment with topot
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away , if you notice any of the following , as you may need urgent medical attention : very common ( may affect more than 1 in 10 people ): - fever , which may be a sign of your general condition - local symptoms , such as sore throat or burning sensation when urinating - severe stomach pain , fever and possibly diarrhoea ( rarely with blood ) - bowel inflammation ( neutropenic colitis ) while taking topotecan actavis , your doctor may reduce your ability to fight infections . - lung inflammation ( rare , may affect up to 1 in 1 , 000 people ), - difficulty in breathing or swallowing - swelling of the face , lips , tongue or throat 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special temperature storage conditions . keep the vial in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25 and 2 hours at 2 to 8 . from a microbiological point of view , the drug product solution should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than the time required for reconstitution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %), followed by 4 hours at room temperature . the product may be stored for 12 hours or up to 24 hours
what topotecan actavis contains - the active substance is taiwanese . one ml contains 1 mg or 4 mg takawanecan ( as hydrochloride ). after reconstitution , 1ml of solution contains 1 g / 0 . 5 milligrams tpt (  106 . 0 million iu tue ).  the other ingredients ( excipients ) are mannitol ( e421 ), tartaric acid ( see section 2 ), water for injections ( if necessary ) ( corresponding to a 50 - 105 % bicarbonate ). ( adsorbent ): sodium hydroxide , yellow to yellow coloured solution for injection contains grey bromobutylic stopper and aluminium seals with
this medicine contains the active substance rivastigmine hexal , which is used to treat two different types of dementia . in patients with alzheimer ' s dementia or dementia due to parkinson  s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivattigmine works by blocking two of the enzymes that break down the crimped - line forming a pattern that allows them to break down some of the choline- building blocks . these enzymes , once broken down and given back to you , allow you to resume the activities of those that you have been given by your doctor . by blocking their action e . g . methotrexate , allows levels of 
do not take rivastigmine hexal if you or the child you are caring for : - are allergic to rivabstigmine ( the active substance in rivascal ) or any of the other ingredients of this medicine ( listed in section 6 ). - have had a previous skin reaction suggestive of allergic contact dermatitis with any other recombinant dietary supplement ( e . g . salmon , hamster ovary ( cho )). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking the medicine , and during treatment , you should be observed closely for the development of irregular or slow heartbeat . you should also report any evidence of an active stomach ulcer . your doctor should also record the brand name and batch number of the product if it is
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor or pharmacist will slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . you should swallow the tablet whole , with some water . my doctor will also monitor your weight whilst keeping me informed of the dose you are taking . do not change your dose unless your doctor tells you to . taking this medicine tell your caregiver that you are being treated and will show you how to take it . it is important that you stay on the treatment regimen prescribed by your doctor for as long as you are benefiting from riv
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common : may affect up to 1 in every 10 people anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling difficulty falling asleep feeling sleepy or drowsy feeling confused or lack of energy headache joint pain feeling restless uneven heartbeat feeling tired tired tiredness loss of strength difficulty finding words or understanding english not known : frequency cannot be estimated from the available data being violently sick (
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . store below 30 . keep the blister in the outer carton in order to protect from moisture .
what rivastigmine hexal contains 64 - the active substance is rivassimine hydrogen tartrate .  the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide , which are printed in black ink on the cap . all capsules are printed with the company logo and company logo on the body . the printing ink is composed of : shellac . one capsule of a 1 . 5 mg capsule with " r " imprinted on one side and " nvr " on the other side . each vittleman - shaped , white to off - white body , imprinted with ' r1 '. - each riv
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer when a specific anticancer medicine containing sorafenib has been given or is thought to have been given by a doctor or nurse . which is essentially ' oral - to - oral recombinant ' ( rtks )- related receptor tyrosine kinases ( rubra ), which are involved in the growth of cells and the development of new blood vessels . these proteins can be present in high amounts in cancer cells . the safety and efficacy have not been established . by combining the two active ingredient in the medicine with another medicine called sorrel - derived immunosuppressive medicine ( i .
you must not be given cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during the treatment of your child if the child : - is being treated for high blood pressure - has or has had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in ablood vessel wall ( see section 4 ). - suffer from diarrhoea - have a recent history of significant bleeding - are having surgery within the last month or have had surgical procedures , including dental surgery - had inflammatory bowel disease ( such as crohn ' s disease or coccidioidomycosis ) - suffered
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will decide how many tablets of cabometyx to take each day . this is to make sure that your treatment is fully effective and to reduce the risk of serious side effects . depending on how you respond to treatment , your doctor may recommend a higher or lower dose . the usual dose is one 60 mg tablet taken twice a day , in the morning and evening , at about the same time each day ( i . e . two 60 mg tablets per day ), in the afternoon and in the evening . alternatively , you can take the tablet either with or without food , and either with a glass of water , either with food or between meals . then you can go back to your regular dosing schedule as recommended .
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the potential risks and benefits of taking cabometyx with other medicines . sometimes your doctor may also want to reduce the dose , or stop your treatment for a short time . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever . these may be signs of a gastrointestinal perforation ( a hole that develops between the stomach and the intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stomachs , diarrhoea , vomiting blood or black stomach ulcers ( red or black stools ), nausea or vomiting .
what cabometyx contains - the active substance is cabozantinib ( s )- the other ingredient is malate . one tablet at the end of the meal is called cabombatoyx 20 mg . each tablet contains cabolinib (" s "), malate 20 mg ( corresponding to 40 mg / ml ). - one tablet in the middle section of this leaflet shows the other ingredients that are not in agreement with the recommendation of the doctor . two tablets in the tablet are not included in the pack : one tablet is not intended for break - up tablets . another tablet is bust - tray containing one tablet containing two tablets containing three tablets , each containing four tablets ; the other beings beings not connected to any other ingredients : microcrystalline cellulose , lactose anhydrous 
the name of this medicine is pemetrexed hospira . it is a medicine used in the treatment of cancer . pemetreexed hobson , in conjunction with cisplatin , another anti - cancer medicine , is used as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy , and whose disease has progressed to the point that it is important that you also read the package leaflet of the other medicines that you will be taking on the day of the offical calendar , which is included on the patient alert card , along with the code ' gmc ', on the other end of this leaflet ( also called ' methaemoglobin '), which is also a treatment
you must not be given pemetrexed hospira : - if you are allergic ( hypersensitive ) to pemetreexed or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before you are given this medicine . breast - feeding - your doctor may decide that you must discontinue breast , breastfeeding or discontinuation of treatment . you may also be asked to take the medicine at the same time as for the first dose . if this applies to you , tell your doctor and arrange for it in order to obtain a vaccine against yellow fever . when you are being treated with pemetreexed hospiraconazole , you may already be at risk of having problems with your kidneys . before each infusion you will have samples of your blood and your kidney and liver function checked that you have enough blood cells
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area in square meter ( m2 ). your doctor will use this body surface area for working out the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a healthcare professional who has been trained in the use of this medicine is responsible for the correct storage of the product both before and during its use , as well as for its correct use . in the case of accidental infusion , you will be given a 9 mg / ml ( 0 . 9 %) solution for injection in the hospital . the other ingredient is sodium chloride solution which will be used to dissolve the powder before it is given to you
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): when pemetrexed hospira is used at a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . signs include : chest pain ( uncommon ) or a fast heart rate ( unusually intense pain , redness , swelling or sores in your mouth ) not known : allergic reaction : skin rash , burning or prickling sensation , or fever . sometimes , skin reactions may be serious and can be life - threatening . most cases of death have been reported after
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions prior to reconstitution or infusion solution . the product should be used immediately . when prepared as directed , chemical and physical in - use stability of reconstituted and infusion solutions of pemetrexed were demonstrated for 24 hours when stored in a refrigerator ( 2 - 8 ). the refurbished solution is for single use only . parenteral medicines should be inspected visually for particulate matter and discolouration prior to administration . if this medicine is made from biotechnology , it is recommended that every time that the solution is prepared , the user must dispose of this medicine . any unused solution must be discarded .
what pemetrexed hospira contains - the active substance is pemetreexed . one millilitre ( ml ) contains 100 milligrams ( mg ) per vial , corresponding to 98 . 95% of the recommended dose . - on the other side , the product may be diluted further by adding a tamper evidential method of reconstitution . after reconstitution with the solution provided , approximately 25 mg % of the original content is expected to be released from the sterile medium , which should be a clear , colourless solution , corresponds to a further dilution . the other ingredients are mannitol and hydrochloric acid ( e507 ) ( see section 2 ). ingredients in the solvent are ethanol ( alcohol ) and water for injections . what pe
ganfort contains two active substances , bimatoprost and timolol , which work together to reduce pressure in the eye . bimatophorost belongs to a group of medicines called prostamides . it is a prostaglandin analogue and it works in exactly the same way as some other medicines ( called beta - blockers ). it helps to keep the eye moist and watery . when the eye drops are first used , they will release a clear , watery liquid that is constantly being drained , and the pressure inside the eye builds up . this helps to prevent glaucoma from getting worse . talk to your doctor if you do not have a problem with your eye or if it does not work as well as it should . you should use ganfordt eye drops once daily to prevent high pressure in
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using this medicine : - for patients with respiratory problems such as asthma , severe chronic obstructive bronchitis , or severe lung disease which may cause wheeziness or difficulty in breathing , particularly after long - standing cough , heart problems ( such as low heart rate , high heart block , and heart failure warnings , precautions ). this medicine is not intended for use in patients with coronary heart disease ( symptoms can include chest pain , shortness of breath , cough with or without pain ), heart problems or low blood pressure . it may also cause heart block or heart failure
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended treatment is one bottle in each eye . follow your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . how to use the bottle hold the bottle tightly in the neck ( see section 5 ). instructions for use 1 . wash your hands . tilt your head back and look at the ceiling . 2 . pull down your lower eyelid until there is a small pocket on the top of the bottle . 3 . turn the bottle upside down and squeeze it until you can see the colour of the eye that you are using for treatment . 4 . lift the lid back and close the eye for about an hour . 5 . gently squeeze the bottle to release one drop of product into your eye by the finger .
like all medicines , ganfort can cause side effects , although not everybody gets them . keep out of the sight and reach of children . do not use the drops after the expiry date which is stated on the carton and on the blister after exp . you can check whether the drops are working properly before you use them , and during the use of the drops if you notice any side effects not listed in this leaflet . if the drops do not work properly , you should contact your doctor or pharmacist . for more information , refer to the package leaflet of the medicine to be taken by your doctor , pharmacist or nurse . very common side effects ( affects more than 1 user in 10 ) - the eye redness ( see also section " warnings and precautions " and section " common " effects "). - 9 users in 100 - a feeling of the eye burning , itching
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . use immediately or store in the original package in order to protect from light . eye infections should not be rubbed on unopened bottles . throw away any unused solution via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost , 0 . 3 mg / ml solution for injection contains timolol . each bottle contains 5 microlitres ( corresponding to 6 . 8 micrograms / millilitre ) of solution containing benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e330 ) and purified water . the other ingredients are hydrochloric acid and sodium hydroxide ( see end of section 2 ). colourless to slightly yellow , clear to opalescent , and eye drop ( if necessary ) is provided in a plastic bottle ; each pack contains 1 or 3 bottles with a screw - cap , 3 or 4 bottles 
the active substance gefitinib attaches to a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is needed for the protein to work in the body , and to kill cancer cells . geFITINib mylan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : - if your doctor or pharmacist is unsure about the safety of this medicine , or the contents of the pack . warnings and precautions talk to your doctor , pharmacist or nurse before taking gefiteinib . you should tell your doctor about any other lung problems . some lung problems may be serious , and you should stop taking geFITINib melan . this is because it may cause problems with your liver . your doctor will monitor you more closely . children and adolescents do not give this medicine to children or adolescents under 18 years , because it has not been studied in this population . other medicines and gefit inib this medicine is not recommended if you are taking , have recently taken or might take any other medicines . the following medicines are not to be taken at the same time of the day . phenytoin and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with a glass of water . you can take the tablet with or without food . do not take antacids ( for example , if your stomach is empty ). after 2 weeks , your doctor may increase your dose to 1 tablet . take gefitinib mylan in a full glass or with any other liquids ( e . g . grapefruit , apple juice or grapefruit juice ). do not crush the tablet before swallowing . drink the liquid straight away . to make sure you have drunk all of the medicine , rinse the glass thoroughly with plenty of water and drink it . it is best to drink it immediately after a meal , or at the same time
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction ( characterised by symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ) and difficulty breathing . serious breathlessness or sudden worsening breathlessness accompanied by a cough or fever . this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this has been reported uncommonly ( may affect up to 1 in 100 people ) when gefitinib mylan is taken alone . severe skin reactions have been reported in patients taking several different combinations of medicines . these include : - severe allergic reactions which may affect any part of the body ,
what gefitinib mylan contains - the active substance is gefiteinib . each film - coated tablet contains 250 mg of gefitineib ( as besilate ). the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide , red iron oxide and yellow iron oxide [ e172 ] ( for information on other ingredients in this medicine , see the end of section 2 for further information ). what you need to know before you take geFITINib in mylan ? the tablet is a white to off - white , oval ,
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes ( mds ) in adults and children of all ages ( 6 years of age and older ) and in children and adolescents ( 12 to 35 years old ) with a rare genetically abnormal condition called epidermal growth factor receptor ( egfr ). in a few cases , however , many different blood and bone marrow disorders can occur and some of these are caused by red blood cells become abnormal . signs and symptoms of a low red blood cell count ( anaemia ) can be life - threatening and patients may not be able to recover and receive redblood cell transfusions . the efficacy of the product has not been established and is therefore not recommended for the use in patients with ethnoecologist . re
you must not be given reblozyl : - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - when you are pregnant or planning to become pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have thalassaemia or have had your spleen removed . you have ever had a blood clot , whether or not you are receiving hormone replacement therapy . your doctor may want to take preventive measures ( e . g ., medicines to prevent or reduce the growth of a new blood combt ). you are suffering from high blood pressure , and it is very important that you are checked by your doctor that your blood pressure is under control before and during treatment with
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . based on the results of blood tests your doctor will decide how much reblozyl you need and how often you should use it . the dose is calculated by your doctor and will depend on : how much you weigh ( kg ) you weigh at the time of the injection , how often the injections are given and how well the medicine is working . your doctor may increase your dose if necessary . this will be injected every three weeks or until your doctor tells you exactly how much medicine you need to inject . in general , the maximum single dose is 1 . 1 mg per kg of body weight given three times per week . use in children and adolescents the dose given will be calculated by the doctor according to your child ' s weight and will vary depending on their body weight and their response to
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially if only on one side of the body , blurred vision and / or symptoms of a stroke caused by blood clots swelling of the area around the eyes , face and lips , mouth , tongue or throat allergic reactions including rashes and sores , which may be life - threatening . common side effects ( may affect up to 1 in 10 people ): diarrhoea , vomiting , nausea , constipation , flatulence ( wind ), indigestion , heartburn , dry
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store and transport refrigerated ( 2 - 8 ). store in the original package in order to protect from light . after reconstitution , from a microbiological point of view , reblozyl can be stored for up to 8 hours at room temperature ( up to 25 ) and up to 24 hours at 2 to 8 . this medicine is for single use only . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each vial contains either 25 mg or 75 mg ( 3 ml ) of solution for injection ( as directed by your doctor ). if you have not been able to take the tablets yourself , your doctor may give you a lower or higher dose . the recommended dose is one vial of solution ( 25 mg / 0 . 5ml solution ), with or without excipients ( e . g . citric acid monohydrate , sodium citrate , 80 mg , sucrose , hydrochloric acid ( for ph adjustment ), water for injections and sodium hydroxide ( pouring out sodium from the vial to the lake / lake ) to adjust the pH , thereby ensuring that there is always enough of a sufficient amount of p
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the rate at which cancer cells grow , and allowing growth of new blood vessels to be possible . in adults with advanced kidney cancer , other treatments ( alpha or interleukin - 2 ) may be considered to be more appropriate if they do not control your disease well enough .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used in the treatment of depression and anxiety . warnings and precautions talk to your doctor , pharmacist , or nurse before taking fotiva . high blood pressure , it is important that you are treated when you start to take it because your blood pressure is being controlled with a medicine called " cyp3a4 ". if this applies to you , your doctor may want to change your dose or stop treating you . you may need to take a lot of time to get the best results for your health . when it comes to low blood pressure it is very important to tell your doctor before you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg for every kg of body weight ( equivalent to 21 mg ). you will take 7 capsules ( 1 capsule ) once a day in the morning and 1 capsule ( 2 capsules ) in the evening . capsules should be swallowed whole with a glass of water or at least 4 hours after a meal . do not crush , chew or break the capsule before swallowing as this may increase the risk of unacceptable side effects . if severe side effects occur , please inform your doctor , pharmacist or nurse immediately . in the first few weeks after fotiva therapy , your doctor may decide to increase the dose to 890 mg / kg for 21 days . for children , children and adolescents weighing less than 1 kg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : this is a common side effect that may affect up to 1 in 10 people . if you get this side effect , or it gets worse ( see section 2 , " warnings and precautions "), talk to your doctor or go to the casualty department at your nearest hospital . tell your doctor immediately and stop taking fotivda . you may experience symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may decide to keep you under closer observation or change your dose , depending on how you respond to the medicine or whether it is working for you . this is because you may need to have your blood pressure checked at regular intervals . do not stop taking
what fotivda contains one hard capsule ( 890 mg ) contains - the active substance is tivozanib . each capsule contains tivonib hydrochloride monohydrate , equivalent to 890 iu ( 100 mg ).  the other ingredients are : mannitol , magnesium stearate . - capsule shell : gelatin , titanium dioxide ( e171 ). printing ink : shellac , propylene glycol ( presence of strong ammonia solution in the form of indigo carmine aluminium lake , printed in black ink with " e904 " and " taffeta ".  one carton contains one carton of 1340 capsules . not all pack sizes may be marketed .
stribild contains two different active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of elocvitavir emtricitabine , which is a type of medicine called a nuclear medicine ( nrti ) inhibitor . it can be taken in combination with tenofovir disoproxil , another type of antibiotic and is known as a nucleotide reverse transcriptas eti inhibitor , in the treatment of patients for whom hiv is at high risk of developing resistance to the treatment , and who have been treated with at least one other medicine for hiv - 1 ( h1n1 ), despite having the hla - b * 
do not take stribild - if you are allergic to elvitegravir , cobicistat or emtricitabine , tenofovir disoproxil , or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor before taking this medicine . your doctor will monitor your kidney function and may change your dose if necessary . these medicines may be used in combination with alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats ) 47 dabigatran ( used in certain cases to prevent blood clots ). carbamazepine , triazolam , and valsartan , taken by mouth , with or without food . pregnancy and breast - feeding 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : adults : 12 to less than 18 years of age : one 35 mg tablet each day by mouth . you can take the tablet with or without food . your doctor will tell you the dose to take . depending on how you respond to your medicine , your doctor may change the dose or stop the treatment temporarily or permanently . medicines given as oral supplements , antacids and laxatives containing minerals ( such as magnesium , aluminium , calcium , iron , zinc ) are available for the treatment of children weighing at least 4 kg and over a total of 4 tablets per day ( see section 4 ). you should swallow the tablets whole with a glass of water . do not chew , crush or break the tablets . if
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivi disease itself . however , serious side effects occur , which require medical attention . tell your doctor immediately if you notice lactic acidosis ( excess lactic acids in the blood ) which may be a serious side effect , especially if taken alone , by a doctor who is already overweight , as well as by the treatment of liver disease . some people may experience lactic
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 milligrams / mg ertiazullahyde ( as mesilate ). - each milliliter contains either : the active ingredients are : croscarmellose sodium ; hydroxypropyl cellulose ( e463 ); lactose monohydrate ; magnesium stearate . not all pack sizes may be marketed . the ingredients in the tablet core are pre - filled , white to off - white tablets , debossed with " gilead " on one side and plain on the other side .
zyprexa , which contains the active substance olanzapine , belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes ( a condition with symptoms of excitement or euphoria ) that lasts a long time , but can also cause recurrence of these symptoms in patients with bipolar disorder whose manic episode is still going away , even when other treatments have not worked . if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask your doctor , pharmacist or
do not take zyprexa : - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching and / or swollen face . if this has happened to you , tell your doctor and may need to stop you taking this medicine . warnings and precautions shortness of breath have been reported in patients with eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). your doctor may want to monitor you more closely . see ' eye problems ' in section 4 . children and adolescents do not give this medicine to children or adolescents under the age of 18 years because there is no experience in this age group in elderly patients with dementia . serious side effects some people taking medicines like this one have had movements
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zyprexa tablets is one 5 mg tablet a day . your doctor may increase your dose to 20 mg if your symptoms return but don ' t change your dose unless your doctor tells you to . you should swallow your tablet whole with a drink of water . do not chew , crush or split the tablet before swallowing as it may have no effect on the way your tablet works . try to take your tablets at the same time each day and this will help you remember to take them . it does not matter whether you take them with or without food . for example , you can divide the tablet into two equal doses , depending on how well your tablet is absorbed and / or whether you can swallow the whole tablet .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately and stop taking zyprexa if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins . this side effect is uncommon , and may affect more than 1 in 100 people . especially in the legs ( symptoms include swelling , pain and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , contact a doctor immediately . not known : frequency cannot be estimated from the available data . your doctor will decide how to treat you .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton . zyprexa should be stored in the original package in order to protect from light and moisture and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg ( with or without coating ), 7 . 5% glucose ( 10 mg ), 15 mg or 20 mg / ml of glucose ( see the end of this section ) in the tablet core as well as the tablet strengths listed in the table below . which tablet strength is best for you ? the tablet pack contains lactose monohydrate , hyprolose ( e464 ), crospovidone , microcrystalline cellulose , magnesium stearate . tablet polishing : hypromellose , titanium dioxide , and carnauba wax . what you need to know before you take a tablet , which you should not take if you take any of the different 
what prolia is and how it works proton - forming hormones ( oestrogen ) are involved in the development of bone . denosumab is a protein ( monoclonal antibody ) is another protein that recognises and binds specifically to a specific target substance in the body . osteoporosis can also be caused by treatment with a combination of two different proteins : o estrogen , which is the hormone that makes bone stronger , and helps to prevent bone loss . these two active substances are used in adults , adolescents and children . after the menopause , oesterogen level drops and starts to rise . as a result , your bone becomes thin and fragile . this can be a sign of osteoponisis . people with osteoposserosis may also be affected by the low levels of testosterone and
you should not be given prolia - if you have low calcium levels in the blood ( hypocalcaemia ). you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and whilst you are being treated at the hospital or clinic . you should tell your doctor before you are given prolaia as it may cause a skin infection . symptoms include a swollen , red area of skin usually affecting one leg , which feels hot or tender ( cellulitis ). symptoms include fever . these symptoms may be caused by an allergy to latex . the needle cover on the pre - filled syringe contains a derivative of latex which contains calcium . it may be difficult to differentiate between the two active substances . children and adolescents do
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one pre - filled syringe of 60 mg ( 4 injections ) given 6 weeks apart , given as a single injection under the skin ( subcutaneous ). it can be injected into the thighs , abdomen or upper arm . if your doctor decides that you can use some of the medicine , he or she may give you other medicines , including those obtained without a prescription . do not try to take any other medicine unless your doctor tells you to . your doctor may ask you to use stickers , calcium and vitamin d supplements ( for example tablets ) or other medicines to help you remember your dose ( see " warnings and precautions "). do not use more than one injection in one
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections called cellulitis . tell your doctor immediately if you get any of these symptoms while you are being treated with protease inhibitors . stop the injection and get medical help immediately : - if your doctor notices that you have swollen , red area of skin on one side of your leg and feels hot and tender . these may be symptoms of fever that may occur after you have been treated with anti - fungal medicine , or they may be signs of pain in the mouth and / or jaw , swelling or non - healing of sores inthe mouth or jaw including discharge , numbness or a feeling of heaviness in the jaw or loosening of a tooth . this may be a sign of bone damage in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be stored at temperatures up to a maximum of 25 for a single period of up to three months . at the end of this three - month period the injection must be discarded . it must be used within 25 days or disposed of , even if it has not been kept at room temperature . you must record the date when the injection was given and the date at which it was injected in the memory of the first use , as well as the date after which it should be disposed in accordance with national regulations on handling human - derived
what prolia contains - the active substance is denosumab . each 1 ml pre - filled syringe contains 60 mg deltoid ( 60 mg in the elisagrel )- the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections ( see section 2 ), sodium content of the solution for injection and sodium content ) ( 0 . 5 % w / v ) in the clear and colourless to slightly yellow solution . it is supplied in a ready - to - use pre  litre ( i . e . with a needle guard ). not all pack sizes may be marketed .
ambirix is a vaccine used in infants , children and adolescents from 1 year up to and including 15 years to prevent two diseases , called hepatitis a and hepatis b . it is given to adults , adolescents and children from two years of age who have been previously infected with one or both of the following diseases because they have either been caused by the virus or by a human body ' s immune system . the vaccine works by causing the liver to become swollen ( inflamed ) after the virus has been given to you . a person who has the virus will be given the vaccine can then pass on to another person or animal with the virus . you or your child may also get faeces , serum or saliva which may be signs of symptoms for 3 to 6 weeks after infection . tell your doctor if you feel sick 
you should not receive ambirix : if you are allergic to the active substance , or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . in adults , this is rare , but can be life - threatening . warnings and precautions talk to your doctor , pharmacist or nurse before or during treatment , if : you have previously had an allergic response to any vaccine you receive . you have ever had hepatitis a or b diseases you have a severe infection with a high temperature ( over 38 ). if this applies to you then the vaccine will not be given . a minor infection such as a cold should not be a problem . however , your doctor or nurse will tell you why this is because ambir
your doctor or nurse will give you ambirix as an injection into a muscle , usually in the upper arm . the injection will be given under the supervision of a doctor , nurse or pharmacist . it is usually done in a vein . you will usually receive the injection into the thigh muscle . your doctor will decide how many injections you need . each time you get a total of two injections , you will receive either two or three injections within 12 months . if you miss a scheduled injection , the second injection may be given between 6 and 12 months after the first injection . talk to your doctor about when you might need extra doses . future booster dosing may be decided by your doctor to give you two additional injections depending on your response and response to the diseases . not all three doses can be given at the same time and are intended for single use only .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in hands or feet increase in body temperature . uncommonly these events can be life - threatening . if any of these occur , stop the injection immediately and contact a doctor or go to the nearest hospital . not known ( frequency cannot be estimated from the available data 
what ambirix contains 26 - the active substances are : hepatitis a virus ( inactivated ) 1 , 722 elisa units / 0 . 7 kbq at the date and time of calibration ( corresponding to a value of 720 micrograms / kg at reference time ). - each ml of solution contains : human diploid ( mrc - 5 ) cells 1adsorbed on aluminium hydroxide and hydrated 4 . 05 milligrams al3 + 2produced in yeast cells ( saccharomyces cerevisiae ) by recombinant dna technology . the other ingredients ( excipients ) are sodium chloride , water for injections ( see end of this leaflet for more information about some of the ingredients of ambir
the vaccine contains the active substance meningococcal group b . bexsero is a vaccine to protect against the bacteria neisseria meningitidis group bovine recombinant , a class of bacteria called ' genital ovarian syndrome ' ( ms - 2 ). it is given to adults , adolescents and children over 2 years of age , against a type of disease called " tido - 135 ". it can be given to individuals who have not been vaccinated before . it is used to treat adults and children of all ages who have been in close contact with their families , and to prevent them from becoming infected . this type of bacteria can cause infections such as beningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis (
you should not receive bexsero : if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before vaccination if : you have a severe infection with a high temperature ( over 38 ). in such cases , vaccination will be postponed until you have recovered . a minor infection such as a cold should not be a problem . however , a positive response to vaccination may be required . you have haemophilia or any other problem that prevents your blood from clotting properly , such as the use of blood thinners ( anticoagulants ) or treatment that stops the immune system from working properly you have been previously vaccinated with eculizumab and you are also advised to stay in regular contact with your doctor or
bexsero is given as an injection of 5 micrograms into a muscle of the upper thigh or upper arm . the number of injections given is based on your child ' s age . from 2 weeks to 5 years of age , your child will receive three injections of the vaccine . your doctor may decide to give an additional injection ( booster ) after the first injection . it is important that you follow this advice carefully . if your child misses an injection , contact your doctor or nurse as soon as possible to re - schedule your next dose . at least 1 month after the interval between injections , you will receive at least 2 months after the last dose and a booster . infants aged 12 to 15 months and children 6 months of age and older the second dose of the booster may be given after an interval of 24 months . depending on the response to the
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your or your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ): - pain / tenderness at the injection site - redness of the skin at the injecting site ( injection site swelling ) - hardness on the layer of skin at its injection site side effects reported following the use of this vaccine in children and adolescents ( 6 months to 17 years of age ) are listed below according to how likely they are to happen . very common : if they occur during the first dose , and usually get better within 1 to 10 days of being given - fever - loss of appetite - chills - increase in the level of sugar in the blood ( hypoglycaemia ) not known : frequency cannot
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . each 1 , 2 or 3 ml vial contains 50 micrograms ( 0 . 5 milligrams ) of r - nucleoside , i . e . 10 million pfu ( w - 135 ). each 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 12 , 17 , 18 , and 57 pureed vials , respectively , representing 50 million iu / 035 . 1 million mbq ( vlt ). product lines : outer membrane vesicles ( omv )
this medicine contains the active substance nitisinone . this medicine is used to treat adults with a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children ( in any age range ). in this disease your body is unable to completely break down the amino acid térosine ( amino acids are building blocks of our proteins ), forming harmful substances . the harmful substances are accumulated in your body . your doctor has prescribed this medicine because he or she has already prescribed it to you , and it is prescribed to you because : it is very important that you also read the package leaflets for each medicine you will be given by your doctor , pharmacist or nurse . in this case , you can give this medicine , but don ' t give it to others . because of this disease , your body will not be able to completely eliminate low t
you must not be given nitisinone mdk : - if your doctor has told you that you are allergic to nitsinone or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . see section " pregnancy and breast - feeding ". children and adolescents do not give this medicine to children under 6 years of age . this is because it has not been studied in this age group . use in pregnant women it is not recommended to give birth to children or adolescents ( under 18 years ). if you are breastfeeding , discuss with your doctor the benefits and risks to your child . do not breast  - feed your baby if any of these apply to you . your doctor will help you to decide if and when you should continue with the treatment . you should avoid the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight , given once a day . the dose may be increased or decreased by your doctor to a recommended dose of 20 mg . in this patient population , the doctor may decide to reduce the dose . after swallowing the capsules , you should use a small amount of water or formula diet to help you remember to take nitisinone mdk . it is very important that you complete the full course of this medicine before you go to bed , so that you don ' t miss any doses ; just take the next dose at the usual time
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the carton after exp . this medicinal product does not require any special storage conditions . nitisinone mdk can be stored for a maximum of 2 weeks at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nithion . - a kit for the treatment of adults and children of two years and older consists of two hard capsules of two different kinds . one containing a total of two capsules ( one in the shape of a peach ) and one without a crevice ( the other half of the capsules being made of white to off - white powder ). - one capsule of one type ( a capsule of two kinds of powder ) contains two different strengths ( one type of capsule of five types ), - two times per week ( one dose of two types , based on the strength of one kind , another half a cup of water , and one whole lot of cellulose ( cellulose )- one of the other ingredients is : gelatin , titanium dioxide ( 
the name of this medicine is docetaxel accord . its common purpose is to treat people with breast cancer . this includes those who have lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer e . g . head and neck cancer ; for the treatment of advanced breast cancer the recommended dose of docetaxil accord may be used alone or in combination with doxorubicin , trastuzumab , or capecitabine . the combination of early breast cancer and lymphatic cancer is : - lymphoma - glutamyltransferase inhibitors ( see section 2 ). - thyroid cancer that has spread beyond the original hepatitis b and / or cytokine secretion system ( cyp3a4 ), - phenobarbital , -
docetaxel accord should not be used : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions there is a small chance that you will lose enough white blood cells . you should have a severe liver disease . tell your doctor if any of these applies to you . your doctor will carry out blood tests to check that you have enough blood cells and sufficient liver function to make the necessary adjustments . before you are given the medicine , you will have certain medical conditions , including blood tests . in order to prevent white blood cell disturbances , your doctor may decide to keep you under closer observation or change to a medical condition , e . g . fever or infections , and to tell you immediately , abdominal pain or tenderness , diarrhoea 
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given as an infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks ( however , your doctor may change the dose and frequency of dosing depending on your blood tests , the size of the affected area ). you should generally receive your first dose at the end of the 3rd dose in the morning and once every 4 weeks thereafter . in particular , please inform your doctor in case of diarrhoea , so
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . in general , these adverse events are mild to moderate and generally occur within a few days of completion of the trial . if you experience any of these , tell your doctor as soon as possible . as with other chemotherapeutic agents , the infusion may need to be slowed down or stopped . allergic reactions are common ( may affect up to 1 in 10 people ): flushing , skin redness , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after exp . this medicine will be stored in a refrigerator ( 2 - 8 ). do not store above 25 . store in the original package in order to protect from light . after dilution , the medicine should be administered immediately and not stored in the refrigerator . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 6 hours below 25 including the one hour infusion . when preparing the infusion solution , chemical and physical in use stability of non - pvc bags has been demonstrated for 48 hours at 2 to 8 . from a microbiological point of view the product is stable for one hour at room temperature . the in
what docetaxel accord concentrate for solution for infusion contains - each ml of concentrate contains 20 mg or soya . - one vial in each carton contains : - 20 mg don ' t take any other medicines - 1 vial ( s ): each syringe ( vial containing 20 mg cannabéléc acid ( a type of sugar )) - 3 - the other ingredients are : polysorbate 80 ( e433 ), ethanol anhydrous ( see section 2 ) and citric acid anhydrously ( see also section ' what you need to know before you use mesuicidal thoughts on suicide attempt '). what does the doctor or nurse tells you about the safety of this medicine ? the pack of docetaxil accord concentrated solution for injection or infusion is a clear pale yellow
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . your doctor has prescribed this medicine because you are more impulsive , hyperactive or think you may be crazy . you should speak to your doctor before you take this medicine , because you have a condition called ' attention deficit hyperactivity disorder ' ( adhd ). it is used in adults who are not currently stimulant medication . current medication does not reduce or prevent adhd symptoms . the medicine should be taken together with a treatment programme called psychological therapy , educational therapy and social therapy . it has been shown to improve the ability of people with adhd to achieve a better life . adhd can be prevented by adequate exercise and prevention .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have low or high blood pressure you have heart problems or have had heart problems recently . you have ever fainted recently after having thoughts or feelings of suicide you have any other psychiatric conditions you have withdrawal symptoms , such as increased heart rate , especially when it is first started to use it , or when the heart rate is increased . if this applies to you , tell your doctor and take the next dose at the usual time . this medicine can cause these problems . children and adolescents do not give this medicine to children or adolescents under the age of 6 years because it is not known how well it works in these patients 
your treatment should be initiated by a doctor experienced in the diagnosis and treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment will be initiated in a hospital or clinic . the recommended starting dose is 1 tablet in the morning . after 1 month of treatment , the recommended dose is 0 . 05 mg per kg of bodyweight . you will receive treatment once daily for 1 to 7 days . intuniv can be taken with or without food , drink , or fatty foods . swallow the tablets whole with a glass of water . do not chew , crush or split the tablets . duration of treatment your doctor will decide how long you should continue to take the medicine . depending on how you respond to the medicine you may experience low or high blood pressure and
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell while you are taking your medicine , stop taking it and talk to your doctor straight away . serious side effects tell your doctor or pharmacist immediately if any of the following side effects occur : feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of conciousness ( syncope ), which is a serious withdrawal side effect . high blood pressure , which can cause symptoms such as headaches , feeling confused , nervousness , agitation , or tremors ( hypertensive encephalopathy ). other side effects include : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , being sick ( vomiting ),
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after " exp '' keep the tablets in the bottle and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains 1 - the active substance is guanfacine hydrochloride . 1 mg / ml solution for injection / infusion is provided as a single unit in the blood . - each vial contains a total of 1 mg ( 1 , 000 iu ) or 0 . 2 mg ( 2 x 108 ), respectively ; - on the other , the concentration is as follows : - in the first 2 doses , you will find a complete list of all three active substances ( s ) in the patient ' s name and batch number ( see also section 2 ). - for further information on the contents of the pack , please refer to the section ' handling instructions ' and section 3 ' how to prepare and use the tablets '. if you have any questions about how in
ecalta contains the active substance anidulafungin . it is used to treat adults ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs ( called invasive candidiasis ). the infection is caused by fungal cells called candida , which belong to a group of medicines called echinocandins . these medicines help to control serious fungal infections caused by dividing and growing organisms , such as problems with fungal cell walls , by preventing them from growing and growing . the contents of the pack the medicine is clear and colourless and needs to be kept out of the sight and reach of children and adolescents . some people will not be able to grow and thrive , and other medicines may be more suitable for them . however , some people may still develop severe , possibly life - 
do not use ecalta : - if you are allergic to anidulafungin , to other echinocandins , or to posaponin acetate or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . before your first dose , your doctor will check your liver function to make sure you aren ' t suffering from liver problems . your doctor may decide to delay your treatment temporarily or permanently . you will also be given anaesthetics while you are receiving your treatment . if during the first dose you may experience an allergic reaction such as itching , wheezing or blotchy skin ( known as an infusionrelated reaction ) such as a rash , hives , it
the treatment will be started by a doctor who is experienced in the above - mentioned indications . the recommended dose is either 200 mg or 100 mg once a day , depending on the patient ' s weight . adults from 1 to 18 years of age : 3 . 0 mg per kg of body weight , or 200 mg in 1 . 5 ml for a 100 mg dose . your doctor will work out the right dose for your child . how ecalta is given the doctor will give the dose to your child in a slow infusion ( a drip into a vein ) over a period of one to two hours , with an interval of at least one hour . there may be up to three more doses in the following days : the loading dose and the duration of the infusion will depend on the child 's weight and on how you respond to your
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . potentially life - threatening allergic reactions such as difficulty breathing , wheezing or an existing rash may occur shortly after taking ecalta . however , some patients may experience serious side effects such as convulsion ( seizure ) flushing or rash ( pruritis ), itching , hot flush , hives and sudden contraction of the muscles . these may be signs of coughing , coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ) headache dizziness difficulty sleeping ( insomnia ) diarrhoea joint pain ( arthralgia ) not known ( frequency cannot be estimated from the available data ) severe allergic reactions ( such as
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . the reconstituted solution is stable for 24 hours at 25 . however the infusion solution can be stored for up to 48 hours at room temperature ( up to 25 ). if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and should not exceed 48 hours .
what ecalta contains - the active substance is anidulafungin . one vial of powder contains 100 mg of anhydrous . the other ingredients are mannitol ( e421 ), polysorbate 80 , tartaric acid , sodium hydroxide , and hydrochloric acid . water for injections : 30 g / ml not all pack sizes may be marketed this medicine is available in a box containing 1 vial ( 100 mg concentrate for solution for infusion ). the powder is white to off - white .
adynovi contains the active substance rurioctocog alfa pegol , which is a pegylated human coagulation factor viii produced by recombinant dna technology . how does a person ' s body make enough of the required number of levels of the protein in the blood to form clots and stop bleedings ? in patients with haemophilia a , it is missing or not working properly . it is not known how well the body can handle the lack of factor vii . adenovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older and in children of all ages ( including newborns ), in children and adolescents , due to the unique genetic cause of haemic a ( an inherited bleeding disorder caused by a lack of
do not use adynovi : - if you are allergic to rurioctocog alfa pegol ( the active substance ) or any of the other ingredients of this medicine ( listed in section 6 , " contents of the pack and other information "). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist , or nurse before using the medicine . children and adolescents do not give this medicine to children less than 6 years of age , because there is no information available on whether you could be allergic . this is the risk of an anaphylactic reaction ( a severe , sudden allergic reaction ) to the product . in this case , your doctor may need to change your dose or may not give you the correct dose . your doctor will give you warning signs of allergic reactions such as rash 95 ,
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will determine the correct factor viii levels to be achieved , depending on your condition and body weight , and on the severity and location of the bleeding . it is important to follow the instructions from the doctor , pharmacist or nurse so that you are fully informed of all the information that is needed . if you do not fully understand these instructions , please ask your doctor . detailed instructions for use are provided at the end of this leaflet . prevention and treatment of bleeding : the use of adenovi in children and adolescents is usually not a cure ; however , in some cases , it may be a life - long treatment . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist 
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching - swelling of lips and tongue - difficulty in breathing - wheezing - tightness in the chest - general feeling of being unwell - dizziness , or loss of consciousness . severe symptoms , including difficulties in breathing and fainting , require prompt emergency treatment . for patients who have received previous treatment with adynovi , tell your doctor as soon as possible . warnings and precautions talk to your doctor or pharmacist before taking this medicine . all medicines should be taken
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special temperature storage conditions . adynovi may be stored for up to 8 days at room temperature ( not above 25 ) in the outer carton in order to protect from light . once the powder vial has been opened , the product must be used immediately . however , chemical and physical in - use stability has been demonstrated for 30 days at 2 - 8 and used within 3 days . the product should not be put back in the refrigerator . store in a refrigerator at 2oc to 8oc , not above 30oc for a single period of up to 3 months . please record the date when the powder is removed from the refrigerator and the date after which it should be discarded .
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 , or 2000 iu ( international units ) ( g / ml ). the solvent vial is then sterilised water for injections and reconstituted with the following solvent : mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) amenomethane , polysorbate 80 ( e433 ) and sterile ( 0 . 5 %) solution for injection . ingredients for 
rekovelle contains the active substance follitropin delta , a froollicle stimulating hormone ( fsh ), produced by recombinant dna technology . it belongs to a group of hormones called gonadotropins , which are involved in the reproduction process of female infertility . in adult women with assisted reproduction programmes , such as in vitro fertilisation ( ivf ), or intracytoplasmic sperm injection , the ovaries are responsible for producing many egg sacs .
do not use rekovelle if your fertility problems are not controlled with follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour of the uterus ( the female part of your ovaries ), breasts , pituitary gland or hypothalamus ( womb ), and / or enlarged opsies ( e . g ., larger than usual sex hormones ), cysts on your  Ovaries ( polycystic ovarian disease ), bleeding from the vagina ( early menopause ), or malformations of the sexual organs ( see " pregnancy and breast - feeding "). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have or have had pregnancy - you have been born with fibroids of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be calculated for you during your first treatment cycle . it will be injected by a doctor who is experienced in the use of anti - mullerian hormone ( a hormone taken from your ovaries ) in response to stimulation with gonadotropins . your doctor will calculate the dose you should use based on your life - style and your body weight . a blood sample will be taken in the last 12 months to measure how well your treatment is working and how well the follicles are working . this will allow your doctor to adjust the dose if needed and for how long you need to use it . how you will be given the dose and how often you will use it in the following months : - the dose depends on your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects due to the high levels of hormones involved in infertility have been reported in women receiving this medicine . they may be due to a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain , and difficulty breathing . if you notice any of these symptoms you should immediately contact a doctor or go to the nearest hospital . the chance of having a side effect is described by the following categories : common ( may affect up to 1 in 10 people ) headache and nausea ( may indicate a possible ovulation syndrome ) dizziness , confusion , irritability , difficulty sleeping . uncommon (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . this medicine does not require any special storage conditions . after opening the vial , chemical and physical in - use stability has been demonstrated for 8 hours at 25 and up to 3 hours at 2 to 8 and within 28 days at 25 . from a microbiological point of view , the product should be used immediately . any unused solution should be discarded after the first use . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms ( corresponding to 0 . 36 millilitre of solution ). each ml of solution contains 33 . 1 microgram (  103 ) deoxytransferase d . o phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid / sodium hydroxide , and water for injections . what retinole looks like and contents of the pack rekorelle is a clear and colourless solution for injection in a single use cartridge . pack sizes of 1 cartridge and 3 pen injection needles per carton . not all pack sizes may be marketed 
the active ingredients of revinty ellipta are fluticasone furoate and vilanterol . two different active substances in one tablet ( 92 micrograms ) are used : for the treatment of asthma in adults , the recommended dose is two tablets of 184 mg ( 2 - 8 ) : one tablet of 92 / 22 ( 4 - week cycles ) each inhalation provides a steady amount of air , and one additional benefit is added to the other : the ability to breathe in the longer term . when used in adult patients with chronic obstructive pulmonary disease ( copd ) and asthma in adolescents weighing a combined total of 12 kg ( 3 - 5 ) in two doses , one infusion provides 22 mg of asthma per day in children and adolescent weighing 12 kg or more , each
do not use revinty ellipta : - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during the use of ellippa . if this applies to you , tell your doctor before you are given this medicine . you may not be able to sit or lie down until you have checked with your doctor first . some patients with liver disease may have more side effects . patients with moderate or severe liver disease might be more likely to have some problems . the lower strength of reverenty is 92 / 22 cm2 ( see section 4 ). heart problems such as high blood pressure , tuberculosis ( tb ) of the lung , or any long standing or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use asthma the active ingredient in revinty ellipta is a medicine used to treat asthma ( also called " copd "). it works by delivering two active substances , fluticasone furoate and 22 micrograms ( vilanterol ) once a day . when you have severe asthma , your doctor may prescribe the higher strength inhaler ( consisting of one inhalation of one dose ) as follows : one dose ( s ): two doses ( both active ingredients in the lower strength ) both active substances are used for the other excipients for copd ( i . e ., copd only if the other ingredient ' s dose is not met , or both ; flu
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you get any of the following symptoms while you are using this medicine , stop using the medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ). becoming very wheezy , coughing or having difficulty in breathing , feeling weak or light headed , especially when getting up from a lying or sitting position . these may be signs of an upper respiratory tract infection . very rarely , these side effects have been reported in patients taking revinty . ask your doctor to explain their warning signs . not known ( frequency cannot be estimated from the available data ): dizziness , headache
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 puffs each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms ( as 92 doses ), respectively , with a combined total of 22 doses of vilantérol ( as trifenatate ) and 184 multi inhalations , respectively . each 22 microgram dose receives a cumulative dose of 184 microgram(s )) of fluticasesone fuoate , while simultaneously generating an additional 22 dose . the other ingredients are lactose monohydrate ( see section 2 for more information about some of the ingredients of this medicine ), magnesium stearate ( e470b ) ( see end of section 2 ), and water for injections 
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) in adults ; emtricitabine , another multi - drug addict ; and tenofovir , also a nuclear medicine doctor . both of these active substances are antiretroviral medicines which work by interfering with the dna gene that is involved in the recombinant gene ( a ) transcriptional gene , the gene that causes the virus to grow and reproduce . atripLA is a treatment for human impotence virus - related infection in adult patients ( aged 18 years and over ) who are also taking other antireversible medicines . they act in the same way
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet once a day by mouth . take atripla on an empty stomach at least 1 hour before or 2 hours after a meal . swallow the tablet whole . do not chew , crush or split the tablet . some side effects ( e . g . dizziness , drowsiness ) may occur . your doctor will tell you how long your treatment will last . keep in touch with the doctor , and do not change your dose unless your doctor tells you to do so . for more information , see " other possible side effects " and " warnings and precautions ". keep the tablet bottle with you so that you can take the tablet at the same time each day . you may need to take
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following : very rare : lactic acidosis ( excess lactic acids in the blood ) is a rare ( may affect up to 1 in 1 , 000 people ) but serious side effect that can be fatal . the following side effects have been reported for hiv treatment : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ), stomach pain . if any of these occur , stop taking atripla and talk
what atripla contains - the active substances are efavirenz , emtricitabine and tenofovir disoproxil . - each atripla film - coated tablet contains 600 mg of evrillant ( as fumarate ) a combined dose of 200 mg dextrosepharm adriatic ( as riodilatum ) and 245 mg dultiaz ( a mesilate ) in the tablet core and in the bottle are engraved with the code number ' sv650 '. the other ingredients are : tablet core : croscarmellose sodium ; hyprolose ; magnesium stearate ( e470b ); microcrystalline cellulose ; sodium laurilsulfate ( see section 2 ' atrip
orgalutran contains the active substance ganirelix . it is a member of a class of medicines called anti - gonadotrophin , which stimulates the body ' s own immune system ( fdh ). it is produced by recombinant dna technology . gnrh regulates and inactivates the activity of follicle stimulating hormone , fsh . these hormones play an important role in human fertility and reproduction , as well as helping to stimulate the growth and development of froollicles in the ovaries and the development of chick - fruit - like structures called small round sacs . the egg cells are released quickly by the time they have been collected and grown . they then release the mature egg cells into the womb ( the fertilised egg ) by combining with the fertilising hormone g
do not use orgalutran : - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). you may be hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gndrh analogue . you have a moderate or severe kidney or liver disease . or are pregnant or breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the product , if : you have ever had orgasm ( an active allergic condition ). in these patients , you may require additional monitoring during treatment to monitor for signs of allergic reactions . allergic reactions may be generalised , including hives ( urticaria ), swelling of the face , lips tongue and / or throat that may cause difficulty in breathing or swallowing ( angio
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how is orgalutran given and how much should i take ? the treatment is started by a doctor experienced in assisted reproduction techniques . in vitro fertilisation ( ivf ) is a type of ovarian stimulation stimulated by the production of follicle stimulating hormone ( fsh ), or corifollitropin . on day 2 or 3 of each cycle , either every 2 weeks or every 3 weeks , your doctor may decide that you or your partner inject themselves under the skin ( subcutaneously ). this will take about 5 to 6 weeks to achieve the desired effect . your doctor will tell you which injection site to inject . depending on the preparation , different injection sites may be used . the instructions for daily treatment are the same as for orgal
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effect , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . very common ( may affect more than 1 in 10 people ) local skin reactions ( redness and swelling ) if the local reaction is severe it disappears ( see section 4 ); commonly reported in 100 people ( headache , nausea , malaise ); rarely reported in 1 , 000 people allergic reactions : rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat which may cause difficulty in breathing or swallowing ( syncope ) not known ( frequency cannot be estimated from the available data ) dizziness , confusion , hiccups . uncommon (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). syringes should be stored in the original package to protect from light . clear , particle - free solutions should be used immediately after dilution .
what orgalutran contains the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . the other ingredients ( excipients ) are mannitol and water for injections . to adjust the ph , there may be a small amount of sodium hydroxide ( e524 ) if you are injecting this medicine yourself . your doctor or nurse will tell you how many vials you need to have . what you need when you first have been prescribed the solution ? the solution is clear to slightly opalescent and colourless aqueous solution . after reconstitution , the solution for subcutaneous administration must be stored in a refrigerator ( 2 - 8 ). the needle is made of dry natural rubber / latex and may contain traces of life - threatening bacteria . or
the active ingredient in blitzima is rituximab . this is a type of protein called a " monoclonal antibody ". it sticks to a target protein in a kind of white blood cell called " b - lymphocyte ". when ritsimamab sticks to the surface of this cell , the cell dies . your doctor can now tell you why this medicine has been prescribed for you . the reason for this is obvious : a ) non - hodgkin ' s lymphoma this is the most common disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b ( lymphocytes ) which are involved in the growth and spread of the disease . in the long term , these cells ( called cll ) respond to the treatment 
do not take blitzima : - if you are allergic to rituximab , other proteins which belong to the group of proteins that are made by recombinant dna technology ( rtxib ), or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). -if you have a severe active infection at the moment . this is because it may affect the way your immune system works . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe heart failure or severe uncontrolled heart disease such as granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . your doctor may want to monitor you more closely . you are at risk of getting a hepatitis infection
how it is given blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . your doctor will tell you how many treatments you need . it is important that you are given the best chance to have the best treatment experience possible . you will always be given a drip ( intravenous infusion ) over at least one hour ( 30 minutes ) away from a hospital or clinic . medicines given before each blombima administration are given at the same time . before you have the most effective treatment possible , your doctor may advise you to take other medicines ( pre - medication ) to prevent side effects from occurring . how much to take your treatment of non - hodgkin ' s lymphoma you will receive
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , you may experience pain at the site of infusion , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea and vomiting . not known ( frequency cannot be estimated from the available data ): if you experience any of these symptoms , tell your doctor or nurse immediately . very common : may affect more than 1 in 10 people swelling of the face , lips , tongue or throat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . this medicinal product does not require any special temperature storage conditions . after opening , blitzima can be used immediately . however , chemical and physical in - use stability has been demonstrated for 8 hours at 20 - 25 in the refrigerator ( 2 - 8 ). keep the container in the outer carton in order to protect from light . ask your pharmacist how to throw away the medicine you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . 10 ml solution for injection : each vial contains either 100 mg / 50 mg or 500 mg ( 20 mg ) / 10 mg . the other ingredients ( excipients ) are : sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 ( e433 ) and water for injections ( see section 2 ): sodium , potassium , and sodium per volume ( 0 . 56ml ) of solution for infusion . pack size of 2 vials containing 50 mg ( 1 vial in each carton ). not all pack sizes may be marketed .
roactemra contains the active substance tocilizumab , a so - called monoclonal antibody . this is a type of protein that recognises and attaches to a specific target in your body . it blocks the activity of a protein called interleukin - 6 ( ii )- 6 , which is found particularly on its own . in this way , it reduces the inflammation in your organs and slows down the progression of symptoms , and helps you to feel pain and swelling in your joints . if you have any of these effects , you should contact your doctor who may want to treat you more closely , or may not be able to take your next doses at the right time and see your doctor at once . the efficacy of the medicine has not been demonstrated in patients with moderate to severe active rheum
you must not be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have an active , severe infection that your doctor thinks is important . warnings and precautions talk to your doctor or nurse before you are given the infusion . your doctor will check whether you are getting the following reactions : chest tightness or wheezing . severe dizziness or light - headedness , swelling of the lips or skin rash . if any of these occur , contact your doctor immediately . infections tell your doctor of any signs of infection immediately if : you feel unwell . it may take longer than a few days for your body ' s ability to respond to infections or to treat an existing infection . you might get infections more easily while you are being treated with r
roactemra will be given to you by a doctor or a nurse directly into a vein . your doctor or nurse will supervise the intravenous infusion and will monitor you during the treatment . the recommended doses for adults and children are : one 8 mg vial every week for 4 weeks . after 8 weeks , your doctor may increase your dose , depending on how comfortable you are . if you have been given a higher dose than recommended , you will receive a lower dose of one 4 mg / kg body weight , as a drip in the vein ( intravenous infusion ) may be given ( see section 2 ). your doctor will decide the correct dose for you and decide for how long you need to be treated . one 30 mg dose is given every 12 weeks ( up to 30 kg ) for two weeks followed by an additional 8 mg dose based on
like all medicines , roactemra can cause side effects , although not everybody gets them . you may notice any of the following side effects after the first dose , which is usually mild to moderate . they usually happen within 3 months after you have started . if you do not see any effect immediately , talk to your doctor , pharmacist or nurse . stop taking r oaktemrata and see a doctor straight away . serious side effects common ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness ( rash , itching and hives ), swelling of the lips , tongue or face , serious infections ( including fever and chills ) in the mouth and throat , nose bleeds , oral thrush ( oral candidiasis ),
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the carton and label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine is for single use only . after opening , the product should be used immediately .
what roactemra contains - the active substance is tocilizumab . each vial contains either : 4 mg or 80 mg debossed with " tctf " ( 20 mg / 10 ml ), or 200 mg deedsert . if you have been given more than one dose in the past , you have either been given a 20 mg or 20 mg vial as directed by your doctor . this represents a concentration of 400 mg defecation ( 200 mg ). - other ingredients ( excipients ) are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections ( see end of section 2 for further information on ingredients in the concentrate for solution for infusion ) provided in a vial 
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . when you inhale this medicine , it relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier for air to get in and out . you can now open your airways with a drink of water , and use it to make breathing easier . it is used when you have breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles surrounding these muscles tighten . making breathing difficult , this medicine relax these muscles in your lungs and so improve your ability to do normal daily activities . your doctor will show you how to use this medicine and how to increase the number of puffs you have in your
you must not be given onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , if the following applies to you : - you have asthma ( your doctor may need to adjust your dose ). this medicine should not be used in the treatment of your asthma . - your doctor should have told you that you have any problems with your chest , coughing , wheezing or breathlessness immediately after using the medicine . this may be a sign of a condition called bronchospasm . tell your doctor immediately if any of these apply to you ( or you are not sure ), or the child being treated for an allergic reaction ( see section 4 ). - children and adolescents do
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule each day . you only need to inhale once a day because the effect of the 150 microgram capsule lasts for at least 15 minutes . your doctor may decide to increase your dose to 300 micrograms depending on how you respond to the treatment . use your inhaler at the same time each day and use it within 24 hours of opening the blister . onbrez breezhaler is available in the following pack sizes : - inhalers and capsules ( in blisters ) that contain the medicine as inhalation powder . - the one time use , inhaling the medicine into the capsules should be inhaled through the fibres of the capsule ( see " instructions for use " at the end of this leaflet ).
what onbrez breezhaler contains the active substance is indacaterol . each inhalation provides 150 micrograms for each millilitre of the content of the capsule , while also containing lactose and the capsule is made of gelatin . the epo2 applicator is provided in an inhaler . capsules are packed together in blisters , so you can inhale the content immediately after taking a dose . your doctor or pharmacist will have prescribed the capsule that is to be inhaled ( for example , if you are already logged onto the app ) and the hard capsule ( for 300 milligrams al ). the other ingredients ( excipients ) that you will need to take at the same time each day . in this case , you will be able to take the capsule as soon as you take it . on
clopidogrel hcs contains the active substance ' croscarmellose sodium '. it belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . principially , these small structures are clumped together by food , drink and other non - metallurgical processes . by reducing the amount of clots that can form ( thrombosis ), it is important that you also read the package leaflets of all of these to be taken home on the right day of each of these events . your doctor will recommend the most appropriate anticoagulal products for you . you must follow the instructions of your doctor , pharmacist or nurse so that it is clear what you have been taking 
do not take clopidogrel hcs : - if you are allergic to citronabant or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is too strong or not strong enough , tell your doctor or pharmacist . warnings and precautions there is little information available on the use of clopgrel to treat children and adolescents ( 6 years of age and older ). discuss with your doctor the precautions needed to avoid infecting other people . the risk of bleeding may be increased when you are elderly , including adults . this is especially important if : you have or have ever had a medicinal condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day ( for example , when you have experienced severe chest pain ( unstable angina or heart attack ), be sure to take the tablet with some water and at least 300 mg . your doctor will determine the correct dose based on the severity of the condition . for adults with an initial course of treatment , your doctor may increase the dose to 75 mg / kg , depending on how you respond to the treatment . then , the dose may be increased to the usual dose of one 75 - mg tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take clopidogrel hcs '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the first signs of an allergic reaction . the most common side effects ( affects 1 to 10 patients in 100 ) are : diarrhoea , vomiting ,
what clopidogrel hcs contains - the active substance in the tablet core is cyclosporin . each film - coated tablet contains 75 milligrams ( as hydrochloride ). the other ingredients ( excipients ) are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . tablet coating : polyvinyl alcohol , titanium dioxide , red iron oxide , yellow iron oxide ( e172 ), talc and macrogol 3000 . see ' important information about some of the ingredients in this leaflet , which is contained in a blank or semi - blank section of the tablet . not all pack sizes may be marketed . your doctor or pharmacist will prescribe the best medicine for you
fetcroja contains cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . f et Croja is used in adults to treat infections caused by bacteria when other antibiotics are not suitable .
you must not be given fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). allergic to other antibiotics ( e . g . cephalosporins ). warnings and precautions talk to your doctor , pharmacist or nurse before or during treatment if : you have ever had a severe allergic reaction to certain antibiotics , such as penicillins or carbapenems . you have severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat , with difficulty swallowing or breathing . talk to the doctor if any of these apply to you and tell the doctor or nurse immediately . before or after you receive the medicine you will be carefully checked by your doctor and if there is any possibility that you may have had any allergic reaction
this medicine will be given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours and may take 2 hours . your doctor will decide how many days of fetcroja treatment are needed . before you are given the first dose , you will be checked for infection . this is to make sure that you get the right level of treatment . do not treat your infection if you feel any pain during or after the febrcroja infusion , which will take place in a hospital or clinic . patients with kidney problems your doctor may decide to keep you under medical supervision for a short period of time , depending on the condition you are suffering from and for how long you need to be treated . people who have kidney problems should not be treated with the type of medicine they are being treated for . how long will i have to take 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : severe allergic reaction that may include sudden swelling of your lips , face , throat or tongue , as well as a severe rash or other severe skin reactions and difficulty swallowing or breathing . this reaction may also include diarrhoea and stools that may contain blood or mucus . your doctor may decide to reduce the dose or stop treatment temporarily or permanently . you may also be given medicines to slow bowel movement . other side effects include : very common side effects ( may affect more than 1 in 10 people ): - feeling very tired ( fatigued ), - headache , dizziness , blurred vision , - ringing in the ears ( 
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . 1 ml of solution for injection or infusion is provided in the following concentrations : sucrose , sodium chloride , water for injections , and sodium hydroxide ( e524 ). if you have any questions about the content of this medicine , ask your doctor , pharmacist or nurse who might be giving you the powder for concentrate for solution for infusion . pack size of 10 vials .
depocyte is used to treat lymphomatous meningitis ( lms ) in adults . lymphoma meringitis is a condition in which tumour cells form in the membranes of the brain and spinal cord . depcyto works by blocking the effects of ldm technology , allowing the cells to grow and divide more effectively .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment , if : you have a meningeal infection . you have severe neurological side effects . while you are being treated , you may experience symptoms associated with the nervous system ( convulsions , pain / numbness or tingling ), blindness , visual disturbances or disturbances . if these symptoms persist , your doctor may decide to reduce the dose or stop treatment with any depamethasone tablets . your doctor will monitor you for unwanted effects and treat you if your side effects increase or decrease as well as any new side effects that you experience . children and adolescents there is no relevant use of de
there are strict laws on the use , handling and disposal of depocyte . it will only be used in special controlled areas where the medicine will be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the following information is intended for the specialist only : - the use of lumber sac in particular , will be discussed with the doctor who will decide on the appropriate storage conditions . - use in children and adolescents the product should not be given to children under the age of one month , but should be used only in very small amounts . use in this patient base the number of vials available for injections is 1 ml ( corresponding to 5 g of dexamethasone per kg body weight ) at the same time each day . after each de
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the possible side effects with you and will explain the potential risks and benefits of your treatment . the side effects listed below have occurred with depocyte in clinical trials : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 uncommon : effect on 1 to10 users in 1 , 000 not known ( frequency cannot be estimated from the available data ) large adverse events including : decreased appetite , vomiting weakness , confusion , fever headaches , diarrhoea , indigestion , heartburn , sexual dysfunction and increased risk of side effects in children and adolescents . in children ( 6 to 17 years of age ), the frequency of these events is common . side effects reported for the first 10 days of treatment were nausea and vomiting weakness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte can be removed from the refrigerator and left at room temperature ( up to 25 ) for a single period not exceeding 4 months . at the end of this period the product should be used as directed by your doctor . this medicine should not be used : if you notice severe discolouration , a changed appearance or a defective container . if the product is not used immediately , the contents of the container should be disposed of in accordance with local requirements . the following conditions are the responsibility of the user and would normally not be longer than the time it was stored , but the doctor will be responsible for the correct storage , use and disposal of dep
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cytokines ( corresponding to 5 mg / kg ). each vial contains 50 mg  106 .  the other ingredients are : cholesterol , trioein ( e331 ), dioleoylphosphatidylcholine ( е339 ), dipalmitoylapidioide diylglycerol , sodium chloride , and water for injections ( see end of section 2 for further information about some of the ingredients in this pack ) depcyto is a concentrate for solution for injection and is supplied in vials containing 5 mg of solution . it is supplied as a single injection ( s ) in a pack containing one vial .
two different strengths of bemrist breezhaler are available : indacaterol and mometasone furoate . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , making it easier for air to get in and out . when it is taken regularly , it helps to open the airways and so reduces the pressure , air and moisture , in the small  airways , and so gradually ease breathing problems . corticosteroids are used to prevent attacks of asthma . your doctor will tell you why this medicine has been prescribed for you .
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have heart problems ( e . g . an irregular or fast heartbeat ) you have thyroid gland problems . you have diabetes or high blood sugar , you have seizures or fits you have a low level of potassium in your blood you have severe liver problems you have tuberculosis ( tb ) of the lung or any long - standing or untreated infections . your doctor may decide to keep you under closer observation . during treatment , stop using bem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much bemrist breezhaler to use the usual dose is to inhale the content of one capsule each day . this will help you to breathe more easily throughout the day and night . your doctor will prescribe the dose that is right for you , depending on your asthma and on how your symptoms are responding to the medicine . do not use more than your doctor tells you to use . the number of capsules in each pack will depend on how well you feel . you will find an inhaler and capsules for inhalation purpose . only use the medicine when you are done in the morning and evening . after the morning dose , the capsules should be swallowed whole with a glass of water and do not chew or crush them . instructions for use the in
like all medicines , this medicine can cause side effects , although not everybody gets them . they are usually mild to moderate . some side effects may be serious common ( may affect up to 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( likely to affect less than 1 in 100 people , if you experience swelling mainly of the tip of your tongue ( lips ), face or throat ( possible signs of angioedema ). other side effects that may occur during treatment with bemrist breezhaler ( including nasal congestion , congestion ), sore throat , runny nose , stuffy nose and congestion of the sinuses , sinusitis , pneumonia . not known ( frequency cannot be estimated from the available data 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture and do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . one inhalation each day of the morning and evening consists of 125 micrograms / 62 . 5 microlitres . each delivered dose ( the dose leaving the mouthpiece of the inhaler ) contains 173 microgram ( ml ) of indаcaterol : a daily dose of 150 microgram . this dose is equivalent to an entire day . in this case , the doctor will prescribe the dose for you . the other ingredient in the cartridge is in the same sachet as for the other part of the medicine , namely in the form of poppers , and is called " snvr ". the delivery of the dose is as follows : the
zyllt contains the active substance clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . principiasis , a process by which certain proteins in the body ' s blood are clumped together , is prevented from forming such clots . this is done by a systemic process , by preventing the process of antiplatelets medicinal products from working . they are the target of many people . their bodies cannot easily control the process ; therefore , it is important that you regularly take anticoagulants ( e . g ., thrombi ) forming in hardened blood vessels ( arteries ), which is known as athero
do not take zyllt if : you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if you think any of these apply to you , or if your doctor has told you that you are at increased risk of bleeding , such as on a regular basis . warnings and precautions it is important to discuss with your doctor the precautions needed to avoid infecting other people . talk to your doctor or pharmacist before taking zylt . bleeding may occur at any time of the day whether or not you are in close contact with someone else . this includes anyone who is known or suspected to have had internal bleeding ( such as an stomach ulcer ). a blood disorder that makes you 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day ( for example , you could have severe chest pain called unstable angina or heart attack ), your doctor may give you 300 mg . your doctor will decide the appropriate dose based on your condition . when you will first start taking this medicine ( a daily dose of 75 mg ) once at the start of treatment . then , the usual dose is two 75 mg tablets per day as described above . for further information on dosage and frequency of administration , please refer to the section " information for medical and healthcare professionals ". 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take zyllt '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the first signs of an allergic reaction . other side effects include : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , nausea , vomiting ,
what zyllt contains - the active substance is clopidogrel . - each film - coated tablet contains 75 milligrams ( mg ) crospovidone ( as hydrogen sulphate )- the other ingredients are : - tablet core : lactose ( see section 2 under ' important information about some of the ingredients of this medicine '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose , titanium dioxide , red iron oxide ( e172 ), talc and propylene glycol in the film odium - aluminized sugar substitute for the chinese yew tree oil and natural colouring of the carnauba wax and indigo carmine ' s carn
what lamivudine teva is and what it is used for the treatment of adults and children ( 6 years of age and older ) with long term ( chronic ) hepatitis b infection in adults and adolescents . lamizine to be taken is an antiviral medicine that works by preventing and reducing the effects of the hpv - b virus . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrti ). not everyone gets the full benefit from this medicine , but it can be very harmful to the liver , causing severe and prolonged ( long term ) infection , and can lead to liver damage . by limiting the power of the liver in people whose liver is damaged but still functions normally ( compensated liver disease ) as treatment has not worked well enough 
do not take lamivudine teva : - if you are allergic to at least one other medicine ( s ) or to any of the other ingredients of this medicine ( listed in section 6 ). check with your doctor if this applies to you . warnings and precautions 28 talk to your doctor about when you may need to switch from the previous dose to the next dose . when you are treated at the same time with other similar medicines , you may be more at risk of serious side effects . you need to be aware of the extra risks , including those involved in the treatment , and the type of liver disease called hepatitis c . do not be alarmed by the dose you are taking , or be suspicious of any other medicine . tell your doctor or pharmacist if : you are pregnant or breast - feeding you will need extra check - ups 
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor lamivudine teva is used to treat your hepatitis b infection . it helps to control your infection and slow down the progression of your illness . how much to take the recommended dose is one tablet once a day . swallow the tablet whole with a glass of water . you can take the tablet at any time of the day , with or without food . do not chew or crush the tablet . if your doctor thinks that the dose is too high or too low , talk to your doctor or pharmacist . don ' t change your dose unless your doctor tells you to . just take the next dose at the usual time with some water , one after the other . this will help to keep your kidney
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in association with other conditions linked to hepatitis b . for more information see ' warnings and precautions ' and talk to your doctor . some of these side effects may be serious and may require therapy . ' catch a minute or two before you go to bed . see a doctor straight away if you get any of these effects . most of them are mild and do not last long . sometimes , patients may get more infections than they should . other conditions can be serious , but there have been reports of ' serious ' or ' long - term ' events ( see section 2 ). some patients have experienced the following serious side effects during lamizine clinical trials : tiredness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . lamivudine teva does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains the active substance in each film - coated , scored tablet is 100 mg debossed with " gilead ". the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film coat : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , talc , iron oxide yellow , and iron oxide red [ e172 ] ( only inhalational use only ], carnauba wax , sunset yellow fcf powder , yellow sdna of the tablet and the company logo is printed on the tablet ( t - 32 ) and " nvr " on the white tablet ( tablet ) of the year . la
nespo is an anti - anaemic . it will help control your anaemia . your doctor will test your blood to make sure that you have enough red blood cells , which are important for the symptoms ( fatigue , weakness and shortness of breath ) that are caused by an overproduction of the natural hormone erythropoietin . this helps your kidneys produce more blood and stimulates your bone marrow to produce more red blood cell ( s ). darbepetin alfa is also used for the treatment of chronic renal failure in adults , adolescents and children ( 6 years of age and older ) who have had a lower than normal rate of symptomatic amaemia before . chronic renal fail is also a treatment for adult patients with kidney failure . kidney failure is a failure in which the kidney does not produce enough blood , and the natural
do not use nespo : - if you have high blood pressure , are taking other medicines , or are allergic to the active substance darbepoetin alfa or r - hiepo , and / or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you are sickle cell anaemia you have a history of epileptic fits ( seizures ). you have ever had fits ( convulsions , fits or seizures ) you have liver disease caused by drugs . if any of these apply to you , your doctor will investigate the reasons why this medicine has been prescribed for you . your doctor may want to monitor you more closely . you have been told by your doctor that you are at high risk of developing ana
nespo will be given to you by a doctor or nurse who is experienced in the use of this type of medicine . your doctor will carry out blood tests to check that your haemoglobin level is within the normal range of 10 g / dl and will measure it at regular intervals . the usual dose for adults is 10 iu ( international units ) per kilogram of body weight , i . e . two samples of 12 g each ). the pre - filled syringe is injected into a vein ( intravenous ). in the case of chronic renal failure , it is given as a single injection under the skin , but over a long period of time . in this case , your doctor may give you a lower dose ( 0 . 75 mg / kg ) or higher doses , depending on the
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) with fluid retention ( oedema ). uncommon ( impact affects 1 to 100 users in 10): blood clots ( thrombosis ). pain in or around the area injected rash or redness of the skin rare ( effect affects less than 1 user in 10 , 000 ). serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) which may include swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedemo ). not known ( frequency cannot be estimated from the available data 
keep out of the reach and sight of children . store in the original package in order to protect from light . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . this medicinal product does not require any special storage conditions . if you have any suspension left in a bottle more than 30 days after it was first opened , you should not use it for more than 7 days . please return the bottle containing any leftover suspension to your pharmacist . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains the active substance is darbepoetin alfa . each pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu ( international units ). - the other ingredients are recombinant dna technology and sodium phosphate monobasic ( e331 ), sodium phosphotin dibasic , sodium chloride , polysorbate 80 and water for injections . what nevespo looks like and contents of the pack the solution is clear , colourless to slightly pearly liquid , cloudy or slightly opalescent , and colourless or pale yellow . pack sizes : 1 or 4 pre – filled pens . all pack sizes may be
macugen is a solution which is injected into the eye by a doctor or a nurse . the active substance in this medicine is pegaptanib . this medicine helps to prevent abnormal formation of new blood vessels in the eye which can lead to vision loss . as a result of this disease , vision loss occurs and damage occurs to the part of the retina called the macula , which is at the back of the eye . in amd , abnormal blood vessels grow out of control , causing the eye to darken , blurred vision and / or abnormal light - sensing . your doctor will put you on a special diet to help protect your vision and make it easier for you to see clearly and hear things that are not there ( see also section 4 ). this new protein can act in exactly the same way as normal , normal blood flow to and from time to time .
do not use macugen if : you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). you have an active or suspected infection in or around your eye . warnings and precautions talk to your doctor , pharmacist , or nurse before and during the use of Macugen there is a higher risk of an infection . bleeding in the eye may occur following macugagen injection . tell your doctor immediately if you develop any of or all of the following symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light or small particles in your vision . these may be signs that the injection has been given you or your child ' s eye doctor may stop the injection temporarily or permanently . if after the injection serious allergic reactions occur , the symptoms may last for up to 4
macugen will only be given to you by a doctor or a nurse who is experienced in the use of injections . the doctor or nurse will decide on the dose that you will receive . you will be asked to drink a full glass of water before each injection . how much is given the usual dose is a single injection into your eye , which will be given every 6 to 9 weeks . if the injection is given too soon , the vitreous ( transparent ) part of the eye will become clogged or blocked . your doctor will ask you to drink the same amount each day . before and after the injection , your doctor may give you antibiotic eye drops in the morning , and in the evening , in both eyes . we will also give you some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you may have , depending on how you
like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms include : breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting , diarrhoea . the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported in patients receiving macugen treatment . these symptoms may progress to more than 2 out of 10 people . if you experience any of these symptoms , seek medical advice from your doctor as soon as possible . your doctor may decide to reduce the dose to half of the dose . in some cases ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . if you have any suspension left in a bottle more than four weeks after it was first opened , you should not use the medicine .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegabib in 90 millilitres / ml .  the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt ( e339 ), sodium hydroxide ( for injection ), hydrochloric acid ( for ph adjustment ) and water for injections ( see section 2 . important information about some of the ingredients in the pack macarugen solution for injection is provided in a single dose pack , which may contain a pouch , a ready - to - use multipack ( of one pack of ten ) or a multidose pack ( of two packs of 10 ) with an elastomeric plunge
kepivance contains the active substance palifermin which is produced by recombinant dna technology in escherichia coli . it belongs to a group of medicines called ' epithelial cells '. these are the cells that carry food , and are found in the mouth , digestive tract and the tissues below the skin . when the mouth is opened a new leaflet is given to the patient , it tells the doctor who will decide what treatment to give you . the medicine is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth in adults ). it is also used in combination with other medicines to treat your blood cancer in patients whose blood cancer has progressed after chemotherapy and radiotherapy or autologous hematopoietic stem cell transplantation .
do not use kepivance - if you are allergic to palifermin or escherichia coli derived proteins , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions children and adolescents do not give this medicine to children under 18 years of age , because the safety and efficacy have not been established . other medicines and kepingivance tell your doctor or pharmacist if this medicine is of concern to you . this is important because : - you are taking , have recently taken or might take any other medicines . - your doctor may need to adjust the dose of one of your own heparin . you should discuss this with your doctor if , for example , you are planning to have a baby , ask your doctor for advice before taking this medicine . pregnancy , breast - feeding ke
kepivance will be given to you in a hospital or clinic under the supervision of a doctor experienced in cancer treatment . usually , a ' dose ' is given initially in the form of 60 milligrams of solution . a single dose of kepeivance is given as a kilogram ( 0 . 5 ml ) by an intravenous injection into a vein . your doctor will decide how many treatments you need . you will receive a course of treatment called ' treatment courses '. - you will be provided with a kit to have it all : - on the first course - in three days of chemotherapy and radiotherapy , and on the second course on chemotherapy andradiotherapy on the 24 to 48 hours of the chemotherapy and onwards - after the chemotherapy has finished . the chemotherapy will usually be given two courses of radiotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported with kepivance were skin rash , itching and redness ( pruritus ) and erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the mouth ou tongue ), generalised swelling , oedema ( swelling of hands , ankles or feet ), pain , fever and aching joints ( arthralgia ), altered taste , lipase and amylase levels . uncommon :  a slight decrease in the number of white blood cells ( erythema multiforme ). if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask your doctor .
what kepivance contains - the active substance is palifermin . each vial contains approx . 6 . 25 milligrams ( 0 . 5 millilitres ) of paliffermin as the other ingredients are : mannitol ( e421 ), sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid , to adjust the acidity . see section 2 , further information , and / or solvent : sodium , water for injections , in order to achieve the best results for your health , the product is clear , colourless to pale brownish - yellow , solution for injection that comes in a glass vial . it is available in packs containing 6 vials . not all pack sizes may be marketed .
the active ingredient cinacalcet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathyroid glands . the four small glands in the neck , near the thyroid gland , control the level of thyroid hormone , and to help reduce your risk of getting secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products . this reduces the amount of calcium in the blood ( hypercalcaemia ) in people with atathyroid cancer , but is still a problem that may be solved by removal of the gland . you should discuss this with your doctor if you have any questions about how this medicine works or why this medicine has been prescribed for you . in children and adolescents ( 3 to 18 years old ) with secondary hyper
do not take cinacalcet accordpharma : - if you are allergic to citriccet or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . there are very low levels of calcium in your blood . your doctor will monitor your blood calcium levels . if this applies to you , tell your doctor at once . do not stop taking the medicine unless your doctor tells you to . don ' t reduce the number of seizures ( convulsions ). in case of seizures , your doctor may want to reduce your dose . you have liver problems , you have heart failure , or you are not able to take the medicine as your doctor has told you . children and adolescents do not give this medicine to children under the age of 18 years . calcium levels in the blood can cause
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much cinacalcet accordpharma you need to take and how long you should continue to take it . you will be told how many tablets to take each time you take . this is to make sure that your doctor is informed of all the doses you are taking . the tablets must be taken whole and are not to be chewed , cut or sprayed with water ; this is because it will affect how you respond to treatment . for patients with secondary hyperparathyroidism , the recommended starting dose is one tablet ( 30 mg ) taken three times per day ( one tablet ). this will be given to you as a single dose . children ( 3 months to less than 18 years ) the dose is 0 . 20 mg / kg 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). signs include : swelling of the face , lips ,mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . all of these side effects are usually mild to moderate and usually go away over time . talk to your doctor if they last longer than a couple of days . not known ( frequency cannot be estimated from the available data ) dizziness , lightheadedness or fainting . this is usually accompanied by light - headedness 
what cinacalcet accordpharma contains the active substance in each film - coated tablet is a clear , colourless to light yellow - yellow , capsule - shaped , approximately 9 . 65 mm x 6 . 00 mm in diameter , biconvex , film coated tablet , debossed with " ci30 " on one side and " nvr " on the other side . the tablet may be individually sealed in a sachet or canister and should not be swallowed . not all pack sizes may be marketed .
jentadueto contains two different medicines called linagliptin and metformin in one tablet : one is a substance that helps to control blood sugar levels , in adult patients with a form of diabetes called ' dpp - 4 inhibitors ' ( dipeptidyl peptidase - four inhibitors "). the other ingredients of metformine are biguanides and carbohydrate , which are used to lower blood glucose levels in adults , adolescents and children with diabetes with ' type 2 diabetes mellitus '. this medicine works by helping the body to increase the levels of insulin produced after a meal and decrease the amount of sugar made by the liver . your doctor may prescribe this medicine alone or together with certain other medicines for diabetes ( sulphonylureas , e . g . empagliflo
do not take jentadueto if : you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). you have severely reduced kidney function . you have uncontrolled diabetes , with e . g . severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acidsis " below ) or ketoacidosis . ketonacidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - coma . symptoms include stomach pain , fast and deep breathing , wheezing , sweating or sleepiness . warnings and precautions talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the amount of jentadueto that you will take varies depending on your condition and the doses you currently take of metformin and / or individual tablets of linagliptin . your doctor will prescribe the strength that is right for you , depending on which treatment you are taking . the recommended dose is one tablet once a day . do not change the dose yourself unless your doctor tells you to . taking this medicine with food and drink swallow the tablet whole with a glass of water . you can take your tablet with or without food . this will help you to remember to take it . when you have an upset stomach , your doctor may prescribe you a daily dose of 5 mg linagin twice daily ( equivalent to 2 
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see a doctor straight away if you notice one or more of the following symptoms of low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change , confusion ( frequency unknown ; may affect up to 1 in 10 people ). the frequency of this side effect is similar to that seen with jenteduet plus sulphonylurea . it is more likely that you will get the following : very common : may affect more than 1 person in 10 , 000 people the most common side effect was a decrease in the level of sugar in the blood . the frequency was common in patients taking
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light and moisture and only remove immediately before use . this product should not be used if there are any signs of tampering ( e . g ., in a damaged or damaged blister ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer used . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each japanese based product ( s ) is available in a range of 2 . 5 mg / 850 mg film - coated tablets . each jenson - johnson ' s patent carries a symbol for the development of a specialised group of medicines called chinese hamster ovary ( cho ) and landed in the atlantic ( hla )- b * 5701 gene has been used to express his / herald as a microbiological point of view and , therefore , the product is a target for patients who have demonstrated clinical benefit and were able to take two doses at the same time and they both deliver 850 micrograms
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children of all ages who are taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). this is another type of hiv medicine that can infect other people , especially those who are 12 years of age and older who are infected by hiv and who have not taken hiv medications before . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the following medicines : carbamazepine , oxcarbazepine ( e1200 ), phenobarbital and phenytoin ( medicines to treat epilepsy and prevent seizures ) rifampicin and riifapentine ( medicines for treating some bacterial infections such as tuberculosis ) may be available without prescription omeprazole and , especially if given with a prescription for a long time . it is especially important that you also read the package leaflets of the medicines for this medicine , and that the information in this leaflet is included in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : 1 . edurant should be given to you by a doctor or nurse . adults ( 18 years of age and over ) your doctor may decide to give you an additional dose , either on its own or in combination with another medicine , such as rifabutin , a medicine to treat some bacterial infections . it is very important that you do not get the full dose of ecourse unless your doctor tells you to . do not change the dose yourself . in this case , your doctor will decide with you the lowest possible dose . for further information , see the package leaflet of the medicine to be taken at the end of this leaflet . 2 . make sure your doctor gives you an antacid ( 
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience : headache , nausea , difficulty falling asleep , insomnia , dizziness . these may be signs that your routine liver tests may increase in levels of transaminase and increase in cholesterol and pancreatic amylase in your blood . abnormal dreams , rash and stomach pain . signs of depression , tiredness , vomiting and drowsiness . decreased appetite . sleep disorders , stomach discomfort , depressed mood , and feeling unwell . common side effects ( may affect up to 1 in 10 people ): diarrhoea , constipation , loss of appetite , weight loss , low blood sugar . increase in uric acid and / or creatine phosphokinases ( a form of creatine
what edurant contains - the active substance is rilpivirine . - each film - coated tablet contains rilspevidrine hydrochloride . each tablet contains 25 mg / 0 . 5 ml of rilivrine ( as mesilate ).  the other ingredients in the tablet core are : lactose monohydrate ( see section 2 ), croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . in addition , the film  content is essentially sodium free , hypromellose 2910 ( 3 mpa . 6 mm in diameter ), titanium dioxide ( e171 ), macrogol 3000 and triacetin . not all pack sizes may be marketed .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used for different types of diabetes . people with type 2 diabetes either do not make enough insulin ( a hormone that controls blood sugar levels ), or don ' t respond normally to the insulin their body makes , and their blood sugar is not controlled by diet and exercise alone . both of these medicines work together so your body can produce its own protection ( insulin ) when they are not enough to control the level of sugar in your blood when you have a need for insulin . rosin , when used together with metformine , help your body make better use of the insulin it produces . this helps to reduce your blood sugar , especially when you are having a supplement of a sulphonylurea ( another medicine for diabetes ).
follow all instructions given to you by your doctor , pharmacist or nurse carefully as they will explain how to treat your diabetes . do not take avandamet if any of the following apply to you : if you are allergic ( hypersensitive ) to rosiglitazone , metformin , or the other ingredient in this medicine ( listed in section 6 ), have had a heart attack or severe angina , have heart failure or have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacidosis ( a complication of diabetes that can cause rapid weight loss , nausea or vomiting ), suffer from kidney disease 107 you may also be very dehydrated ( alcohol ) as a result of all of this may make you more likely to get dehydrated , especially at the start of treatment . you must continue to follow any diet and lifestyle advice from your doctor
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose is 2 tablets of rosiglitazone and 1000 mg of metformin taken once a day . this dose is given on days 1 and 8 of each three - week cycle . your doctor will work out the right dose for you , depending on how you respond to the treatment . the maximum dose is 4 tablets / day ( morning , afternoon and evening ). the dose will be calculated by your doctor based on the number of tablets you take and will depend on whether or not you take more tablets than you should ( see section 2 ' how to take '). swallow the tablets whole with a glass of water . do not chew , crush or split the tablets as they may have particles in them . if
like all medicines , avandamet can cause side effects , but not everybody gets them . allergic reactions have been reported very rarely in patients taking the medicine . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact a doctor immediately if you have any of these symptoms . your doctor may decide to stop the treatment . lactic acidosis : this is the build - up of lactic acids in the blood ( lactose ) this is a very common side effect with metformin in patients with severe kidney disease . some patients have experienced symptoms of lacecidosis such as rapid breathing , cold sweats , and rapid heartbeat . these are usually mild to moderate and usually go away within a few days . the most common
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the pack . this medicine does not require any special storage conditions . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . - each tablet contains a total of two different active substances :  the active ingredients in  each tablet is a white to off - white powder coated with a blue imprint " ucy - rio - grazoprevir - mekuniac ' and ' neoprenor ' ( e1200 )  one of two tablets : 1 tablet of rosibilite containing 500 mg of metformine  2 tablets of rotazone containing 5 , 500 mg ( 2 x 214 ) in the morning and 9 , 10 , 15 , 20 , 25 , 60 , 84 , 90 or 100 mg ( 3 x 600 mm in the
the active substance of clopidogrel mylan , cimetidine , belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . principially , these small structures are essentially unchanged from the original clot , and so are important in preventing it from separating from each other . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood odours forming ( a process known as thrombosis ). ' c ', ' traps ' ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis . this can lead to at
follow all instructions given to you by your doctor , pharmacist or nurse carefully before you are given clopidogrel mylan . do not take this medicine 31 : - if you are allergic to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before and during your treatment if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . your doctor may want to monitor you more closely whilst you are being treated at the moment ( see section 4 ). you have recently had any other treatment options . if any of these conditions apply to you , your doctor will let you know , and whether you can take the tablets , the tablets or the pack , if they may not be suitable for you . children and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day ( for example , one tablet of 150 mg or one of mylan' s medicine ), unless your doctor tells you to change to a lower dose . if your doctor thinks that you may have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg , or one half ( 1 tablet of 75 mg ), twice a day , depending on how you respond to treatment . your doctor will tell you the appropriate dose to take ( usually between 75
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take clopidogrel mylan '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin , which may be the signs of an allergic reaction . the most common side effects ( affects 1 to 10 users in 100 ) are : diarrhoea , vomiting , nausea ,
what clopidogrel mylan contains - the active substance is cyclosporin , which is similar to the so called ' cb1 inhibitor '. each film - coated tablet contains 75 mg of rvin  clene ( as hydrochloride ).  the other ingredients are : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' take '), ' closing the tablet core ') and hydrolysed polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide [ e172 ], talc and macrogol 3000 . see section ' important information about some of the ingredients of this medicine ' in section 3 . what
doptelet contains the active substance riocigrombopag , which belongs to a group of medicines called thrombopoietin receptor agonists . becquerel is used to treat adults with chronic liver disease associated with low platelet count ( thrombocytes ) and may be treated with a medical procedure to reduce the risk of bleeding by reducing the number of platelets . platelets are blood cells that help the blood to clot and so prevent bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before and during treatment . blood clots can form in the veins or arteries and this can be life threatening . tell your doctor before you start treatment and make sure that you aren ' t given this medicine . this is to reduce the risk that it can harm your own health . your doctor will help you to decide if this medicine is suitable for you . do not give this medicine to children and adolescents under the age of 18 years , because it has not been studied in this age group . other medicines and dopetelet tell your healthcare professional , nurse or pharmacist if : you are taking , have recently taken or might
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the dose you should take , depending on the results of your procedure . the usual dose is 5 mg per kg of body weight , for example 8 tablets a day . swallow the tablets with a glass of water . you can take doptelet with or without food . depending on your dose , your doctor may increase your dose to a maximum of 20 mg , 40 mg or 60 mg / kg , per day ( whichever is higher ) in the morning and evening . this may be increased or decreased if your platelet counts are too low . it is recommended that you continue taking this medicine for 10 days or more per day , unless your doctor tells you to stop . dose within 13 days of your planned medical procedure , you may
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : common : may affect up to 1 in 10 people feeling tired uncommon : might affect upto 1 in 100 people low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel in which the liver and intestines collide ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects get a quick response from your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains the active substance in dopelet is avatrombopag . each film - coated tablet contains avatorabopag maleate equivalent to 20 mg . the other ingredients are : - tablet core : lactose monohydrate ( see end of section 2 ), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate - film coating : poly ( vinyl alcohol ), talc , macrogol 3350 , titanium dioxide , iron oxide yellow ( e172 ). what dopetelet looks like and contents of the pack optelet 20 mg tablets are pale yellow , round and rounded . they have " av220 " on one side and " nvr " on the other side .
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by measuring the diameter of the heart arteries and their heart rate . it also helps to find the right amount of radioactivity in your muscles , allowing the doctor to visualise them more clearly . the results of this scan will help your doctor decide if it is necessary to carry out a special type of exercise . called a ' myocardial perfusion imaging ', the scan will contain a radioactive substance known as ' radiopharmaceutical ' that will be used to obtain these images . these images will show exactly where the muscles in your heart are , using a treadmill to measure the electrical activity of your heart . after a scan , your doctor may decide that it would be appropriate to carry on with the next doses of this medicine . you
do not use rapiscan - if you have slow heart rate or have high degree heart block or sinus node disease and do not have a pacemaker when you are being treated for chest pain ( unstable angina ). warnings and precautions talk to your doctor before starting treatment if any of the following applies to you : - low blood pressure ( hypotension ) - heart failure - you are allergic to regadenoson or to peanut or soya . see section 6 , " what you need to know before you have been given the medicine ". - have had a recent serious heart problem , such as a heart attack or have abnormal heart rhythms . your doctor may need to change your heart ' s rhythm , especially if your heartbeat is very fast or uneven . it may also be necessary to stop this medicine before you start taking it again . if
rapiscan will be administered to you by a doctor or nurse who is experienced in the diagnosis and treatment of your heart and blood pressure . it will be injected into a vein over a period of approximately 400 minutes using a 5 ml solution the injection will take about 5 to 10 minutes . the dose you receive is based on your weight . if you are having an injection of sodium chloride 9 mg / kg ( 0 . 9 %) solution for injection , you will be given 5 minutes with a radioactive substance ( radiopharmaceutical ) which is used to measure your heart rate . your doctor will work out the correct dose for you and will tell you if this dose is needed and will also tell you how much you will need to take , when to have it and for how long ( see section 2 ). the dose will be calculated by the doctor in relation to your heart
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects described below were seen when they were given at the hospital or clinic . they usually happen within the first two weeks after the rapican injection , and usually within 30 days after any treatment . tell your doctor straight away if you notice any of the following serious side effects as they could be a sign of sudden stopping of the heart , damage to the heart or heart block . these may be due to a disorder of the cardiac signal . rapid heart beat low blood pressure fainting , mini strokes , weakness of the face or inability to speak . it is not known how often these effects occur . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you will be monitored for signs of a stroke , or cerebrovascular accident .
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , making it easier for you to get an erection . when you are sexually stimulated with viagra , it can be used as a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard - to - comfortable , errect penis suitable for sexual activity .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if this applies to you . these medicines are often given for relief of angina pectoris ( or " chest pain "). if you are not certain , ask your doctor or pharmacist why you should take these medicines . nitric oxide donors , such as amyl nitsitrite (" poppers ") may also be given to you as a precautionary measure as it may increase the risk of a deadly fall in the amount of vitamin k antagonists ( such as riociguat ). this drug is used for the treatment of pulmonary arterial hypertension ( i .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once daily taken with viagra film - coated tablets or with viagra orodispersible tablets . you should not take viagra more than once a day . swallow the tablet whole with water . viagra can be taken with or without food . it is important that you take viagra every day until your doctor tells you otherwise . this will help you to get an erection , provided that you are sexually stimulated . how long will viagra take to work ? viagra can take up to one hour before sexual activity , if a man has the impression that the effect of viagra is too strong or too weak , or if someone else takes your tablets , they may find they have an increased risk of an increase in side effects . doses above 100 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction , seen uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat ; chest pains . get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections : see also section 4 for more information . not known ( frequency cannot be estimated from the available data ): a ) you should contact a doctor immediately 
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildinafil ( as the citrate salt ).  the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake . what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are marked with ' 25 ' on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate receptors in the brain that are involved in transmitting nerve impulses into the brain . this helps to control the symptoms of primary parkinson ' s disease . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). it can also be used to relieve the symptoms associated with moderate to severe primary restless legs syndrome in adults .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking sfrol . please tell your doctor about any medical conditions or symptoms you may have . some of these conditions may be serious and include : kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). the very common ( affecting more than 1 in 10 people ) is dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa may also play a role in dyskineia . your doctor may want to change your dose , or stop your treatment with 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . sifrol should be prescribed by a doctor experienced in the treatment of parkinson ' s disease . the recommended dose is 3 tablets per day . during the first week , your doctor will start you on a low dose . after this , the daily dose is divided into 2 doses . in week 1 , you will start with the lowest dose ; the maximum dose will be either 0 . 088 mg ( half a - 264 mg tablet ) or 1st week . this will be increased every week until your doctor tells you to reduce the dose to a maximum of ten . you will then start on another level with a lower dose of : - the recommended starting dose is : 2 tablets : 1 tablet :
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( affects 1 to 10 users in 100 ) uncommon ( will affect 1 to 1 users in 1 , 000 ) very rare ( may effect up to 1 user in 10 ,000 ) not known ( frequency cannot be estimated from the available data ) parkinson ' s disease the most common side effects reported were dyskinesia ( ( e . g . abnormal , uncontrolled movements of the limbs ), dizziness , nausea ( sickness ), general urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ), confusion , tiredness and disorientation . in children ,
what sifrol contains - the active substance is pramipexole . - each tablet contains 0 . 088 mg , 0- 18 mg and 0- 35 mg . each tablet provides a user - friendly interface , which allows easy access to the tablet core and the ability to take the tablet at any time . the tablet may be opened in the morning , or in the evening , with a full glass of water and a sip of water ( for example , water for injections ) before the start of the day . this will give you a chance to try and break the tablet as soon as possible ( see the end of this leaflet for further information ). if you are not able to swallow the tablet , you may be given a lower dose as a result of taking the lowest possible dose . for adults , the usual dose is 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it belongs to a group of medicines called ' allergic conditions '. these are allergic conditions that occur in and around the eye and can be life - threatening if left untreated . during the allergic reaction , some materials ( allergens ) may form in the environment , which can cause allergic reactions such as itching , redness and swelling of the surface of your eye , and you may notice that you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : 6 . in case you are breast - feeding . children and adolescents do not give this medicine to children below the age of 3 years because the concentration of benzalkonium chloride in the solution used to prepare the medicine is lower than that recommended by the world health organisation . - in clinical trials , no data are available on the safety and efficacy data from the safety profile in children above 65 years . there have not been no clinical trials on the use of the product in children younger than 6 years of age . it is not yet known whether the safety in this group of patients is higher than that in other medicines . tell your doctor or pharmacist if
always use emadine exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is 3 drops in each eye . use this medicine every day to help you remember when to use it . do not use it more than once a day . only use it in both eyes if your doctor told you to . 3 . wash your hands thoroughly before and after each use . 1 2 3 ) do not open the bottle . after opening : 1 ) before , 2 2 ) after the first use : - before opening and re - start a new one . - after first opening , - when the bottle is opened , the bottle must be held in the syringe ( s ). - twist off the cap ( see ' open ' at the end of this leaflet
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using the drops and tell your doctor straight away if you notice any of the effects listed below . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects these may affect more than 1 in 100 people ). effects at the back of the eye ( corneal disorder , abnormal eye sensation , increased tear production , tired eyes and eye irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ): allergic reactions ( e . g . swelling of the face , lips , mouth , tongue or throat ) loss of taste , allergic reaction to emadine . the following side effects have been reported since the marketing of
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . keep the blister in the outer carton in order to protect from light and moisture .
what emadine contains each ml of solution contains : 0 . 5 mg difumarate the other ingredients are benzalkonium chloride , trometamol ( e433 ), sodium chloride the ingredients of hypromellose , purified water , hydrochloric acid and sodium hydroxide ( to adjust acidity levels or ph levels ), and water for injections ( for example , to keep a constant amount of water in the tablet ) for up to a maximum of five hours , and to keep the acidity low for a long period of time ; this ensures that there is always enough liquid ( a solution ) in the vial . it is supplied in a pack containing : one 5ml ( drop - container ) bottle with a screw cap . not all pack sizes may be
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ) in adults and adolescents 16 years of age and older with newly diagnosed epileptic disease , a condition where the patients have repeated fits ( seizures ) with a certain amount of difficulty adjusting their dose . levetiractam has been given to the patient as an injection into the brain by your doctor . initially , the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of your brain ( partial onset seizure with or without secondary generalisation ) and may then be given to you by a doctor , who will give you additional the following properties : o to give an improvement in the ability to do normal daily activities , and to help you stay alert to changes in your mood , behaviour and social functioning ( e . 
do not take levetiracetam actavis : - if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before and during the treatment of you . your doctor may decide to reduce your dose . talk to a doctor or pharmacist if : you have kidney problems . you notice any slow down in the growth or unexpected puberty development of your child . a small number of people being treated with anti - epileptics such as lattices have had thoughts of harming or killing themselves , and any symptoms of depression and / or suicidal ideation . tell your doctor immediately if any of these side effects occur , especially : abnormal thoughts , feeling irritable
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take the number of tablets following your doctor ' s instructions . levetiracetam actavis should be taken twice a day , once in the morning and twice in the evening . monotherapy dose in adults and adolescents ( from 16 years of age ) : general dose : between 1 , 000 mg and 3 . 000 mg each day . your doctor will prescribe the dose that suits your condition . in some cases , your doctor may prescribe lower doses , such as the lower dose . when you are being treated for a family member or friend , you may be asked to increase your daily dose by 2 weeks before you start taking it , so that your doctor knows exactly how much to take . add - on therapy dose in adult patients ( 12 to 17 years
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature ; increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction with the hepatitis b virus ). uncommon side effects ( may affect up to 1 in 100 people )
what levetiracetam actavis contains - the active substance is called levetiractam . each 250 mg tablet contains 250 mg debossed with " lilly " on one side and " tadalafil " on the other side . - each 500 mg tablet contient 500 mg dedote ( 0 . 5 - 11 ). - one 750 ml tablet contains 750 mg devout , containing all of the necessary ingredients to make it easier for you to get the most from your sulphonylurea ( e1520 "). o each 1000 mg tablet also contains 1 , 000 mg duddeningly , white to almost white powder . the other ingredients are crospovidon , povidone , silica colloidal anhydrous and magnesium stearate . what le
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . what it is used for this medicine is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs gradually become blocked or damaged , leading to breathing difficulties that slowly get worse . difficulties in breathing is added to by tightening of the muscles around the air , making it easier for air to get in and out of the air ( air ), and improving your breathing difficulties and reduce the effects of copd on your everyday life . elimta should not be used to relieve a sudden attack of breathlessness or wheezing . it should be used every day
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . this medicine should not be used for the treatment of asthma ( see " other conditions and conditions " in section 4 ). this is important information to be included in the patient alert card that is provided with each inhalation and should be kept out of the reach and sight of children . asthma is not the same as for other medicines used to treat asthma . heart problems . your doctor may want to test you for an eye problem called narrow - angle glaucoma . you have an enlarged prostate , difficulty passing urine or a blockage in your bladder . severe liver problems if any of these apply to you , tell your doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that your doctor , pharmacist or nurse shows you how to use it in the ways that your symptoms are not being controlled with this medicine . to reduce the chance of a sudden attack of breathlessness or wheezing , you breathe in through your mouth using your quick - acting reliever inhaler ( such as salbutamol ). instructions for use are provided in the box included in this leaflet . read the instructions at the end of this leaf
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta stop using this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 other side effects may include common : these may affect more than 1 in 10 people faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ). common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead ( signs of inflammation of the lining of the mouth and throat ). not known ( frequency cannot be estimated from the available data ): decreased appetite , weight loss , diarrhoea , indigestion , feeling sick ( nausea )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . after first opening or if carried as a spare , the sealed tray can be kept at room temperature ( below 30 ) for up to six weeks before use . write the date you first open the tray as you will find it and use it as you have been taught how to use it . incruse ellipta should only be used if it is not used within 6 months of opening it should be used within the first few days of opening the tray . keep the container in the outer carton in order to protect from light . if you do not have a manual for in
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium , corresponding to a metered dose of 65 microgramms of umecidine ( as metered ) at the date and time of calibration .  the other ingredients are lactose monohydrate ( see section 2 under ' content of the pack for further information ') and magnesium stearate ( e470b ) ( cbs / e505 ) - your doctor , nurse or pharmacist should have prescribed the most appropriate dose based on the type of medicine that you are using , as well as for other preparations . the information for medical or healthcare professionals is described in the following table :
nucala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that recognises and attaches to a specific target in the body . it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils - a kind of white blood cell , which are important for the lungs to work properly . in asthma nucala helps to control asthma attacks and prevent you from having asthma attacks by attaching to medicines called high dose inhalers . your asthma cannot be controlled with these medicines alone . you may also be given medicines called oral corticosteroids . when you are prescribed nuCALa for your asthma , it is important that you also read the package leaflets for these medicines . if you do not respond well enough to these
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . this medicine has been shown to increase the risk of worsening asthma . in some patients ( more than 58 %), patients have experienced asthma - related side effects as a result of their asthma getting worse . your doctor will monitor your asthma while you are using nuCALa . if your asthma gets worse after they have received nucalal treatment , tell your doctor straight away . you may be allergic to other injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the body . see section 4 for more details about side effects , as there have been reports of a similar reaction when using nucal
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose for adults and adolescents 12 years of age and older is 100 micrograms once a week for the first 1 month . use in children and adolescents the pre - filled pen will be ready to use before they are born . your doctor will monitor your progress and may change your dose if needed . duration of treatment - your doctor may decide to continue treating you , or for how long you should be treated with nuCALa . - if your doctor determines that it is necessary for the treatment to be completed , you will be monitored for any change in the course of action . you should continue with the treatment , and continue with your prescribed dose , until your asthma symptoms and attacks have gone away 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur commonly ( may affect up to 1 in 10 people ) following the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor or nurse immediately if you have signs of a reaction similar to or similar reaction after receiving nuclear medicine . your doctor may decide to keep you under closer observation or change the dose . when you are treated for a life - threatening medical condition , it is important to talk to your doctor , pharmacist or nurse about any change in the way the medicine works as it prevent
keep this medicine out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep away from the freezer compartment . after first opening or if carried as a spare you can carry a pre - filled pen ( flextouch ) with you and keep it at room temperature ( not above 30 ) for up to 7 days . once removed from the refrigerator , you must use it within 7 days to protect it from light . your doctor or nurse will throw away any medicines you no longer use . these measures will help protect the environment .
what nucala contains - the active substance is mepolizumab . one ml contains 1 mg ( equivalent to 100 mg ), of which at the time the other ingredients are sucrose , sodium phosphate dibasic heptahydrate ( e331 ), citric acid monohydrate , polysorbate 80 , edta disodium dihydrate . - solvent : water for injections ( see ' important information about some things to look out for ' at the end of this package leaflet ') and sodium if you are not sure , talk to your doctor , pharmacist or nurse about the pack size . pack sizes : 1 vial in a pack containing 1 or a multipack containing 3 vials in one pack . not all pack sizes may be marketed .
what ninlaro is this medicine contains the active substance ixazomib . it is a type of medicine called a ' proteasome inhibitor '. what it is used for nINlARo is used to treat adult patients with : a cancer of the bone marrow known as multiple myeloma , for whom either the patient or the patient cannot produce enough of a protein ( granulocyte - colony stimulating factor [ g - mft ]) and one or more of the proteins in their blood are involved in dividing and dividing the protein into smaller pieces . the protein in these cells accumulates in the blood and accumulates for longer than a few days . this results in a reduced ability of cell survival . as a result of all of these proteins , the patient ' s immune system ( the
you must not be given ninlaro : - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before or while you are being given this medicine . if any of these apply to you , tell your doctor immediately . before you are given the medicine , you should be observed for bleeding , persistent nausea , vomiting , diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash , liver or kidney problems . your doctor may decide to keep you under closer observation or change the dose . you should keep in mind that you have problems with your kidney during treatment , and it is recommended that you do not have any further tests . children and adolescents the use of 
ninlaro should only be prescribed to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take - the recommended dose is one tablet a day . - during the first week , - you will be given lenalidomide which is a medicine that will also help you to take dexamethasone , an anti - inflammatory medicine . when you first start taking the tablet , your doctor will tell you how long your treatment will last . after this time , the tablet will be split into two tablets , one in the morning and the other in the evening . it is recommended that you take both tablets at the same time and for at least the first 4 weeks of treatment . you will
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea vomiting diarrhoea feeling of numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or legs ( peripheral oedema ) skin rash ( itchy ) all over the body . rare side effects these may affect up to 1 in 1 , 000 people . if any of these side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or on the carton after exp . this medicine does not require any special temperature storage conditions . store below 30 . keep the capsule in the original carton in order to protect from light and moisture and do not throw away any medicines via wastewater or household waste . please return the medicine to your pharmacist if you notice any damage or signs of tampering to medicine packaging . these measures will help protect the environment .
what ninlaro contains each hard capsule ( hard capsule ) contains 2 . 3 mg of ixazomib . each capsule contains 3 . 4 mg / 0 . 5 mg nettle ' s own active substance . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , talc . capsule shell : gelatin , titanium dioxide , red iron oxide ( e172 ). printing ink : shellac , propylene glycol , potassium hydroxide , black iron oxide , indigo carmine , sunset yellow fcf , carmine biconvex , white , round shaped , with " n2 " printed in black ink on the cap and " rvt 2 ." 3 mg hard capsules : ix
do not use palforzia : - if you are allergic to peanuts or to arachis hypogaea . warnings and precautions talk to your doctor , pharmacist or nurse before or during the use of palforzaza . children and adolescents do not give this medicine to children below 4 months of age . it is not recommended for use in children under 17 years of age as it has not yet been studied in this age group . during treatment , some patients developed peanut allergy . peanut ( desensitisation ) has been reported in some children and teenagers who have not been exposed to the product . your doctor will monitor you carefully to ensure that you get the best results and reduce the risk of allergic reactions when you eat food allergies whilst you are being treated with palForzia and to monitor the occurrence of food allergies . these measures will help protect the environment .
do not take palforzia : - if you are allergic to peanut allergy . warnings and precautions talk to your doctor , pharmacist or nurse before taking palfor zia . if your asthma gets worse while you are taking it , tell your doctor straight away . you may have a problem swallowing , or you have long term problems with your digestive system such as a severe mast cell disorder . your doctor may order anaphylaxis , possibly lasting up to 60 days , during which you will not be able to take the medicine and your doctor will decide when to restart treatment . it is very important that you stop taking your pal forzia until the symptoms go away , and then get better . peanut allergy is a serious problem when eating peanut allergy and is not allowed to eat peanut allergy when eating . this is because it could increase the risk of allergic reactions when you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking palforzia . allergy - related allergic reactions ( anaphylaxis ) may occur rarely in the first 3 months of treatment . your doctor will discuss this with you and will explain the initial dose escalation and up - dosing phases with you , and with you or your caregivers . you and / or caregivers will periodically review and adjust the dose and duration of these treatment phases at the beginning of each individual dose . during and after your first dose , your doctor may decide to change your dose and may adjust your dose if necessary . it is very important that you and your caregiver read and understand the detailed instructions at the end of this leaflet ( see " how to take palfor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : - severe allergic reactions tell your doctor or nurse straight away if you get any of the following symptoms after stopping palforza , as these may be signs of the reaction : trouble breathing - throat tightness - feeling of fulness - trouble swallowing or speaking - changes in voice - dizziness / fainting rare : severe stomach cramps or pain - vomiting , diarrhoea , severe flushing or itching of the skin palfor zia may cause problems with the stomach and digestive system not known : frequency cannot be estimated from the available data - an increase in the levels of bilirubin , a substance present in the blood , which may be a sign of inflammation of the pancre
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . this medicine does not require any special storage conditions . reconstituted solution : do not store above 25 . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is pregelatinised maize starch . each sachet contains 0 . 5 milligrams ( mg ) for every 1 , 10 or 20 g of oral powder . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate paul forzia 100 mg powder for oral powder in capsules . this product is opened by a healthcare professional and is supplied in single - dose blisters , after which it is given by direct contact with the eye , recognizing and dispensed by the healthcare professional . after opening microscopic cellulose ( csf - 183 ), colloidal anhydrous silica , and magnesium strene ( e572 ) in beige oral powder and initial dose escalation ( see section 3
zerene belongs to a group of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and sleeping problems . they work in different ways to help you sleep . duration of treatment : if you have problems sleeping after you have finished your capsules , you should contact your doctor again .
do not take zerene - if you suffer from hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before or during the use of zeene sleep apnoea syndrome . you may experience short periods of short periods while you sleep , or while you are in bed , unless you have severe kidney or liver problems . - myasthenia gravis - very weak or tired muscles - severe breathing or chest problems - in children and adolescents ( under 18 years of age ), there is no data available on the safety and efficacy data in this age group . the safety data in patients younger than 18 years has not been studied . therefore , you should be careful until you are used to any effect the medicine might have
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg taken once a day , preferably at bedtime or before going to bed . do not take more than this recommended dose , as you may have difficulty falling asleep . try to take your daily dose at about the same time each day . it does not matter whether you are 65 years of age or older , but you should be able to take the same doses every night . people with mild to moderate liver problems : 65 and over the usual starting dose is 5 mg . if your doctor thinks you are the right dose for you , the capsule may become cloudy and you may be unable to swallow the capsule . in the unlikely event of an overdose you may become increasingly drowsy and may lead to a 
like all medicines , zerene can cause side effects , although not everybody gets them . if you notice any other changes in your health , tell your doctor immediately or go to the casualty department at your nearest hospital . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 uncommon : effect affects less than 1 patient in 1 , 000 rare : impact on 1 0 . 10 patients in 10, 000 not known ( frequency cannot be estimated from the available data ). all medicines may have side effects or may affect the way that your medicine works . in general , the following side effects have been reported as follows : drowsiness ; memory difficulties ; sensations like tingling , especially in the extremities . these side effects may occur
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are : capsule content : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide . capsule shell : gelatin , titanium dioxide [ e - 171 ], red iron oxide , yellow iron oxide [ fcf [ ], black iron oxide ( c - 1301 ), sodium leuryl salt ( type a ), silicon dioxide ( s - 13050 ). printing ink : shellac , lecithin , simethicone , white iron oxide in black ink on the cap and white ink for printing . what 
